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SCOPE OF THE THESIS 
Since the development of light microscopic analysis of oncological processes at the 
end of the last century, tumor grading proved to be a powerful diagnostic and 
predictive tool. The visual grading of tumors arose from years of practical experience 
and has its roots in the empirical analysis of tumor material. In grading, tumors are 
scored on tumor characteristics for which etiology is ill understood. It is purely 
descriptive. 
The multiparameter nature and empirical approach resulted in a low compliance 
of grading systems among pathologists. As discussed in the introduction of this thesis, 
the use of quantitative analysis of light microscopic images can help to grade tumors 
in a reproducible way. Moreover, quantitative analyses can shed light on biological 
tumor features such as heterogeneity and tumor development. Hence, quantitative 
tools serve a wide field of purposes. 
The aim of this thesis is to study the potential of quantitative analysis for the 
grading of urological tumors. Several karyometric features will be tested. A panel of 
known features is designed including morphometry, densitometric, and texture 
features, to enable comparison with earlier studies. 
The Introduction presents a review of the literature on the use of quantitative 
microscopy for urological tumors. 
In Chapter 1 two studies are presented. Cytomorphometric measurements of 
bladder wash material is conducted analyzing nuclear profile area. Several material 
processing methods are applied to study the influence of embedding and staining 
techniques on nuclear appearance. In the same Chapter a multivariate karyometric 
approach to grading of bladder cancer is presented. 
The reproducibility of interactive and semi-automatic karyometric analyses is 
commented upon in Chapter 2. An answer is sought to the question whether 
subjectivity, hampering visual tumor grading, also plays a role in karyometric studies 
and can be annulled in the latter technique. 
Whereas the first two Chapters deal with correlation with visual tumor grading, 
in Chapter 3 and Chapter 4 two studies are presented on the clinical application of 
karyometric analysis. In Chapter 3 nuclear features are studied in histological material 
of recurrent superficial bladder cancer for the prediction of tumor progression. A 
clinical approach to the quantitative follow up of superficial bladder cancer patients 
by karyometric analysis is described in Chapter 4. In order to use the developed 
g Scope of the Thesis 
system in routine settings, we studied the logistics of material sampling and reportage 
in this study as well. 
In the following two Chapters, Chapter 5 and 6, karyometric analysis is applied 
for the grading of renal cell carcinoma. Regarding extensive intra-tumor heterogeneity, 
different tumor areas are karyometricly analyzed to come to a quantitative description 
of variation in intra-tumor nuclear phenotype. 
The final study deals with karyometric analysis of prostate adenocarcinoma 
(Chapter 7). Multiple tumor loci within the prostate are analyzed and karyometric 
data are compared to tumor location and pathological tumor stage. The heterogeneity 
of karyometric features in different tumor locations is studied in different stages of 
local progression in organ-confined disease. 
Overall we aim at applying quantitative light microscopic techniques for the 
analysis of tumor biological characteristics in urologica! cancers. Special attention will 
be paid to the clinical applicability of the methods studied. 
Introduction 
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1 INTRODUCTION 
Prognosis in cancer depends on three factors, as stated by Mostofi': 'the response of 
the patient, the commissions and omissions of the physician, and the potentialities of the 
neoplasm'. In 1858, Virchow discussed the microscopic changes that take place in 
tumor cells and their nuclei. The morphological characteristics of tissue, cell, and 
nucleus proved to reflect malignant behavior and were used to evaluate neoplasms 
with several grading systems. Here, we will give an overview of the different grading 
systems used in uropathology in historic perspective. 
Low reproducibility and the inability to quantitate features by visual analysis 
render the grading systems less applicable. Digital images analysis of tissue and cell 
characteristics in microscopic images is used to study quantitatively the histologic and 
cytologic changes of neoplasms in an objective and reproducible way. In line with this 
we discuss the literature on quantitation of microscopic features of prostatic 
adenocarcinoma, transitional-cell carcinoma of the bladder, and renal-cell carcinoma 
and we dwell on the pitfalls of the use of quantitative light microscopy (QLM) in 
routine uropathology. 
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2 VISUAL GRADING OF UROLOGICAL TUMORS 
2.1 Grading of Prostate Adenocarcinoma 
The number of grading systems proposed for prostate adenocarcinoma outnumber 
those for renal and bladder tumors. The first grading system for prostate cancer was 
introduced by Broders in 19252 and was based on the estimated percentage glandular 
differentiation. Many grading systems followed but did not always show significant 
correlation with survival.345' On the other hand several grading systems showed low 
reproducibility or were not tested for it. Three histologic features correlated with 
prognosis; 1. tumor volume, 2. glandular differentiation, 3. nuclear anaplasia. The four 
most commonly applied grading systems for prostate adenocarcinoma will be 
discussed here. In table 1 an overview is given of the literature on grading of PCA. 
For each study is indicated whether glandular differentiation, nuclear anaplasia, or 
both are included. 
In 1975 Mostofi7 introduced a grading system based on the nuclear anaplasia 
and glandular differentiation of the tumor glands. Several studies used this system and 
found it useful in assessing tumor prognosis.6,9 However, other studies found the 
Mostofi grading system less useful to identify high risk patients.'0" 
Besides the Mostofi system the Gleason system'2 is widely used. The system 
graded prostate adenocarcinoma according to four tumor growth pattern 
characteristics: glandular size and shape, glandular differentiation, and invasion in 
stroma. The two most predominant patterns were recorded and their values added to 
arrive at a grade ranging from 2-9. Gleason found the reproducibility of the grading 
system about 80%, others found lower rates varying from 50 to 70%. " " э " Conflicting 
results were obtained when Gleason score was used to predict lymph node 
metastases.15'8'7 Fine needle biopsies graded according to the Gleason system showed 
significant variation when compared to the prostatectomy specimens."1920 
In 1982 Boeking and associates2' proposed a grading based on glandular 
differentiation and nuclear anaplasia. The part of the tumor with the highest grade 
determined tumor grade. The intraobserver reproducibility of one of the authors was 
assessed in this study and was found 87.5% for the entire system. The reproducibility 
for the cytology part (nuclear anaplasia) being lower than for the histology part 
(glandular differentiation). In other hands the Boeking grading system showed 75% 
agreement between three pathologists.9 
Brawn and associates (1982)"и objected to the grading systems of Mostofi and 
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Gleason and attempted to improve both the reproducibility and simplicity of grading 
by developing a low-power microscopic examination method, the M.D. Anderson 
Hospital (MDAH) system. Initially four grades were used, likewise Broders 
classification, based on the percentage of tumor that forms prostatic glands. Since 
grade 2 and 3 did not seem to have prognostic significance these two grades were 
combined. 
Schröder and associates (1985а,Ь,с)&и in collaboration with Mostofi attempted 
to replace "grade" by a single grading feature in order to simplify the Mostofi grading 
system. A retrospective study using multivariate analysis including several grading 
features showed that three independent features were of significance: architectural 
features, mitotic activity and nuclear anaplasia. The grading resulted in the subdivision 
of 5 classes of the patients with different outcome. 
De las Morenas and associates (1988)° compared four grading systems (Gleason, 
Mostofi, Boeking, MDAH) and concluded that the Boeking system was preferable 
considering both reproducibility and correlation with stage. The MDAH-system 
proved to have the best reproducibility, but lacked a good correlation with stage. 
Unfortunately in this study no correlation between grade and survival was 
investigated. Grading of tumor cells in transrectal biopsies showed even lower values 
for reproducibility in different studies varying from 50% to 60%.2 β ί 7 Μ 
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Table 1. Visual grading of histologic and cytologic prostate adenocarcinoma and prognosis in different 
studies' 
study Grading system 
glandular nuclear predictive material ref.nr. 
diff. anaplasia value 
Muir (1934) 
Kahler (1938) 
Pool and Thompson (1956) 
McNeal (1965) 
Gleason (1966) 
Utz and Farrow (1969) 
Esposti (1971) 
Esch et al (1972) 
Mostofi (1975) 
Epstein and Fatti (1976) 
Barzell et al (1977) 
Harada et al (1977) 
Kern (1978) 
Voeth et al (1978) 
Murphy and Whitmore (1979) 
Kramer et al (1980) 
Gaeta (1981) 
Boeking et al (1982) 
Brawn et al (1982) (MD Anderson) 
Catalona et al (1982) 
Boeking (1983) 
Lange and Narayan (1983) 
Garnett et al (1984) 
Schröder et al (1985c)(Mostofl/ 
Schröder) 
Mills and Fowler (1986) 
Layficld et al (1987) 
de las Morenas et al (1988) 
Gallee et al (1990) 
Mukamel et al (1990) 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
Gleason 
Gleason 
Mostofi 
Mostofi 
-
Gleason 
Gleason 
Gleason 
+ 
+ 
Gleason 
-
Gleason 
Gleason 
+ 
Gleason 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
Esposti / Gleason 
Gleason 
Mostofi 
Boeking 
MD Anderson 
Broders 
MD Anderson 
Mostofi 
Gleason 
Mostofi-Schöder 
MD Anderson 
high 
high 
high 
none 
high 
none 
high 
none 
high 
high 
none 
low 
low 
high 
low 
low 
none 
low 
high 
high 
low 
low 
low 
high 
high 
low 
high 
low 
low 
high 
low 
high 
high 
low 
low 
high 
high 
h 
h 
h 
h 
h 
h 
с 
h 
h 
h 
h 
h 
h 
h 
с 
h 
h 
h 
h 
h 
с 
с 
c/h 
с 
h 
c/h 
c/h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
h 
[5] 
[3] 
[6] 
[4] 
[12] 
[260] 
[188] 
[261] 
Π [262] 
[151 
[10] 
[8] 
[28] 
[14] 
[ ΐ η 
[16] 
[21] 
[ " ] 
[18] 
[26] 
[263] 
[20] 
[25] 
[264] 
[189] 
Ρ] 
[30] 
[265] 
h = histology; с = cytology 
*) A selection of different studies over the years is made This list is not covering all studies on the 
topic but to the authors opinion, the most important articles are cited. 
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In 1983, Grayhack and Assimos2" reviewed the literature on grading and staging of 
prostate adenocarcinoma and concluded that grading and staging should be familiar to 
both pathologist and urologist and that one should bear in mind that despite good 
correlation with prognosis, in some cases these observations may provide no 
prognostic information. 
Gallee and associates (1990)30 compared the prognostic accuracy of five grading 
systems (Broders, MDAH, Mostofi, Gleason, Mostofi-Schröder) and did find the 
Gleason system of minimum prognostic value. The Mostofi-Schröder system showed 
reasonable predictive power, however the Broders system was preferred considering 
the low interobserver variation compared to the Mostofi-Schröder system.31 
Concluding can be stated that grading of prostate adenocarcinoma showed to be 
in good correlation with survival to some extend for the individual grading systems. 
Both glandular differentiation and nuclear anaplasia do correlate with malignancy. 
Low reproducibility though, may render some grading systems less useful. For the 
grading of tumors by biopsies assessment of grade of the worst part of the material 
seemed to be most useful,*" albeit variation in grade compared with prostatectomy 
material is often high. 
2.2 Grading of Transitional Cell Tumors (TCC) 
Since Broders (1925)2 introduced a grading system for transitional cell carcinoma 
several changes in the grading system have been made. Early grading systems for TCC 
included the level of tumor infiltration. A correlation up to 80% of tumor grade with 
pathologic stage have been reported, the predictive value of grade within the same 
tumor stage however seems to be of less value.32 
Franksson (1950)33 described a grading system that combined depth of 
infiltration with cellular differentiation to classify the tumor in one of seven grades. 
Using this system 30-40% of the TCC of the bladder were graded benign" only 
recognizing malignancy when invasion of the lamina propria had occurred. In contrast 
with this, and likewise Broders,2 were the grading systems proposed by Friedman and 
Ash (1959)M and Marshall (1956)" These systems regarded a malignant behavior as 
soon as the urothelium deviated from the normal appearance. 
Dean and associates (1954)3" proposed a grading system using histological 
arrangement (papillary or nodular), extent of infiltration and tumor size in concert. 
They compared the original grading (Armed Forces Institute of Pathology) with their 
review grading. Again the so-called papilloma group showed discrepancies between 
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the two grading systems. Especially differentiating between high-grade papillomas and 
low-grade carcinomas. They concluded that both grading systems offered a good 
prognostic index of tumor behavior especially when the infiltration status was taken 
into account. 
Marshall (1956)35 found a higher 5-year survival (47%) rate in patients with high-
grade and low-stage tumors, than in patients with low-grade and high-stage cancer 
(15%), both treated surgically. They also discussed the diagnosis of papilloma and 
stated that, however the overall cure rates of the carcinoma population can be blurred 
by including papillomas in the grade-1 carcinoma group, this seemed to be warranted 
considering the more often occurrence of carcinoma in patients with papillomas. 
Mostofi (1956)37 divided 2678 patients in having non-infiltrating or infiltrating 
tumors of the bladder. The group of patients (332 cases) with non-infiltrating grade 1 
TCC showed a 5-year survival of 85%. The survival rate decreased to 20% for 
patients with infiltrating grade-3 tumors. 
In 1965 Bergkvist and associates38 described a grading system based on pattern 
of growth as well as cellular and nuclear morphology. Referring to "cellular deviation" 
when deviation of the cellular pattern from normal urothelium is to be described. 
They found a clear distinction between survival in the grade-0 and 1 group and in the 
grade-2 to 4 group. 
The most widely used system was presented by Mostofi in 1973 (WHO).3" The 
protocol contains three grades characterized by difference in anaplasia. Whether the 
simplicity_of this system adds to its objectivity was doubted.™41 
In 1979 Collan and associates42 stated that clinical staging would be more 
effective than histological grading, and they suggested that grading should be used to 
complement clinical staging. Ooms and associates (1983)43 investigated the 
reproducibility of the histological grading (WHO) of TCC. Disturbingly low inter and 
intra-individual consistency was found in a group of five pathologists. 
The grading according to the WHO standards resulted in an equal distribution 
of tumors over the three tumor grades.3*·3842 An increase with tumor stage however, 
was accompanied with a increase in tumor grade. 
Besides histological grading, urinary cytology enables assessment of the presence 
of TCC. Papanicolaou and Marshall (1945)44 described a technique of sampling cells 
from urinary specimen. Grading systems for urinary cytology are based on the cellular 
and nuclear features.38454*47·48'485051 However, screening for cancer appeared to be less 
successful and cytology seemed to be more useful in detecting recurrent tumors. 
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Whereas low-grade lesions have a detection rate of approximately 60%, high-grade 
lesions could be readily detected even with negative cystoscopic findings.*·"53 Studies 
on the reproducibility of cytological tumor grading, however, showed results similar to 
the low intraobserver and inter consistency found in histological grading.™ 
A specific type of TCC should be mentioned here. Melicow and Holowell 
(1952)" described the intraurothelial lesions in a macroscopically normal bladder. The 
cells of these so-called carcinomas in situ (CIS) were often of high-grade malignancy* 
and approximately fifty percent of the patients developed invasive carcinoma within 
five years of diagnosis.57™ Boon and associates (1986)" indicated the importance of 
cytology in these patients: histology may be false-negative due to denudation as a 
result of excessive exfoliation of the malignant CIS cells. 
In summary, the grading systems for TCC, though useful in several studies, 
clearly lack consistency. The staging of TCC was found to be of more predictive value 
than grade. Though differentiation of TCC as assessed in light microscopic analysis 
has prognostic value, a reproducible and consistent grading system is still lacking. 
2.3 Grading of Renal Cell Carcinoma (RCC) 
Since Grawitz™ described the RCC in 1884 and found its resemblance to the adrenal 
cortex, many studies discussed origin and prognosis of this tumor. The renal origin of 
the tumor was supposed by Stoerk in 1908.β1 In 1944, Melicow"* found that patients 
with granular cell renal tumors had a worse prognosis compared with the clear cell 
tumors. Other studies confirmed these findings.83"72 Several studies, however, were not 
able to find a correlation between cell type and malignant behavior.™0 An 
explanation can be the frequent presence of multiple cell types within one tumor. 
An other division of RCC is in papillary and non-papillary growing tumors. In a 
multiparameter analysis Delahunt and associates (1987)"5 did not find correlation 
between the histological pattern and prognosis. A clear correlation was not to be 
expected since only 77% of tumors showed heterogeneity in histological pattern. 
Geneticly, however, the two histological types were found to be distinct.'1 
Like prostate and bladder cancer tumor grade seemed to offer merely additional 
prognostic value to tumor stage and the presence of metastases.""'7,7'"*·74,7'"*90 
The grading of RCC can be divided into two kinds of systems. One, the general 
impression of the grade of anaplasia in the tumor material. The second kind of 
grading systems is based on cell nuclear characteristics. 
The present review will discuss the two kinds of systems separately. Nuclear 
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grading will be discussed in particular since image analysis so far is mainly concerned 
with nuclear features. Considering the large variability in the investigated patient 
populations and the many different grading systems used it is not warranted to 
compare the results of the different studies. Hence, the main problems and findings 
will be discussed in short for some of the studies. In general it might seem clear to the 
reader that with an increase of grade the prognosis worsens. 
The first grading for RCC on base of the cellular differentiation was proposed 
by Hand and Broders in 1932."7 They drew up four grades of malignancy and found a 
decrease in post-operative life expectancy with an increase of tumor malignancy. Their 
grading was based on histological as well as cytological features. In an even larger 
population Priestley (1939)" used this grading system and concluded that the system 
could be useful in assessing the general percentage of survivals, however, it contained 
insufficient evidence in itself on which to base an accurate prognosis in a single case. 
In the years following many authors proposed their own grading systems,"•"•" 
Mathisen and associates (1965)87 found grade to be one of the most important 
prognostic factors. In 1965 Arner and associates73 classified RCC in low and high 
degree of malignancy and an intermediate group. They found the degree of cellular 
differentiation the best predictor of prognosis. The grading system by Arner was used 
in several studies.71 Μ β β β 4 β 5 In 1978 Syrjänen and Hjelt™ found different survival rates 
for the different grades compared to the data in Arner's study73. The overall 5-year 
survival rates of both studies, however, did not differ. Syrjänen and Hjelt suggested 
that this was due to a lack of reproducibility of the grading as described by Arner and 
associates (1965).73 Selli and associates (1983)71 found lower tumor grades in patients 
without metastasis at time of diagnosis. The prognosis of the group of patients without 
metastasis in this study was again closely related to tumor grade. 
In 1971, Skinner and associates72 introduced a grading system that was based on 
nuclear features alone. In this study the grading was mainly based on the visual 
interpretation of the size of the nuclei present. Tumor grade increased with an 
increase in nuclear size. Also in contrast with the grading system of Hand and Broders 
(1932)" is that not the general impression determined grade, but that grade was 
defined by the area with highest grade, present in the tumor. In the same study they 
found a good correlation of nuclear tumor grade (based on anisonucleosis, chromatin 
pattern, nucleoli and mitotic figures) with survival. However, the majority of patients 
had tumors in the intermediate category, thus limiting the classification value of this 
system. 
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Fuhrman and associates (1982)" studied the significance of stage, grade, tumor 
size, and cell type and found nuclear grade the best predictor of distant metastasis. 
Grade-1 tumors only metastasized in 9% of the patients. They found best disease free 
survival in patients with oncocytomas compared to other cell types. Grade-2, 3, and 4 
did not show significant difference in metastasis rate. Correlation of grade with 
survival was significant. Grade-1 tumors showed highest survival rates, grade-2 and 3 
intermediate, and grade-4 cancer correlated with low survival. Although survival was 
similar for grade 2 and 3 tumors, these two grades were morphologically quite distinct. 
The authors did not discuss a reason but suggested study on larger populations. On 
the other hand there appeared to be large difference between stage 1 grade 1 and 
grade 2,3,4 tumors as far as malignancy was concerned. The frequency of metastases 
within the latter group was not different. This again reduces the stratification 
capabilities of the system by only differentiating high and low grade malignancies. 
The grading system according to Fuhrman and associates" was also used in a 
study by Medeiros and associates (1988).™ No significant difference was found in 
survival between grade 1 and 2 as opposed by the study of Fuhrman and associates 
(1982).M They concluded that nuclear grade rather than cell type may be important 
for determining prognosis. 
Summarizing the results of the different grading systems, the data suggest that 
nuclear grading rather then general histological classification is important for assessing 
prognosis in RCC. This is a promising result considering the simple grading criteria in 
the nuclear grading systems. Despite a higher reproducibility of the nuclear grading 
systems limited stratifying power is to be expected. 
3 QUANTITATIVE PATHOLOGY 
The changes associated with atypia or tumorous growth can often be perceived with 
microscopic grading techniques. Description of the changes led to the development of 
grading systems in which histologic, cellular, and nuclear features were described and 
related to malignant potential. However, as described in the proceeding part of this 
chapter the descriptive, often subjective nature of the grading systems resulted in low 
reproducibility.003'*'9*'97 As opposed to the subjectivity of visual assessment of tumor 
properties in light microscopy, quantitation of nuclear, cellular, and tissue architectural 
characteristics can provide a more accurate and reproducible description of 
microscopic images of tumor tissue. 
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Several techniques can be used for quantitation. Visual estimation of size based 
on references within the image and point-counting techniques are simple and 
inexpensive methods for quantitation of a small number of features. Flow cytometry 
(FCM) is a commonly used technique to assess DNA content of cell nuclei. Digital 
image analysis permits relatively inexpensive and fast multiparametric analysis of 
microscopic images. It can also provide extra information about the tumor cell not 
perceptible by the human eye, such as DNA content, high-order texture description, 
and specific shape irregularities. 
Quantitative light microscopy (QLM) includes histometry (description of tissue 
architecture) and cytometry and karyometry (measurement of cellular and nuclear 
characteristics respectively). Results of QLM in measuring DNA content cannot be 
interpreted without referring to the vast number of FCM studies on urologie tumors, 
so the results of FCM studies will be briefly reviewed as well. 
3.1 Quantitative Light Microscopy Features 
After digitization i.e., pixel-wise recording with a video camera and translation of grey 
values into 8-16 bits computer memory, the objects (cells and nuclei) can be detected 
(segmentation). The features used to describe the cellular (cytometry) and nuclear 
characteristics (karyometry) after segmentation consist of three groups (Figure 1): 1. 
morphometric, related to size and shape of objects; 2. static cytophotometric (SCM), 
related to staining intensity (in the case of Feulgen staining, refers to quantitation of 
nuclear DNA content); 3. and textural and contextural, related to chromatin pattern; 
and to cellular and nuclear arrangements, respectively. 
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Figure 4. Features studied in quantitative light microscopy. 
3.1.1 Morphometry 
Morphometric features describe size and shape of objects. Size can be measured 
relatively simply by counting the number of pixels occupied by the object and 
calibrating for magnification. Description of shape demands a more complicated 
mathematical approach. Before starting an entire panel of shape descriptors, one has 
to determine which shape needs to be described. Two commonly used shape 
descriptors are the elongation factor (FormEll) and the nuclear roundness factor 
(NRF). FormEll is the ratio of the minor to the major axis of the object. NRF is a 
ratio of area to perimeter (see Glossary). FormEll is 1 for a circle and smaller than 1 
for an ellipse. NRF decreases when an object deviates from a circle, as is the case in 
an ellipse as well as in an irregularly-shaped round object. Hence, NRF confuses 
roundness and circularity™ and so is less useful as a shape descriptor. Several authors 
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have described this problem and suggested other descriptors of shape, with the 
inevitable pitfalls of using them.9"™ 
3.1.2 Static Cytophotometry vs Flow cytometry 
A common method for quantitating DNA content in cell nuclei is flow 
cytometry,100·101·"*2·1'0 which uses nuclei in suspensions. In QLM, DNA content is 
measured in a similar way, except that the nuclei are on slides104,105 instead of in 
suspension - the technique is called static cyto(photo)metry (SCM).101·10" SCM can be 
applied on cytologic as well as histologic material; smears,,0T10eic,e.1,<'·11' cytospin 
préparations,112'113'114 or tumor imprints101,11''11"'117 obtained from either paraffin-
embedded archival material,11"'11"120 fresh-fixed tissue,101 or urine112 allow more accurate 
measurements of DNA content than sections of embedded histologic material.101,107 
DNA-content measurements in histologic sections, however, were applied in several 
studies121·122'123,124'129 and proved to be useful,110 and the substantial loss of cell 
populations by disaggregation of paraffin-embedded archival material113,11"·11"120 implies 
substantial benefit of SCM on histologic slides. 
For SCM, stoichiometric DNA staining according to Feulgen is generally 
used.101107,12* With Feulgen staining, the integrated optical density per nucleus 
correlates with DNA content. Fluorescent staining techniques, as with acridine orange 
and DAPI, can also be used to quantitate DNA content.120 
SCM and FCM seem to have different specificities; SCM recognizes structural 
alterations, whereas FCM describes minor DNA-content alterations in the tumor 
stem-line more exactly.108,10" Another important difference between FCM and SCM is 
the inability of nuclear visual selection in FCM. SCM offers the pathologist the 
opportunity to preview or review the measured objects: for each nucleus or cell, both 
data and microscopic images can be stored. That not only reduces noise in measuring 
specific objects, but can also assist the pathologist during screening of the slide. 
However, the number of cells needed for analysis is much higher in FCM than SCM 
and that favors SCM, especially in the analysis of histologic slides or when sampled 
material contains only few nuclei (e.g., prostatic fine needle aspirates, urinary cytology, 
and renal biopsies) (Table 2). 
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Table 2. Advantages and 
Characteristic 
disadvantages of flow cytometry (FCM) and staue cytopholometry (SCM). 
FCM SCM 
Application 
Material 
Tissue processing 
Amount of material 
needed 
Accuracy 
Sensitivity 
DNA content and other 
markers 
Cell suspension 
Elaborative (single cell 
suspensions) 
Large (approximately 10,000 
cells), no visual selection of 
the objects possible 
High, but debris and 
clustered nuclei might 
produce noise in histogram 
High for minor shifts in 
DNA content, but, cell 
populations with few cells 
might be missed 
DNA content and other 
markers 
Cytology and 
histology 
Simple, when routine 
material used 
Small FNA or biopsy 
material can be analyzed, 
visual interpretation still 
possible 
Coefficient of variation often 
higher, DNA index less 
accurate 
High, especially with few of 
aneuploid cells (selection) 
Reproducibility 
Sample preservation 
Costs 
Measuring time 
(per sample) 
High 
Hours because fluorescent 
staining techniques are used 
High 
Minutes 
High, but dependent on 
selection criteria and 
sampling size 
Months to years, when 
Fculgen staining is used 
(provided stored properly) 
Moderate 
Minutes to hours, dependent 
on computer used 
3.1.3 The DNA histogram 
SCM and FCM both result in a DNA histogram, a representation of the distribution 
of cells in the tissue in the different phases of the cell cycle. The cell cycle can be 
divided into three basic compartments: the G„G, phase or resting and non dividing 
phase; the S phase, or synthesis phase; and the G2M phase in which nuclear DNA is 
doubled and cell division takes place (mitosis). The peaks in a DNA histogram, 
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whether obtained with FCM or with SCM, reflect the distribution of cells in the 
compartments of the cell cycle. A normal dividing cell has a diploid (2c) peak (which 
represents the G0G, phase), a tetraploid (4c) peak (with the cells in the GjM phase 
having twice as much DNA as normal DNA), and some cells between these peaks (S 
phase). 
On the basis of a DNA histogram, tumors are divided into diploid and 
aneuploid. Diploidy indicates that the mean peak in the DNA histogram is around the 
2c region and the DNA pattern resembles the distribution of cells over the cell-cycle 
phases of a normal cell population. Aneuploidy, or nondiploidy, refers to DNA 
histograms with main peaks outside the 2c region or the presence of one or more 
abnormal peaks in DNA distribution. The definition of diploid and aneuploid, 
however, is not always clear. Besides the place of the main peak related to the 2c 
region, the percentages of cells in the different peaks also determine ploidy. A normal 
cell population is characterized by a diploid pattern with approximately 90% of cells 
in the 2c peak. 
Notwithstanding the definitions of ploidy patterns, a subset of DNA histograms 
will still be difficult to interpret visually.'03 Table 3 shows some algorithmic approaches 
to DNA histograms obtained with SCM. Tumor heterogeneity, i.e., several cell 
populations with different DNA content within the same tumor, resulting in very close 
or overlapping peaks in the DNA histogram may render histogram interpretation 
difficult. The finding of 'a large diploid' tumor may be caused by inadequate sampling 
of material: the aneuploid tumor cell populations are missed. 
Table 3. Interpretation of DNA histogram obtained by SCM or PCM 
aleorhitmic interpretation 
Boeking et al. ** 
Opferraann et al. **7 
Koss et al. , < 0 
visual interpretation 
Auer et al. *" 
Forsslund et a l . m 
abbrev. 
2cDI 
5cER 
DNA-MG 
PB 
PI 
DI 
CV 
diploid 
aneuploid 
D-rype 
T-type 
A-type 
name 
2c Deviation Index 
Sc Exceeding Rate 
DNA-malignancy grade 
Ploidy Balance 
Proliferation Index 
DNA Index 
Coefficient of 
Variation 
I 
II 
III 
IV 
diploid 
tetraploid 
aneuploid 
remarks 
deviation of 2c reference value 
cells > Sc minus 2c exponents 
1.757 · log(2cDI+l) 
difference euploid and aneuploid 
% of cells between peaks 
place of peak mean relative to 2c 
peak lightness 
(SD/mean). 
normal histogram, <0.S % more 
than Sc 
GjM > 15%, more 2% of cells 
over 5c 
abnormal G^l exceeding control 
with > 2xSD 
wide range of DNA values 
all cells lower (han 2.5c or 
inbetween 3.5c and 4.5c 
like D-type but with a higher 
tetraploid peak 
non D or Τ type 
To determine the normal 2c value in the DNA histogram, a reference is needed. As a 
reference for diploidy several cells are used: trout red blood cells,"4 fibroblasts, 
endothelial cells,"" lymphocytes,110127 and small phosphor particles in fluorescence 
techniques.178 Reference material should be stained at the same time as the test 
material, and differences in hydrolysis time related to differences in chromatin 
structure should be taken into account126 when Feulgen staining is used. 
SCM is useful for assessing DNA content, especially when only little cytologic 
material is available. The most accurate DNA values can be measured in smears or 
imprints. However, loss of cell populations can be a major problem when archival 
material is used. For correction of histograms obtained in histological material several 
mathematical approaches have been suggested.129 
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3.1.4 Texture and Contexture Analysis 
Various approaches to chromatin-pattern analysis have been extensively discussed 
elsewhere130,131,,32 and have been shown to be useful in the discrimination of the phases 
of the cell cycle133 and in quantitation of therapy effect.13* Features used are based on 
the co-occurrence matrix130,131,132 or on run-length distributions.13* 
Tissue architecture (context) in histologic slides (histometry) can be described 
with features like cell density or glandular size in prostatic cancer. Similar features are 
used for cell-group analysis in cytology.135 Furthermore, histometry is used to describe 
cyto architectonics e.g., the epithelium to stroma ratio,13" glandular cellularity in 
prostatic tissue,137 location and polarity of nuclei in stratified epithelium,138 and 
macroscopic analysis of the number of tumor-containing prostatic chips in material 
from transurethral resection.139 
3.2 Material Preparation Techniques 
Fixation 1 0 7 , 1 * 0 , 1 * 1 1 4 S ! and other processing techniques106,122,1*3 play an important role in 
both cytology and histology. Hence, standardization is obligatory. Routine formalin 
fixation for histology and ethanol-based fixation for cytology can be used. Whereas the 
use of sectioned material makes it necessary to measure slices of objects, smear or 
cytospin techniques require more complicated processing techniques and entail the 
loss of histologic context and the selection of some cell populations with enzymatic or 
mechanical disaggregation methods.113 Feulgen-Schiff staining, a relatively easy-to-use 
3-hour staining procedure is generally applied for karyometric analysis. 
For histometry,1*,,14','4e not only routine paraffin embedding, but also plastic 
embedding, resulting in more constant and thinner sections, can be used.122,143 The 
section thickness to use depends on the size of the objects to be measured.1*0,1*3,1**1*7 
To recalculate the data obtained from sectioned material to the three-dimensional 
domain, several stereologic approaches are а аі1аЬ1е.",,іг,,1*в,1*в,15° No study has yet 
compared the stereologic approaches, but results indicated that DNA histograms 
obtained in histologic sections lack the information provided by SCM-derived DNA 
histograms of cytologic material.10" 
3 J Quantitative Microscopy and Immunohistochemistiy 
Besides DNA analysis, cytophotometry can be applied to the quantitation of 
immunohistochemical stains. Antigens specifically detected by antibodies and 
visualization with labeled secondary reagents can be quantitated. Acquisition of 
images at different wavelengths allows measurement of antigen expression per 
nucleus'51 or as a percentage of tissue area.152,1U,,S* Specific staining techniques can be 
used for quantitation of markers of proliferation, such as: mitosis frequency,'55,158·'57 
bromodeoxyuridine,'58,158 and КІ67 labeling techniques.151 Chromosomal changes 
detected with recently developed interphase cytogenetic techniques can also be 
quantitated with image analysis techniques.1" 
3.4 Quantitative Microscopy Systems 
Developments in computer technology have enabled fast and precise measurements of 
objects in microscopic images. Several image-analysis systems have been developed 
according to the following principles. The image is recorded with a CCD videocamera 
and stored in computer memory (RAM) or on other storage media. After shading 
correction,155 the image is segmented to define objects of interest.181,1<B That can be 
done with manual contour drawing (interactive system) or with segmentation 
algorithms. In an interactive, or open, system, the operator selects the objects to 
measure. Automated systems use a decision scheme to identify objects of interest.183,1"4 
Reproducible measurements can be obtained with interactive systems.97'85'171 
Selection of objects to measure, however, can be a major reason for 
inconsistency.185,188,168,171,172 Ooms and associates188 introduced a histomorphometric 
selection technique for transitional cell cancer (TCC) based on specific parts of the 
tumor as assessed in the visual grading. They distinguished three cell groups in the 
tumor: superficial cells, deep cells, and cells with large nuclei. Although simple and 
reproducible, this technique is less applicable to nonpapillary growing tumors. 
Selective cytomorphometry, measuring nuclear profile area has correlated well with 
cytologic grading and has proved to provide more information than histomorphometry 
in TCC samples alone.'70 Considering the large variety of nuclei present in the tumor, 
it is mandatory to define clearly the parts of the tumor used for analysis. 
Histomorphometry performed in this way has shown a correlation between visual 
grading and QLM and has proved to be more predictive than measurements of 
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randomly selected nuclei.97 ,ββ"171 
Collan and associates'72 discussed the difference between diagnostic and 
investigative interactive-morphometry. They concluded that, as analyses in 
investigative morphometry are more standardized, the number of objects to be 
measured when morphometry is applied as a diagnostic tool is often much larger for 
the same level of accuracy. 
4 QUANTITATIVE MICROSCOPY AND UROLOGIC TUMORS 
4.1 Prostatic Adenocarcinoma (Table 4) 
4.1.1 Morphometry 
41.11 Nuclear size 
Since the first report of the correlation between nuclear size and tumor grade in 
prostatic adenocarcinoma (PCA),173 several studies have found correlation between 
the degree of differentiation and distributions of nuclear size in fine-needle aspirates 
(FNA)173 or biopsy material.137175,7e Unfortunately, no characteristic pattern of 
diagnostic criteria was found either for prostatic cancer cells in general or for the 
different tumor grade in cytologic material from the prostate.175 Blom and associates1™ 
empirically found a cutoff value of 34% for the coefficient of variation of nuclear size 
(V„.) measured in histologic slides to be of prognostic value in prostatectomy 
specimens. However, sensitivity and specificity of the test were only moderate. In 
general, the nuclear size and especially its coefficient of variation seem to increase 
with tumor grade. High values correlate with a decreased survival rate, but, many 
false-positive and false-negative results render this feature alone less useful for routine 
clinical use.177 
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Table 4. Morphometry, static cytophotometry, and (oon)texlure analysis in prostate adenocarcinoma. 
Morphometry 
Stöber and Schmidt'73 (1980) 
Diamond and associates'7* (1982) 
Spaander and associates'7* (1982) 
Tannenbaum and associates'" (1982) 
Boeking and associates178 (1984) 
Epstein and associates'" (1984) 
Paulsen and associates'85 (1986) 
Ambcrson and associates1*4 (1987) 
Clark and associates"7 (1987) 
Eichenberger and associates'79 (1987) 
Monier and associates'" (1988) 
Partin and associates"2 (1989) 
Hutchinson and associates'*3 (1989) 
Tritz and associates'*" (1989) 
Bibbo and associates204 (1990a) 
Blom and associates'7' (1990) 
Petein and associates'77 (1990) 
Schultz and associates'" (1990) 
material 
(nr) 
1.(71) 
1.(17) stage B2 
5.(6) 
1.(52) 
5.(52) 
1.(19) stage A2 
1.(105) 
5.(34) 
5.(26) st. A-B 
1.(20) 
1.(15) st. A-B 
1.(18) 
5.(26) stage A2 
5.(?) 
1.(30) 
1.(2 
3.(39) 
5.(35) 
parameter 
NRF 
P+ 
P+ 
pO 
pO 
p0 
P+ 
P+ 
go 
go 
go 
NPA 
g+ 
pO 
g+ 
g+ 
P+ 
g+ 
g+ 
g+ 
g+ 
g+ 
NuA 
P+ 
Npo Ell 
g+ 
P+ 
P+ 
P+ 
g+ 
g+ 
Densitometry 
grade 
Sprenger and associates"7 (1974) 
Zetterberg and associates"* (1976) 
Boeking and associates17* (1984) 
Seppelt and associates200 (1984) 
Seppelt and associates203 (1986) 
Ambcrson and associates1*4 (1987) 
Boeking and associates'09 (1988) 
Bibbo and associates'37 (1990b) 
Forsslund and Zetterberg20' (1990) 
Petein and associates'77 (1990) 
Peters and associates202 (1990) 
Stenkvist and associates'" (1990) 
Greene and associates'25 (1991) 
ploidy bad prognosis/high 
5.(32) 
5.(33) 
5.(52) 
5.(80) 
5.(85) 
5.(34) 
5.(52) 
1.(30) 
5.(213) 
3.(39) 
1.(44) st. A-B 
5.(22) 
1.(30) 
g-
g+ 
go 
g+ 
g+ 
po 
P+ 
g+ 
P+ 
g+ 
P+ 
go 
g+ 
hetero- aneuploidy 
increased with grade 
2cDI, 5cER, ploidy 
rate 
automated grading 
not possible 
DNA-malignancy 
grade 
aneuploidy (5cER) 
A-type (aneuploid) 
histogram 
aneuploidy 
aneuploidy 
peripheral zone non-
diploidy at lower 
volume 
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Table 4 (continued) 
(Con)texture analysis 
Boeking and associates175 (1984) 
Hutchinson and associates" (1989) 
Bibbo and associates204 (1990a) 
Bibbo and associates137 (1990b) 
Schultz and associates135 (1990) 
5.(52) 
5.(26) 
1.(15) 
1.(30) 
5.(35) 
ChP 
go 
g+ 
g+ 
g+ 
Contexture 
g+ 
g+ 
g+ 
g+ 
g+ 
(material 1. paraffin section correlation: 
2. smear/cytospin 
3. imprint 
4. plastic (GMA) section 
5. tine needle aspirates/biopsies 
6. urine 
p= prognosis 
g= tumor grade 
s= tumor stage 
d= DNA ploidy 
+ = pos; -=neg; 0=no correlation 
features: 
NRF = nuclear roundness fator 
ND = nuclear diameter 
NCr = nuclear crowding 
PND = proximate nuclear distance 
Fell = ellipticity by Fourier analysis 
N/C = nucleus/cytoplasm ratio 
NPA = nuclear profile area 
NuA = nucleolar profile area 
Npo = nuclear polymorphism 
Ell = formELL (minor/major axis) 
SDA = SD of nuclear profile area 
ChP = chromatin pattern 
M/V = mitotic index (Table 1) 
4.1.1.2. Nuclear shape 
In several studies, a correlation of interactively measured nuclear roundness factor 
(WRF)"""1*2 and other descriptors of nuclear shape17'"""1"3 was found with clinical 
prognosis. Other studies, however, could not confirm the findings."7·17"'18*"187 The 
reasons for the discrepancy, with NRF as a prognosticator for PCA, can be: 
- differences in material processing, 
- differences in analytic techniques, and 
- differences in patient and material selection. 
Although Epstein and associates1"0 found a correlation between the NRF 
measured in FNA and histologic material, studies using FNA material did find NRF a 
useful predictive tool in PCA,1081"7 in contradiction to studies on histological 
material.17*182 The use of paraffin-embedded material also did not result in uniform 
recognition of the predictive value of NRF.178,185 Section thickness, fixation, and 
staining techniques were not similar in different studies, but difference among them 
are unlikely to have caused the discrepancies. 
That the inconsistency of the value of the NRF was due to differences in 
measuring equipment is made less likely by the findings of Diamond and associates:178 
NRF was a useful prognosticator in A2, Bl, and B2 tumors, but in a larger population 
of patients with prostatic cancer, neither Diamond nor Blom and associates178 found it 
a useful prognosticator. Clark and associates187 suggested that NRF is of prognostic 
value only in low-stage PCA; other studies could not confirm this.17"'185 Although not 
all studies used similar algorithms for calculation of NRF, differences in equations 
were minor and do not account for the inconsistent value of NRF as a predictive tool 
in PCA. 
All studies that did find NRF useful as a predictive tool, however, contained 
fewer than 30 patients, whereas studied populations that found it of doubtful value 
were larger.17"1"6 A patient-selection bias might have caused the inconsistent findings 
concerning NRF and the prognosis of patients with PCA. 
Besides NRF, other descriptors of nuclear ellipticity have been tested175182 and 
found useful, but again, all the studies contained small patient groups. 
To summarize, karyometric shape analysis resulted in questionable predictive 
value of histologic material in PCA.17""1"1 In FNA material, nuclear shape was not 
useful in predicting outcome.182,188'183,184188 Multiparametric analysis on larger 
populations with known followup are necessary to investigate the microscopic features 
and their clinical applicability in prediction. 
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4.1.1.3 Other morphometrìc features in prostate adenocarcinoma 
Studies using visual grading have shown the importance of nucleolar features for 
tumor grading.1™"1"0 Larger nucleolar areas were found in histologic sections of patients 
who died of prostatic cancer after prostatectomy, than of patients who survived.191 
Among several nuclear and cellular features, such nucleolar features as size and 
frequency proved most potent in differentiating between cancer and noncancer in 
FNA biopsies.175 
4.1.2 Static Cytophotometry 
Before a review of the literature on SCM in PCA, it is useful to mention the 
conclusions obtained from studies of FCM. FCM studies have shown a correlation be-
tween DNA pattern, tumor malignancy, and differentiation in prostatic cancer.1*21" 
Not all studies confirm the usefulness of measuring DNA content in PCA. Bichel and 
associates1™ could not find increased aneuploidy in anaplasia and suggested that PCA 
was a more benign type of cancer. In a FCM study on archival material, Jones and 
associates1" concluded that aneuploidy was not required for progression. Ploidy did 
correlate with grade and stage but not with prognosis, in disaggregated archival 
material.1™ 
SCM studies revealed a correlation among DNA-histogram patterns, the 
presence of tumor,117 tumor grade,1™ tumor stage,1™ and survival.™,!№a2 Several studies 
used FNA material,1™111М0гоіда although different DNA-histogram interpretation 
techniques were used, all except one111 agree on the value of DNA measurement for 
clinical diagnosis. Forsslund and Zetterberg201 stated that, although SCM ploidy levels 
can accurately discriminate between low- and high-grade malignant tumors, the 
discrimination depends heavily on the method of measurement and analysis of the 
DNA histogram. 
The DNA malignancy grade (DNA-MG) is a quantitative, reproducible, and 
objective descriptor of the DNA histogram. Strong correlation with prognosis was 
found for the DNA-MG in cytologic archival PCA material.1™ An increase in DNA-
MG was correlated with a decrease in survival time.1™ 
Besides the DNA-MG, division of the DNA histogram obtained with SCM into 
diploid and aneuploid patterns correlated with prognosis.1*201 A striking example is 
the recent study of Forsslund and Zetterberg,201 who demonstrated the prognostic 
value of DNA-pattern description with SCM on FNA material. In two extreme patient 
groups, the optimal limits of the aneuploidy and diploidy definitions were chosen. 
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When the same criteria were used for DNA description in another population of 79 
PCA patients, all patients who died within 5 years of diagnosis had aneuploid DNA 
histograms, whereas patients who survived more than 5 years had diploid or tetraploid 
histograms. Greene and associates129 demonstrated the use of SCM in histologic 
sections, analyzing ploidy patterns in different foci of PCA. Nondiploidy occurred at 
lower tumor volume, especially in tumors originating in the peripheral zone, compared 
with tumors in the transition zone. 
To summarize, the results suggest that both FCM and SCM studies agree in 
showing aneuploid tumors to have more frequent anaplasia and more malignant 
behavior. However, the clinical application of SCM in the individual patient is not yet 
clear, partly because of the different definitions of diploidy and aneuploidy used. SCM 
with histologic slides proved useful in differentiating between PCA of different parts 
of the prostate. 
4.1.3 Texture and Contexture Analysis 
The grading according to the method of Mostofi, assessed by three pathologists, 
correlated well with the number of nuclei per slide, their distance from the glandular 
center, and nuclear chromatin patterns.'3"04 Petein and associates'" used nine 
chromatin texture characteristics of nuclei in tumor imprints and found three 
descriptors of chromatin clumps (short run-length, long run-length, and contrast) to be 
significantly different in cancers. 
Boeking and associates'79 showed that the irregularity of nuclear arrangement 
was significantly higher in material from transrectal biopsies of prostatic cancer than 
in normal prostatic tissue. Architectural features were also useful in discriminating 
between degrees of differentiation in aspirated material. 
It can be concluded that there is evidence that both chromatin pattern and 
tumor architecture can be quantitated and used in differentiating prostate tumor from 
nontumor material. Although (con)texture features alone will not be able to grade 
PCA, multiparametric studies have indicated a role of these features in the prediction 
of prognosis in PCA in conjunction with other QLM features. 
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4.2 Transitional Cell Carcinoma (Table 5) 
4.2.1 Morphometry 
4.2.1.1 Nuclear size 
Early studies on the use of QLM in transitional cell carcinoma (TCC) revealed a 
correlation between nuclear size and tumor grade.™6"* Nuclear size increased with 
tumor grade; but, in the same ploidy class, the more differentiated carcinoma cells 
showed nuclear enlargement.™" That is a remarkable finding and was explained by a 
decrease in chromatin concentration in the more differentiated carcinoma. Nuclear 
enlargement and anisokaryosis proved to be a reliable marker of tumor grades and 
prognosis in TCC cytologically2072™ and histologically.""·157'•"••«••"«» 
Koss and associates'1"'"17 presented several studies on the computer recognition 
of cells in urinary cytology. Their system included nuclear and cellular size 
characteristics and several texture features. Whereas the nucleus-to-cytoplasm (N/C) 
ratio was significantly higher in malignant cells, the nuclear profile area was not. They 
concluded that computer recognition of benign, malignant, or atypical cells provide 
important information and offers an approach to automation of cytology of the 
urinary sediment. Their method was found to be superior to visual grading.183 
Boon and associates507,20* could differentiate between grade-1 and 2 cells in 
voided urine by using the N/C ratio. Although good correlation with tumor grade was 
shown, the prognostic value of urinary morphometry has not yet been established. 
QLM was also used to analyze tumors in histologic sections.127·143'1·920·'2112'* Again, 
nuclear size correlated positively with tumor grade. Several studies combined FCM 
and morphometry and compared their prognostic value. The presence of very large 
nuclei, as measured with morphometry in a study by Blomjous and associates210 
correlated positively with high-grade lesions and could be used to predict tumor 
recurrence,210213 but, was inferior to DNA ploidy as a prognosticator.210 Considering 
the high correlation between DNA content and nuclear size, that is not surprising. 
Helander and Tribukait21* paid special attention to grade-2 tumors and found FCM 
and morphometry complementary for recognition of tumor grade. A third group of 
studies combining FCM and morphometry concluded that morphometric measures 
were the better predictors of outcome.157212 Lipponen and associates212 did not find the 
FCM DNA content to be a useful prognosticator and favored only morphometry next 
to clinical staging. The predictive value of nuclear morphometry was about similar in 
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these studies, despite the use of completely different selection criteria. It needs to be 
stated here that the different selection techniques whether based on nuclear size,1"21' 
location,1™ or context in cytology,'70'71 seemed to result in similarly good prediction of 
grade or outcome, this was not the case when a low number (50) of nuclei were 
measured at random.'7' 
Nielsen and associates214 estimated nuclear volume with point-counting and 
found that only one of 35 patients with mean nuclear volume below 300 μπι3 died of 
cancer within a 5-year followup, whereas 18 of 19 patients with a mean nuclear 
volume above 500 μΐη3 developed metastasis or died of cancer. The prognosis of 
patients with carcinoma in situ could not be predicted from nuclear volume. 
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Table S. Morphometry, static cytophotomctry, and (con)tezture analysis in transitional cell carcinoma. 
Morphometry 
Levi and associates** (1969) 
Fossa and Kaalhus*" (1976) 
Koss and associates"0"""*1 7 
Boon and associates207 (1981) 
Ooms and associates** (1982) 
Ooms and associates16· (1983) 
Helander and associates1*3 (1984) 
Helandcr and associates209 (1985) 
Montironi and associates127 (198S) 
de Sanctis and associates213 (1987) 
van der Poel and associates170 (1988) 
Helandcr and Tribukait218 (1988) 
Blomjous and associates210 (1989a) 
Blomjous and associates211 (1989b) 
Blomjous and associates188 (1990) 
Lipponen and associates212 (1990a) 
Lipponen and associates187 (1990b) 
de Prez and associates116 (1990) 
van der Poel and associates122 (1991) 
van der Poel and associates266 (1992) 
Borland and associates267 (1993) 
Densitometry 
Levi and associates209 (1969) 
Lederer and associates232 (1972) 
Fossa and associates2" (1975) 
Atkin and associates238 (1979) 
Hofsladler and associates115 (1980) 
Bjelkenkrantz and associates231 (1982) 
Montironi and associates'27 (1985) 
Bass and associates126 (1987) 
Koss and associates112 (1987) 
Stöckle and associates114 (1987) 
de Prez and associates116 (1990) 
van der Poel and associates122 (1991) 
(Con)texture analysis 
Fossa and Kaalhus20· (1976) 
Koss and associates103"2215·217 
Helander and associates143 (1984) 
de Prez and associates"6 (1990) 
van der Poel and associates122 (1991) 
material 
(nr) 
2.(36) 
2.(25) 
6.(15) 
6.(24) 
6.(41) 
1.(27) 
4.(27) 
4.(28) 
1.(35) 
1.(30) 
6.(50) 
2.(125) 
1.(80) 
1.(61) 
1.(61) 
1.(83) 
1.(30) 
3.(46) 
4.(28) 
1.(36) 
1.(14) 
2.(36) 
3.(21) 
2.(24) 
2.(61) 
3.(49) 
1.(3) 
1.(27) 
6.(67) 
6.(54) 
2.(46) 
3.(46) 
4.(28) 
2.(25) 
6.(15) 
4.(27) 
3.(46) 
4.(28) 
parameter 
NRF 
g+ 
g+ 
go 
ploidy 
g+ 
g+ 
g+ 
0 
P+ 
g+ 
g+ 
g+ 
g+ 
P+ 
g+ 
g+ 
ChP 
g+ 
g+ 
ND 
dO 
P+ 
P+ 
NPA N/C 
g+ 
go g+ 
g+ 
g+ g+ 
g+ 
g+ 
g+ 
g+ 
P+ 
g+ 
d+ 
P+ 
g+ 
g+/s+/p+ 
P+ 
g+ 
g+ 
g+ 
P+ 
P+ 
SDA NuA M/V 
g+ 
P+ P+ 
g+ g+ 
bad prognosis/highgrade 
triploid/hcxaploid 
not in individual case 
letraploidy/aneuploidy 
high 5cER 
high PI and PBI 
high 5cER and 2cDI 
Contexture 
g+ (nuclear volume densities) 
g+ (run length features) 
g+ (Markovian features) 
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4.2.1.2 Nuclear shape 
In contrast with its use in prostatic adenocarcinoma, few studies discuss the use of 
nuclear or cellular shape descriptors in TCC.1"42*"2"7 From cytologic criteria, we know 
that cells in lower-grade tumors have more elongated nuclei, whereas cells in high-
grade tumors contain nearly circular or irregularly-shaped nuclei. NRF1 7 ' is less 
suitable for discrimination between these two types of shape,™ but was found useful to 
differentiate tumor grade."7 The use of histologic material in which elongated nuclei 
could be cut in the tangential plane and appear more round might have caused the 
relatively low NRF values in low-grade tumors in the study cited.'27 As discussed 
earlier, NRF is not preferable as a descriptor of nuclear shape." Although other 
studies used nuclear shape in multiparametric analyses of urinary cytology"4219 or 
tumor imprints,1'" important prognostic value has never been found. 
4.2.1.3 Other morphometric features 
Besides nuclear size and its standard deviation, the N/C ratio20720" and the nucleolar-
to-nuclear ratio221 positively correlated with tumor grade. Cytoplasm is much more 
subject to degradation or deformation than the nucleus, especially in the Feulgen 
staining, so material processing technique will strongly influence cytomorphometric 
analysis. Hence, cytoplasmic morphometry is less suitable as a routine diagnostic 
procedure. Finally, a group of multiparametric studies needs attention. These studies 
described the recognition of atypical and benign cells in voided щ-in^»"*1«'·4·"».»'»·2'«1· 
imprints,11" or histologic material.122 The early findings of Koss and associates217 were 
elaborated on103 and resulted in the designation of the "selective mapping 
algorithm",184 in which "objects" were selected for higher-magnification analysis. Cells 
in the urinary sediment were scored as benign, atypical, suspicious, or malignant and 
that rendered the system useful for automated prescreening of slides. However, as 
Brugal and associates219 stated: "Although the rationale involved in the hierarchic 
decision tree would have to be based on statistical approaches, ... the lack of 
confidence in the cytologist's cell-to-cell reference classification would alter the 
meaning of any sophisticated cell-to-cell automated decision making based on it." 
Clinical application of such a system is not yet feasible, even apart from the costs of 
the fully automatic cell-scanning device. 
It can be concluded that nuclear size and its standard deviation, measured with 
either point-counting, cytomorphometry or histomorphometry showed significant 
increase with tumor grade and seemed to have prognostic value.211214 However, 
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absolute values for nuclear size differ between studies, because of preparation 
methods, and standardization of these methods is mandatory. Irregularity of nuclear 
shape was correlated with higher grade, but its predictive value has not been 
unequivocally proved. So far quantitative features seem to be most predictive of grade 
and outcome. Tumor stage and QLM, where investigated, showed less correlation. 
4.2.2 Static Cytophotometry 
Tribukait and associates m 2 2 0 2 2 2 found, in FCM studies, a correlation among DNA 
ploidy patterns, proliferative activity, histologic classification, and prognosis. Aneuploid 
tumors had a strong propensity to progress into invasive and metastatic lesions. 
Tumors with a tetraploid DNA pattern, however, appeared to have a more moderate 
potential for malignancy. Heterogeneity was often found in the primary tumor223224 and 
between the primary tumor and the metastasis.225 The use of FCM in the followup of 
patients seemed rewarding in several studies.1" гі°гг,-2гв-2Э° 
Like FCM, histologic visual classification correlated with the ploidy pattern as 
assessed by SCM in both sectioned material11512712" and smears.1"112вгз,2аз 
Determination of individual prognosis of low-malignancy tumors and differentiation of 
histologically borderline cases, however, were not possible.115 In general, it was 
concluded that low-grade TCC had diploid cell populations, whereas more malignant 
tumors showed tetraploid, polyploid, or triploid DNA patterns with increasing tumor 
grade.11'205234"5 
Studies correlating SCM data from TCC with prognosis are rare. Stöckle and 
associates235 found DNA ploidy, proliferation, and number of cells with more than 5c 
DNA content to correlate with survival in disaggregated, deparaffinized archival 
material. Urinary cytology material, well suitable for SCM DNA analysis, was also 
successfully used in several studies and proved to offer information in addition to that 
gained from visual interpretation.11112" 
Like FCM, SCM analysis revealed DNA heterogeneity in bladder tumors.209 ** 
More malignant behavior was found in tumors with a higher number of 
cellpopulations. 
To summarize, it is clear that aneuploid tumors behave more malignantly than 
diploid tumors. Some studies have shown that aneuploidy does not necessarily 
correlate with malignancy.225237 Furthermore, several descriptors of the DNA 
histogram indicate more heterogeneous cell population in more aggressive tumors. 
DNA content alone, however, has not been shown to be of clinical use in assessing 
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tumor prognosis. In contrast, data from individual followup and measurement of 
treatment response can be applied in combination with other karyometric or clinical 
features. In particular minimally invasive techniques, such as bladder washings can 
offer a rich harvest of cells suitable for SCM analysis. 
4.2.3 Texture and Contexture Analysis 
Fossa and Kaalhus20* found the less-differentiated tumors in a given ploidy group to 
have greater chromatin concentration. Several texture features changed significantly 
with grade'1"13 patterns were more coarse and irregular in high-grade tumors. 
However, the absence of uniformity in the features used, renders comparison of data 
difficult. 
4.3 RENAL CELL CARCINOMA (Table 6) 
4.3.1 Morphometry 
4.3.1.1 Nuclear size 
In contrast with prostatic adenocarcinoma and transitional-cell carcinoma, renal-cell 
carcinoma (RCC) comprises several different types of cells. Skinner and associates72 
differentiated clear-cell, granular-cell, and spindle-cell RCC. Metastatic rate" and 
survival72 were found to vary for the three types of tumor. However, heterogeneity of 
DNA or cell type often occurs in RCC, so morphometric approaches to nuclei, 
regardless of cell type or heterogeneity, might not yield an appropriate selection of 
nuclei.23"43 
The presence of large nuclei correlated with a poor prognosis in several 
studies.23"402*3 Nuclei from metastatic RCC were found to be larger and more 
polymorph than those in the primary tumor,248 but the patient groups studied were 
small. Although correlation of nuclear size and survival23"240 existed, Tosi and 
associates239 found 18% (n=17) false positives in stage-1 RCC. Moreover, Bibbo and 
associates240 did not find the increase in nuclear size significantly different between 
patients free of disease and those who died from the disease during an 11-year 
followup. Both studies used histologic material. Morphometry applied to tumor 
imprints242 confirmed the correlation of nuclear size and tumor grade. 
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Table 6. Morphometry, static cytophotometry, and (con) texture analysis in renal cell carcinoma. 
Morphometry 
Colvin and Dickerson23* (1978) 
Gilchrist and associates'43 (1984) 
Tosi and associates239 (1986) 
Bibbo and associates240 (1987) 
Murphy and associates241 (1990) 
vanden Houte and associates242 (1991) 
van der Poel and associates244 (1993) 
material 
(nr) 
1. 
1.(32) 
1.(67) 
1.(19) 
1.(20) 
3.(16) 
1.(121) 
parameter 
NRF 
pO 
p0/g+ 
pO 
NPA NuA Npo Ell Fell 
P+ 
p+ ('discordant nuclei') 
p+ ( > 32 μνη2 ) p+ 
p+/g+ p+/g+ 
p0 p+ 
g+ 
p+ p+ features describin 
heterogeneity 
Densitometry 
Bennington and associates123 (1983) 
Ljungberg and associates124 (1986a) 
Ljungberg and associates2*4 (1986b) 
Bibbo and associates240 (1987) 
Stöckle and associates233 (1990) 
vandenHoute and associates242 (1991) 
(Con)texture 
Bibbo and associates240 (1987) 
vanden Houte and associates2*2 (1991) 
Mulders and associates249 (submitted) 
ploidy bad prognosis/high grade 
1.(21) 
1.(55) 
P+ 
p+/s+/g+ 
1.+2.(32) p+ 
1.(19) 
2.(49) 
3.(16) 
1.(19) 
3.(16) 
1.(52) 
T,,„N„M 
pO/gO 
P+ 
g+ 
ChP 
g+ 
P+ 
0 
aneuploidy 
increased DNA content 
ancuploid metastasis 
hypertiploidy 
DNA-ploidy/heterogeneity 
Contexture 
PND NCr 
pO/gO p+/g+ 
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4.3.1.2 Nuclear shape 
Murphy and associates2" measured 25 shape descriptors, earlier found to be of 
possible predictive value in prostatic cancer,1" in 10 patients who survived 5 years 
after surgery for RCC and 10 patients who died of metastatic disease. Two individual 
shape descriptors (the relative mean of the 10 largest convexity values and median 
quartiles of ellipticity according to Fourier analysis) successfully classified the 
prognosis of 18 of the 20 patients. Ellipticity value increased as contours deviated 
from an ellipse. The more simple elongation factor with prognostic value, as 
established by others,2" was not measured in the study. Murphy and associates"1 
found higher ellipticity values in the nonsurvivor group; that suggested an unfavorable 
prognosis when the nuclear shapes deviated from elliptical, which does not necessarily 
contradict earlier findings by Bibbo and associates.240 They also found a strong 
correlation between nuclear elongation and survival. Murphy and associates241 could 
classify 16 of the 20 patients correctly, using NRF, its values being higher in the 
nonsurvivor group; which does not agree with Bibbo and associates.240 Bibbo found 
NRF to correlate with tumor grade, but not with survival.240 In addition, Tosi and 
associates238 found neither nuclear elongation nor NRF of prognostic value in stage 1 
RCC. The discrepancy in findings of the predictive value of nuclear shape in RCC 
resemble that in the findings in prostatic adenocarcinoma, and small patient groups 
most likely again caused the inconsistent findings. Moreover, the tremendous tumor 
heterogeneity, often present in RCC may have hampered analysis of the most 
significant area in the tumor. In a recent study we found several nuclear features to 
correlate with survival244 and progression.245 Among them nuclear shape, as described 
by features derived from the Freeman chain code of the nuclear contour. However, in 
a multivariate analysis features that described tumor heterogeneity showed strongest 
correlation with tumor behaviour among the karyometric features. For locally confined 
disease (Τ,^ΝοΜ,,) heterogeneity in chromatin pattern was even the strongest 
predictor of tumor progression.245 
To summarize the results of the morphometric studies on RCC, it is clear that 
both size and shape of tumor-cell nuclei provide some, but not much information 
about prognosis. Although Tosi and associates23* found a rather clear cutoff value for 
nuclear profile area between survivors and nonsurvivors, others merely found an 
increase in nuclear profile area with grade and tumor-related death.K"24e243 The 
reports on shape analysis are too ambiguous to support any consistent conclusion. 
Although nuclear size and shape were successfully used for visual grading of RCC, 
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studies on larger patient groups are needed to test the predictive value of quantitation 
of these features as prognosticators in RCC. Tumor heterogeneity will be an 
important phenomenon in further analyses. 
4.3.2 Static Cytophotometry 
FCM studies247 ** indicated the usefulness of tumor ploidy in the prediction of 
outcome, metastasis251252 and grade24'24925'252 of both fresh24'*51 and archival252 material 
of RCC. However, results are not always consistent, and the routine application of 
FCM in RCC is doubtful.253 
Like FCM data, SCM data on the predictive value of DNA content are not 
always unanimous.123124240 Several studies used SCM to examine sections123124254,255 and 
smear material23125' in RCC. 
Ljungberg and associates124 found diploid or near-diploid DNA histograms in 32 
of 33 patients still alive 10 years after surgery for RCC. All 22 patients who died 
within 4 years after surgery showed nondiploid DNA histograms. In some patients 
whose clinical course deviated from the expected in clinical grade and stage, survival 
correlated well with the SCM DNA pattern. However, the good correlation between 
DNA content of the primary tumor and survival was lost in metastasized RCC.254 
Patients with diploid and neardiploid metastases had significantly longer survival than 
those with aneuploid metastases, whereas the correlation between ploidy pattern of 
the primary tumor and survival was lost.240,254 
SCM of nonsectioned material is rare. Some correlation of survival with DNA 
content and of heterogeneity with tumor grade242 and survival233 was found, but, 
patient groups were small242 or seemed nonrepresentative.233 
To summarize the results of SCM studies in RCC, it can be concluded that RCC 
show a considerable DNA heterogeneity.233,255 In some studies, DNA content 
correlated well with tumor grade. Correlation with prognosis is less clear, perhaps 
because metastases occur in diploid and aneuploid tumors at similar frequency. 
However, aneuploid metastases show a more progressive growth; therefore, the DNA 
content of metastases correlated well with prognosis.225 The divergence in DNA-ploidy 
pattern between the primary tumor and the metastases is often high.225 
4.3.3 Texture and Contexture Analysis 
Bibbo and associates240 found an increase in nuclear crowding'35 in the tumors with 
worse prognosis. The proximate nuclear distance (see Glossary) did not have any 
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predictive value. Because nuclear crowding (see Glossary) yields a rough estimate of 
the N/C ratio, that means an increase in N/C ratio in more malignant tumors, as was 
found for transitional-cell carcinoma. Nuclear crowding can easily be incorporated into 
QLM routines and should certainly be tested on larger patient populations. 
5 CONCLUSIONS 
The use of QLM in urologie oncology has been explored in many ways. This paper 
has reviewed the application of QLM in the diagnosis of prostatic adenocarcinoma, 
transitional-cell carcinoma, and renal-cell carcinoma. 
Karyometric analysis of prostatic adenocarcinoma (PCA) revealed an increase in 
nuclear size and anisokaryosis in more malignant tumors. Nuclear shape analysis as a 
predictive tool is questionable for PCA and not yet suitable for routine application, in 
light of the inconsistency of findings which is most likely due to patient selection bias. 
DNA content in PCA, measured with either SCM or FCM showed more abnormal 
patterns in both histologic and FNA material in tumors with a worse prognosis, that 
seemed to be important merely from a research point of view, rather than as a tool 
for individual clinical tumor grading. Tissue-architecture descriptors, such as glandular 
size, shape, cellularity, and descriptors of chromatin pattern correlated well with 
routine visually assessed PCA tumor grade, in both histologic and cytologic material. 
Additional information obtained with these features could give insight into glandular 
formation as a measure of tumor differentiation as applied in the visual grading. 
Morphometry of transitional cell carcinoma (TCC) showed an increase in 
nuclear profile area with tumor grade, stage, and prognosis. The predictive value of 
shape descriptors in TCC was evaluated in few studies, but correlation with tumor 
grade has been reported. Absolute values of both nuclear size and shape features, 
however, vary among the different studies. SCM data agree with FCM findings: the 
presence of aneuploid populations correlated with high tumor grade and worse 
prognosis. Description of chromatin and nuclear patterns enabled assessment of tumor 
grade in TCC. However, correlation with prognosis has not yet been established. 
Because TCC show a recurrent and multifocal incidence, recurrent tumors and 
random biopsies of tissue next to the tumor need further investigation. Recent studies 
showed no prognostic value of nuclear size in carcinoma in situ of the bladder, but 
further study of the different growth patterns of TCC and its precursors, such as 
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atypia, is necessary. Moreover, longitudinal quantitative follow up be means of 
karyometric analysis of urine cytology enables comparison of subsequent samples and 
could be a tool for early detection of tumor recurrences or progression. 
Of the three urologie tumors discussed, the least literature is available on renal-
cell carcinoma and QLM. An increase in nuclear profile area correlated with a worse 
prognosis. Of the shape factors, descriptors of ellipticity seemed to be important. Not 
all studies agree on the value of DNA assessment in RCC regarding primary tumor 
heterogeneity; aneuploidy of tumor metastasis was found to be a more important 
prognostic factor. Of the textural features, nuclear crowding in the tumor was found 
to correlate with prognosis. 
DNA analysis suggested that aneuploidy correlates with greater malignancy in 
the three urologie tumors. Aneuploidy has been classified into tetraploidy, triploidy, 
and hyperdiploidy. Tetraploid cells appear in the more benign tumors with polyploid 
cells. Triploid populations seem to merge from the tetraploid cell lines because of loss 
of chromosomal material. Hyperdiploid aneuploidy, as a result of gain of 
chromosomal material of a diploid population, possibly predicts malignancy. Partly 
because of tumor heterogeneity, there are too many exceptions to the rule that: 
"diploidy equals non-malignant behavior" for DNA analysis alone to be a strong 
predictive factor. 
The reason for applying QLM, as discussed in the introduction, was the high 
inconsistency of visual tumor grading. The results of QLM studies so far, however, 
indicate that it is a more consistent, way of tumor grading. Three types of 
inconsistency, however, still exist: 
- The heterogeneity of tumors renders results largely dependent on the method of 
selection of material used for analysis. Multiple samples and clear selection criteria 
are necessary to overcome these problems. 
- Preparation method influences results and standardization of these techniques is 
mandatory. 
- Differences in methods of quantitation, consisting of differences in image recording 
and processing techniques and nonuniformity of features used warrant a clear 
description of apparatus and software. Because several studies agree on various 
characteristics as prognostic factors in urologie oncology, uniform prospective studies 
using these features are to be performed. 
So far, quantitative pathology is valuable in support of pathologic diagnosis only 
in research settings. As long as standardized automated fixation, embedding, staining, 
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selection, and measuring techniques are lacking, data obtained with various 
preparation methods will differ too much to support consistent conclusions. Therefore 
QLM is not yet applicable as a routine tool for tumor grading, but can play an 
important role in patient followup because of the possibility of qualitative comparison 
of subsequent samples, such as obtained in urinary cytology. 
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INTRODUCTION 
As discussed in the introduction of this thesis, quantitative analysis of light microscopic 
images provides objective grading. In this chapter our studies on the grading of 
transitional cell carcinoma of the bladder are discussed. Earlier studies on the 
quantitative grading of transitional cell carcinoma (TCC) showed good correlation 
between karyometric grading and histopathological interpretation by the pathologist.1 
In the present studies we evaluated the use of an image analysis system as used by 
Ooms et al. (1984)1 for quantitative grading of cytological and histological material of 
bladder cancer patients. Since preparation technique plays an important role in the 
nuclear appearance,* several embedding and staining methods were applied to the 
cytological material. The Kontron system, used in the study in the first part of this 
chapter enabled analysis of only a limited number of nuclei and nuclear features. We 
evaluated the role of nuclear profile area, analyzed interactively with the Kontron 
system for the grading of cytological material.3 Visual grading of tumors by 
microscopic images, however, is based on an extensive number of tissue, cellular, and 
cell nuclear characteristics.4 Hence, in a second study multiple nuclear features were 
studied for the grading of histological material from bladder cancer using the IBAS 
2000 system.5 Earlier studies' reported successful application of ultra-thin (2 μιτι) 
sections using plastic-embedding techniques. Since this type of section allows 
stereologica] analysis of data and estimation of three-dimensional structures, plastic 
embedding instead of routine paraffin embedding techniques were applied. 
The aims of the studies presented in this chapter are: 1. To evaluate the 
correlation of nuclear size in cytological material with histological tumor grade and 
nuclear size; 2. Comparison of different cytological preparatory techniques and their 
influence on nuclear size; 3. To investigate the karyometric features useful for the 
grading of bladder tumors in a multivariate analysis. In Chapter 3 and 4 we present 
clinically oriented studies on the applicability of karyometric grading. 
MATERIAL AND METHODS 
Material for anafysL· with MOP-video plan 
Cytological material 
The material for cytomorphometrical analysis consisted of 50 consecutive cases, 39 
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with the histological diagnosis of bladder tumor and 11 with inflammatory changes in 
biopsy material. Each bladder tumor was graded histologically according to the WHO 
system by one pathologist. Eleven were graded as grade 1, 16 as grade 2, and 12 as 
grade 3. In all patients the follow up was complete until 2 years after the bladder 
washings. Prior cytology and histology specimen were available. 
For the cytological preparations the bladder was rinsed with saline solution .T,M 
The bladder washings were obtained in the Westeinde Ziekenhuis in The Hague 
during 11 months (february-december 1986). After rinsing, the sample was centrifuged 
and the cell pellet resuspended in 50 cc fixation fluid prior to further processing. The 
fixative used was composed as follows: 70cc polyethylene glycol (MW 300), 800cc 
ethanol 96%, and ІЗОсс distilled water (Kryofix, Merck). After centrifuging, the 
sediment was divided into two parts. One was used to make the smears, the other to 
embed in paraffin. In this latter case the pellet was dehydrated in ethanol 96% twice, 
ethanol 100% twice, and toluene once. Paraffin was added to the dehydrated pellet 
and after it was solidified the test tube was broken, and sections were prepared from 
the block. Because not every sample contained enough material, not all techniques 
could be used in all cases. One smear and section were stained according to the 
Papanicolaou method (Pap-smear and Pap-section) and according to the Feulgen 
method (Feulgen smear and Feulgen section). 
MOP video plan system (KONTRON) 
The cytomorphometrical measurements were made by means of a microscope 
connected with a computer MOP-video plan (KONTRON, Zeiss, Germany). This 
system consisted of a digitizer tablet and a video screen. The microscopic image was 
recorded and projected on the screen. With a mouse the nuclei were manually 
delineated. 50 nuclei per slide were delineated and measured for nuclear profile area 
by the computer. This procedure took approximately 15 minutes per slide. All 
measurements were done by one person not knowing the histological grading. 
Selection of nuclei for cytomorphometry 
To select nuclei for analysis a stepwise screening of the slide was conducted prior to 
analysis. The slide to be measured was first screened to obtain a general impression 
and to circle the diagnostic cell groupings of the highest grade (for definition see 
further text). Only those nuclei that were clearly visible and not covered by other 
nuclei were taken for measurement. Three types of diagnostic cell groups were 
distinguished. Type 1: Large, dense papillary groups with smooth outlines. Type 2: 
smaller, less dense papillary groups with regular outlines. Type 3: Loose clusters of a 
few clearly malignant cells. In addition, the washings contained sheets with ragged 
borders and lacking a papillary architecture. 
Grade-1 tumor cells are almost exclusively in type-1 cell groupings (Figure 1). 
The nuclei are often pale in the Papanicolaou staining with nuclear clearing and there 
is a prominent nuclear envelope and clumping of some chromatin. The nuclei are 
predominantly oval or round some with abnormal shapes. The nuclei measured were 
those situated at the edges of the papillary groups. The nuclei in the center are not 
clearly visible, thus do not fit for analysis. Oval as well as round nuclei were 
measured. 
Grade-2 tumor cells are arranged in predominantly type-2 cell groupings and 
sometimes as single cells or in type-1 groupings (Figure 2). Cases with inflammatory 
reaction in histological evaluation have mainly isolated cells and sheets. The cells are 
often cylindrical with an eccentric nucleus. In this group there are no papillary groups 
so nuclei in single cells are measured. 
Grade-3 tumor cells area mainly arranged as single cells and in addition in type-
3 cell groupings (Figure 3). Cells selected for measurement have a very high N/C 
ratio1011 and the chromatin pattern shows uneven distribution. Often there is more 
than one, irregularly shaped large nucleolus. 
Prior to measurement the slide was screened and the diagnostic cell groupings of 
the highest malignancy grade were circled for analysis. Thus, in case of an admixture 
of type-1 cell groupings (with no or little atypia) and type-3 cell groupings (clearly 
malignant), the latter were circled for measurement. In case of type-2 and type-3 cell 
groupings, the scattered single clearly malignant cells in the neighborhood of the cell 
groupings were also analyzed. 
For comparison with histomorphometric evaluation, histological material was 
obtained by transurethral resection after the bladder washing. Each biopsy was 
processed into 3 blocks. The grade-1 tumors were all noninvasive in contrast to the 
grade-3 tumors. In each case the most abnormal parts of the tumor tissue were 
selected for histomorphometric analysis. In these areas, three types of cells were 
measured: A, deep cells (DEEP); cells near the stroma, B, superficial cells 
(SUPERF); cells near the bladder lumen, C, cells with large nuclei (LARGE).1 In 
each tumor 240 nuclei were analyzed. Cells with evident pyknotic nuclei or 
degenerating cells were not selected for this study. 
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Figure 1. Example of camera-lucida drawing of grade-1 tumor cells. 
Figure 2. Example of camera-lucida drawing of grade-2 tumor cells. 
Figure 3. Example of camera-lucida drawing of grade-3 tumor cells. 
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Material for analysis on IBAS 2000 system 
Histological material 
The material consisted of 28 cases with the diagnosis of bladder tumor, graded 
histologically according to the WHO system. The histological material was obtained by 
transurethral resection and consisted of 9 grade-1, 11 grade-2, and 8 grade-3 tumors. 
The material was fixed in an on ethanol-based coagulant fixative as described above 
(Kryofix, Merck). 
Plastic embedding 
The histological material for analysis with the IBAS 2000 system was embedded in 
plastic. Glycolmethacrylate (GMA) was used in the process of the plastic embedding 
(Table 1). 
Tabic 1. Mixtures used for plastic-embedding 
Solution A 
Glycol methacrylate with 200 ppm hydroquinon 
(Merck-Schuchardt; no. 800588) 90 cc 
2-butoxyethanol (Merck-Schuchardt; no. 801SS4) 10 cc. 
Benzoylperoxide (with 20% Н
г
О) (Baker; no. 9104) 0.5 g% 
Solution В 
Polyethylene glycol 400 (Fluka AG; no. 39430) 15 parts 
Ν,Ν-dimethylanilinc (Fluka AG; no. 39455) 1 part 
The histologic material was incubated in solution A (Table 1) overnight. After 
incubation solution A was decanted. For polymerization, a mixture of 30 parts of 
solution A and 1 part of solution В (Table 1) was prepared, stirred by hand for two 
minutes, and added to the material. The histologic material was placed into a plastic 
moulder. A block holder was placed on top and covered with paraffin. The plastic was 
ready for cutting after two hours, 2 μτη sections were made from the blocks. The 
GMA sections stretched well on a water-bath surface. At lOOx magnification the 
sharp-depth was 1-2 μπι and approached the section thickness. This enhanced the 
chromatin-pattern analysis and nuclear-boundary tracing 
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IBAS 2000 system 
Image analysis was performed by means of a microscope (Axioplan, Zeiss) connected 
with a dual processor system, the IBAS 2000 (Image Basis Analysis System) of 
Kontron Electronics, Zeiss.12·41 The marked areas were scanned with a lOOx oil 
immersion objective by a Hitachi CCTV video camera. At this magnification the pixel 
size was 0.012 μπι2. 
The menu based image processing available in the system was used for 
morphometrical and densitometrical measurements. The SCRAPE function was used 
to delete objects less than 10 μπι2, since our earlier study3 revealed no smaller 
urothelial-cell nuclei. 
For the IBAS 2000 there was no commercially available software to calculate the 
texture features. For this reason software was developed in TURBO-Pascal to 
recognize the nuclei and perform the Markovian texture analysis on an IBM 
compatible PC. The selection of tumor areas in the histological sections was done by 
the pathologist in the haematoxylin-azofloxin-stained (HA) sections. The section 
adjacent to the HA-section was Feulgen stained and used for the karyometric analysis. 
In each Feulgen-stained slide 200 nuclei in the marked areas were measured. This 
took about 20 minutes per side. Since the IBAS 2000 system segments nuclei semi-
automatically we did not apply the selection criteria developed by Ooms et al. (1983)1 
and used in the comparison with cytomorphometry earlier in this chapter. Randomly 
selected nuclei from all two (DEEP, SUPERF) tumor areas were taken. 
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Table 2. Morpbomelric and deositometiic kaiyometiy features tested in multivariate analysis. 
Morphometry 
1. real mean AREA (rAREA) = mean (mAREA) - (10/3) 
2. PERIMETER 
3. percentage of nuclei over 60 pm* AREA: 60 ym 2ER 
4. percentage of nuclei over 90 μπι2 AREA: 90 Mm2ER 
5. FormELL: minor axis 
major axis 
6. FormPE: 4π · AREA 
PERIMETER» 
Features derived from the smoothed Freeman difference chain (SFDC) code67. 
7. MAC (Mean Absolute Curvature) 
1 N 
= Σ K(n) 
C * N i=l 
( С = number of contour pixels 
N = width of smoothing operator 
K(n) = SFD-value in n) 
8. MBEN (Max. Bending Energy) (= difference between highest and lowest value in SFDC-
code) 
9. PASS (= number of passes through threshold in SFDC-code) 
Densitometry 
10. optical density (OD): mean optical density of pixels in nuclear boundary: -log10 
TRANSMISSION 
11. integrated optical density (IOD): OD * AREA 
12. 2c Deviation Index (2cDI):17 
1 N 
2cDI= - Σ (q-2c) 
N i = l 
13. Sc Exceeding Rate (ScER): the percentage of nuclei per slide over 5c DNA value minus the 
exponents of 2c.'7 
14. mean total DNA content: mlDNA: see equation (5) 
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Nuclear features and stereology 
The computer calculated the features AREA, PERIMETER, FormELL, and FormPE 
(Table 2) of the Feulgen-stained slides. The mean value of AREA was not equal to 
the mean value of the maximum profile area. 
The necessary corrections were well understood, and described in the 
literature." Two corrections were used in the current study. First, as an acceptance 
criterium for nuclei AREA was required to be larger than 10 дт 2 . This value is 
referred to as cut-off area (у
еіЯЫ1). Small caps of nuclei therefore were not taken into 
account. For plane sections of spherical nuclei an exact correction term could be 
calculated, 
< W > = <AREA> - (szMJ3), (1) 
where the angular brackets denote mean values of all nuclei (cf. Eqs. (12.6) and 
(12.12) of Kok'4). Eq. (1) was used to correct for the effect of the lower detection 
limit on the profile size. Second, one should correct for the fact that not all nuclei 
were cut centrally (for example for spherical nuclei the centre of the sphere was often 
not contained in the cut section, especially for thin cut sections). Hence, the nuclear 
profile ί,,,,η,. obtained was not the largest possible profile area, that could have been 
obtained by cutting somewhat higher or lower. In the model situation that all nuclei 
are spherical the correction formulas can easily be worked out. 
Stereology 
From the measured morphometrical features for the two-dimensional microscopical 
image the mean value of an essentially three-dimensional feature of the nuclei, 
namely the volume, could be derived. Matsushita" used the following approach to this 
problem. From the mean profile area <spronte> he calculated a length, d„ = 
2 /(<5
ргоЯ
.>/тг), referred to d„ as mean nuclear profile feature, then used Eq. (5.25) of 
Weibel13, D„ = (4djn) - t to define a 'mean nuclear diameter' £>„. As a last step he 
used V„ = (тг£>
п
3)/6) to calculate what he referred to as nuclear volume V„. In the 
present study the feature t was used, in such a way that 2/ is the section thickness. 
In the current approach a slightly different and more precise formula (cf. Eqs. 
(31.3) and (50.3) of Kok'4) was used, <V
nMln,> = <height> * <simM,>, which holds 
for spheres and ellipsoids of revolution. For spherical nuclei one can derive for very 
thin (i.e., f=0) sections (Ref. 25, Eq. (72.2)) 
<?> 
<
 ткШт
> = я 2 (2) 
<r> 
For more general nuclear shapes we therefore shall use the formula 
< ΐ
ρ η Λ
„ > 
< ^ > = ^ (3) 
<W> 
which reduced to (2) for spherical nuclei, indeed. For sections with 2f > 0 correction 
factors could be calculated for both the numerator and the denominator of the right-
hand side of (2). The following first-order correction was used, by which the right-
hand side of (3) must be multiplied2*, so that 
mtVOLUME = я* χ ( 1 ) ( 1 + ) (4) 
<w*> 
Densitometry 
Densitometrie features consisted of optical density (OD) and integrated optical density 
(IOD) (see Table 2). Nuclei of white blood cells, almost always present in the slide, 
were used as reference using the correction factor of 1.19 for the difference in 
hydrolysis properties." The algorithms according to Boeking et al.17 were used to 
describe the DNA histogram. The 5c Exceeding Rate (5cER) and the 2c Deviation 
Index are defined in Table 2. 
To calculate the mean total DNA content per nucleus we used the formula 
<j/ > 
mtDNA = — * IOD. (5) 
The average volume of the cut slice of the nucleus in lowest-order approximation in 
the section-thickness parameter l clearly is <
 Ля
> = 2i<jpromt>. From (5) one finds 
to next order of approximation in t (using Eqs. (72.9-10) a simple form for mtDNA: 
4/(я(я)*) <(w>*> + ' 
mtDNA = * IOD. (6) 
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Texture analysis 
Texture features used were thoroughly discussed in earlier studies.'1'"" Five 
(described in Table 3) of the 21 Markovian features were used in biological images, 
because a high correlation has been found among subsets of these 21 features.'*'" 
The Markovian analysis describes 'stickiness' of pixels with the same grey value. The 
equations use grey-value classes for comparison to neighboring pixels. To fill these 
classes a method of requantization was necessary: histogram equalization (H) and 
linear requantization (L) were used in this study for each nucleus.™ HI described the 
entropy of the co-occurrence matrix. The coarser the chromatin pattern, the greater 
will be the tendency of the high values to concentrate near the diagonal of the matrix, 
this was expressed by H3. H2 expressed the tendency of the neighboring pixels to be 
of different grey value. H4 and H5 measured whether the grey values were evenly 
distributed over the image.™ LI and L5 were the same features in the linear 
requantization method. 
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Table 3. Texture features. 
selected Markovian texture features: 
16. H l + L l ENTROPY: 
R R 
HI = Σ Σ -t(i,j) log t(i,j) for t(i,j) о 0 
i = l j = l 
17. H2+L2 DIFFERENCE MOMENT: 
R R 
H2 = Σ Σ (i-j)» t(ij) 
i = l j = l 
18. H3+L3 INVERSE DIFFERENCE MOMENT: 
R R t(i,j) 
H3 = Σ Σ 
i = l j = l l + (i-j)» 
19. H4+L4 ROTATION MOMENT: 
R R 
H 4 = Σ Σ ((M)» + (j-t)»)t(i,j) 
i = l j = l 
with t = R/2 for histogram equalization 
and t = f
mrlom(a for linear requantization 
20. H5+L5 INVERSE ROTATION MOMENT: 
R R t(i,j) 
H5 = Σ Σ 
i = l j = l l + (i-t)î + (j-t)2 
R (here R = 8) denotes the number of grey values in the rcquantized grey value scale, and t(i,j) 
the frequency of transition of a grey value i followed by value j . fmiMmM| denotes the median grey 
value of nuclei of normal specimens.20,51 
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Feulgen staining 
For both studies similar reagents were applied for staining according to Feulgen". For 
the Feulgen staining of the plastic sections, we tested different times for hydrolysis in 
5 N and 1 N HCl and the Schiffs reagent (Merck 9033). Eventually, the staining 
method according to Feulgen was selected with hydrolysis in 5 N HCL for 30 minutes 
at 2ГС and 30 minutes in Schiffs reagent at the same temperature. The Feulgen-
stained sections were used for the IBAS measurements, for visual grading and 
marking of parts of the tumor to be measured, haematoxylin-azofloxin-stained sections 
were prepared. The marks were copied on the parallel Feulgen-stained sections. 
Statistical analysis cytomorphometric analysis 
In the univariate cytomorphometrical analysis we choose as a tool for data reduction 
the calculation of the natural logarithm of the mean nuclear area value in order to 
obtain a variance stabilizing transformation. The regression of grade (low versus high) 
on the histomorphometrical and cytomorphometrical variables to be considered was 
studied using a probit model.21 To test whether the cytomorphometric variables can be 
used in addition to histomorphometric variables in the grading of the bladder tumors 
and vice versa, the likelihood ratio test was applied.22 The test was used to investigate 
whether one cytopreparatory technique is sufficient. The statistical package GLIM21 
was used to perform the analysis for the probit model. 
In the multiparameter analysis using the IBAS 2000 system discriminant analysis 
for karyometric tumor grading was performed using the SPSS/PC+ statistical package. 
For entry in the discriminant analysis the method according to Wilks was used.18 The 
F to enter is set one. 
RESULTS CYTOMORPHOMETRIC ANALYSIS 
In Table 4 the mean nuclear profile area values of the variables (log mean values and 
SD values) of the four groups are shown. For the bladder carcinomas, all 
histomorphometric and cytomorphometric values increase with increasing grade. 
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Table 4. The mean logarithmic nuclear profile area for histomorphomctiy and cytomorphometry. 
histological findings 
Grade 1 Grade 2 Grade 3 Inflammation 
л mean ± SD π mean ± SD л mean ± SD л mean ± SD 
Histomorphometry 
LARGE 
DEEP 
SUPERF 
Cytomorphometry 
Pap smear 
Feulgen smear 
Pap section 
Feulgen sect. 
11 
11 
11 
11 
9 
11 
10 
4.209±0.243 
3.767+0.214 
3.492±0.238 
3.584±0.549 
3.441 ±0.380 
3.424±0.260 
3.118±0.363 
16 
16 
16 
16 
12 
15 
16 
4.635±0.208 
4.184±0.348 
3.840±0.248 
4.123±0.379 
3.985±0.356 
3.758±0.220 
3.646±0.282 
12 
12 
12 
12 
9 
11 
11 
4.807+0.196 
4.332+0.318 
4.048±0.375 
4.781+0.371 
4.440±0.463 
4.020±0.229 
3.948±0.284 
0 
0 
0 
10 
1 
10 
9 
3.390+0.157 
3.045 
3.428±0.142 
3.056±0.198 
The values for the group of inflammatory cases are in the same range as for the 
grade-1 carcinomas, The significance of the differences between the four groups (see 
Table 4) was tested univariably, with the two-sided Mest. Between the group of 
inflammatory changes and grade-1 carcinomas, none of the variables proved to be 
significantly different. The results of the Mest for the bladder carcinomas are shown in 
Table 5. For all variables, there were significant differences between grade-1 and 
grade-2 tumors, and between low grade (grade 1 and 2) and high grade (grade 3). 
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Tabic 5. Mest results. 
inflammation-1 Grade Grade Grade 
1-2 2-3 1+2-3 
Histomorphometry 
LARGE < < < 
DEEP < = < 
SUPERF < = < 
Cytomorphometry 
Pap smear = < < < 
Feulgen smear < < < 
Pap section = < < < 
Feulgen section = < < < 
P<0.05 
= : not significantly different for mean nuclear profile area 
< : value of first group significantly smaller value than second group 
In Table 6 the correlation matrix for the variables of the bladder carcinomas is shown. 
Grade 
LARGE 
DEEP 
SUPERF 
Pap 
smear 
Feulgen 
smear 
Pap 
section 
Feulgen 
section 
1.0000 
(0) 
0.7265 
(39) 
0.5803 
(39) 
0.6022 
(39) 
0.7430 
(39) 
0.7156 
(30) 
0.7123 
(37) 
0.7211 
(37) 
Grade 
1.0000 
(0) 
0.8461 
(39) 
0.7398 
(39) 
0.6126 
(39) 
0.6262 
(30) 
0.6858 
(37) 
0.6312 
(37) 
LARGE 
1.0000 
(0) 
0.7831 
(39) 
0.3874 
(39) 
0.3429 
(30) 
0.6191 
(37) 
0.4726 
(37) 
DEEP 
1.0000 
(0) 
0.5059 
(39) 
0.5434 
(30) 
0.6722 
(37) 
0.5372 
(37) 
SUPERF 
1.0000 
(0) 
0.8942 
(30) 
0.7582 
(37) 
0.8721 
(37) 
Pap 
smear 
1.0000 
(0) 
0.7465 
(28) 
0.8763 
(28) 
Feulgen 
smear 
1.0000 
(0) 
0.8023 
(35) 
Pap 
section 
AJÍ coefficients are positive and, with the exception of the coefficient between Deep 
and Feulgen smear, significantly differing from zero (cr=5%, two-sided test). Within 
the histomorphometric variables, LARGE correlates best with grade, and of the 
cytomorphometric variables Pap smear is best. In Figure 4 these two are plotted for. 
all cases to obtain an impression whether classification is feasible. 
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Figure 4. Scaiiergram of the log mean nuclear area values for LARGE with Pap smear 
and LARGE by histological tumor grade. 
The results of the probit model for testing significance of additional information of 
cytomorphometry with regard to histomorphometry are given in Table 7. 
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Table 7. Significance of the additional information provided by cytomorphometry for the 
histomorphometry and vice versa. 
Additional information Significance 
in: 
Pap smear 
LARGE/DEEP/SUPERF 
Pap section 
LARGE/DEEP/SUPERF 
Feulgen smear 
LARGE/DEEP/SUPERF 
Feulgen section 
LARGE/DEEP/SUPERF 
All cytomorphometry 
LARGE/DEEP/SUPERF 
with regard to: 
LARGE/DEEP/SUPERF 
Pap smear 
LARGE/DEEP/SUPERF 
Pap section 
LARGE/DEEP/SUPERF 
Feulgen smear 
LARGE/DEEP/SUPERF 
Feulgen section 
LARGE/DEEP/SUPERF 
All cytomorphometry 
39 
30 
37 
37 
26 
P<0.001 
n.s. 
P<0.05 
n.s. 
n.s. 
n.s. 
P<0.01 
n.s. 
n.s. 
n.s. 
Three of the four cytomorphometric methods add to the value of the 
histomorphometric data, but the converse is not true. Note that for the calculation of 
the significance of the additional information of all four cytological methods combined 
we had only 26 cases available. This may be the reason that the Ρ value was over 
0.05. In addition we found that combining cytological methods did not improve results. 
Using one out of the methods is sufficient and as the Pap smear is the easiest we 
preferred this method. The probability for high grade, using histomorphometry, can be 
estimated using the formula: 
Φ (-17 + 4 χ LARGE - 2 χ DEEP + 1 χ SUPERF) 
(see error curve of standard normal distribution). The probability for high grade using 
Pap smear can be estimated using the formula: 
Φ (-10 + 2 χ Pap smear). 
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RESULTS HISTOMORPHOMETRIC ANALYSIS 
Table 8 shows the F values for the different features. No significant difference (P > 
0.05) between grade 1 and 2 was calculated for the following features: 60 дігіТЖ, 90 
μπιΈΚ, FormPE, 5cER, and all texture features, except LI. For all morphometric 
and densitometric features there was a significant difference (P < 0.05) between low-
grade (grade-1 and 2) and high-grade (grade-3) tumors. 
Morphometry 
Of the morphometrical features the 60 дт 'ЕЯ showed the highest F value (Table 8). 
The stereological calculated mtVOLUME had the second highest F value in the 
morphometry group. The form features FormELL and FormPE had lowest F values. 
The 60 iimsER and the 90 μπιΈΚ showed the highest mean values in grade-3 tumors. 
There was no significant difference for both features between grade 1 and 2 (P > 
0.20). Both features, though, showed significant difference between low-grade (grade 1 
and 2) and high-grade (grade 3) tumors (P < 0.001). 
Densitometry 
The 2cDI (Table 2) showed the highest F value of the densitometric features (Table 
8). Figures 5-7 show the DNA histograms of examples of three different tumor grades. 
The difference between 5cER of grade 1 and 2 is not significant (P > 0.05). The 
values of 5cER differed significantly (P < 0.001) between low-grade (grade 1 and 2) 
and high-grade (grade 3) tumors (Figure 8). The grade-2 tumors could be divided into 
a group of 5 cases (55%) without nuclei with a DNA value exceeding 5c, and a group 
of cases (45%) with such nuclei. Except for significant differences in 2cDI and 5cER 
(P = 0.025), there were no significant differences between these two groups for the 
other features {P > 0.15). 
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Table 8. F-valucs for the features in the discriminant analysis. The features marked with an astern are 
used in the canonical classification rule in the discriminant analysis. 
Morphometry: 
1. rAREA 
2. mtVOLUME 
3. PERIM 
4. 6 0 μ ι η ^ · 
5. W ^ m ï R 
6. FormELL* 
7. FormPE 
Densitometry: 
8. OD 
9. IOD* 
10. 2cDI* 
11. 5cER 
12. mtDNA 
Texture analysis: 
13. hi 
14. h2 
15. h3 
16. h4 
17. h5 
18. 11* 
19.12 
20.13 
21. 14· 
22. 15· 
F-value 
19.597 
20.095 
14.447 
24.368 
12.775 
8.757 
4.277 
3.609 
43.103 
56.005 
33.627 
42.386 
4.110 
3.212 
1.898 
1.329 
1.216 
2.466 
0.871 
-
6.495 
0.926 
Wilks Lambda 
0.38945 
0.38350 
0.46388 
0.33905 
0.49456 
0.58804 
0.74507 
0.77597 
0.22481 
0.27099 
0.18247 
0.22774 
0.75254 
0.79558 
0.86821 
0.90392 
0.91132 
0.83521 
0.93483 
-
0.65808 
0.93103 
• features used in the classification function of the discriminant analysis 
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Figure 5. DNA-histogram Figure 6. DNA-histogram Figure 7. DNA-histogram 
of grade-1 tumor of grade-2 tumor of grade-3 tumor 
Texture analysis 
The texture features showed predominantly low F values (Table 8). The data 
indicated that higher tumor grades contain nuclei with more coarse and irregular 
chromatin patterns, but significance of these features in tumor grading is low. 
Figure 8. Distribution of 5cER 
by tumor grade. Notice 
the two groups in the 
grade-2 tumors. 
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Multiparameter analysis 
The discriminant analysis resulted in a class model containing seven features (out of 
the 22) listed in Table 9. 
Table 9. Standardized canonical discriminant function coefficients. The order of the features is the step 
order in which the seven features are entered in the discriminant analysis. 
Step 
1. 2cDI 
2.L4 
3. IOD 
4. FormELL 
5. LI 
6. 60 μπι= 
7. L5 
ER 
Function 1 
1.1568 
-0.8079 
0.0437 
0.6024 
0.5434 
1.1568 
0.4929 
Function 2 
-0.2443 
0.3957 
1.2197 
0.0881 
0.7314 
-0.2443 
-0.6048 
Table 10. Classification results. 
Actual grade 
I 
11 
III 
η 
9 
11 
8 
predicted grade 
I II 
7 
1 
0 
2 
10 
0 
III 
0 
0 
8 
Of the seven features, two were morphometry, two were densitometric, and three 
were texture features. Note that the form feature FormELL was included. This model 
gave a classification rule of 89% correct classifications over three grades. All grade-3 
tumors were correctly classified (Table 10). The final F value was 17.7194 (degrees of 
freedom 6 and 46). The scattergram of the two canonical discriminant functions is 
shown in Figure 9. We were aware that to use a stepwise discriminant analysis with 28 
cases and 22 variables to select from was not ideal. However, as the final F value 
turned out to be highly significant {P < 0.001) the danger of overinformation23 seems 
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to be limited in this case. To evaluate the value of the stereologically calculated 
features mtVOLUME and mtDNA, a discriminant analysis was performed using only 
these two features. The classification rule obtained this way predicted 79% of the 
cases correctly. 
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DISCUSSION 
The importance of grading of bladder carcinoma is well recognized, however, the 
question is how to achieve reproducible results. Colpaert et al. (1987)24 showed that 
with precise criteria, with examination of the total section systematically field by field, 
and with recording of a grading per field, a better interobserver consistency can be 
obtained. The simple criterion of nuclear size (sometimes within a small 
subpopulation of cells) appeared to be a very important factor in the subjective 
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grading of histological sections. This is in accordance with our quantitative findings: of 
the histomorphometric features the value for LARGE nuclei correlated best with 
Grade. It seems that architectural features of the tumor, such as arrangement of 
nuclei, coalescence of papillae and whorl formation occurring increasingly in higher 
grades are closely correlated with nuclear size.24 As for the histological grading of 
cancer of the larynx, there is also a close correlation between tumor architecture and 
nuclear size variation, both less well correlating with degree of keratinization.2* It is 
likely that nuclear size as a discriminator is exclusively of value in tumors with a 
morphological continuum. Transitional cell carcinomas do represent a kind of tumor 
with increasing cell abnormalities in the higher grades.4,101,M 
In this chapter we, present our work on the grading of transitional cell 
carcinoma. First we use a single nuclear feature, nuclear size, and found it useful for 
tumor grading of bladder washings. An important point in the evaluation of a low 
number of cells (50) per slide is the selection of material (see Chapter 2). The 
selection criteria proposed in the cytomorphometrical grading of bladder washings use 
the cellular arrangements rather than the cellular atypia for selection of nuclei. 
Hence, the low number of measured nuclei is compensated by selection of the most 
representative tumor cells. In Chapter 2 the selection criteria will be tested on 
reproducibility and compared to at random analysis. 
Nuclear size was of use in histomorphometric analysis as earlier shown by Ooms 
et al. (1983).1 All three histomorphometric features used in the present study are 
closely correlated. LARGE (the best discriminator of grade) correlates best with the 
cytomorphometric features Pap smear (Table 6). The value for this feature depends 
on the presence of a subpopulation of cells with large nuclei in the histological 
sample. The fact that highly malignant cells with large nuclei are easily dislodge, thus 
are likely to appear in cytological material27'2" probably accounts for this correlation. 
For analysis of cytological material, bladder washings were preferred over voided 
urine. In particular in grade-1 and grade-2 carcinomas the harvest of tumor cells is 
much larger in washings. Moreover, material in bladder washings is more suitable for 
morphometry than voided urine.e,,3M2 The values for the four types of cytopreparatory 
techniques showed interesting patterns. The mean nuclear profile area values for the 
Papanicolaou stained cells (both in the smears and the cell blocks) were larger than 
those for the Feulgen-stained cells. It seems unlikely that staining itself changes the 
size of the nuclei." We first postulated that the impression of the nuclear contour in 
the two staining procedures is different, influencing the manual measurements. Later 
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study, however,33 revealed influence of Feulgen staining on nuclear size. It was 
postulated that the HCl step in the Feulgen-staining procedure resulted in nuclear 
shrinkage. The nuclear area in the smear preparations (both for the Papanicolaou and 
for the Feulgen staining) was generally larger when compared with those for the cell 
blocks. In the Papanicolaou staining, this was the case in 21 of the 27 low-grade 
carcinomas, whilst for all 12 high-grade carcinomas the values in the smears were 
higher. For the nine grade-1 carcinoma cases in which both smears and cell blocks 
were available the mean size difference was 8%, for the 13 grade-2 carcinomas 14%, 
and for the 9% grade-3 carcinomas 24%. Similar trends were observed for the 
Feulgen preparations. Physical factors such as nuclear rigidity are evidently important 
here and seem to vary between the different tumor grades.29 Another reason for this 
difference in nuclear area can be found in the Holmes' effect. Holmes described a 
correlation between the mean nuclear area and the thickness of the section.34 The fact 
that not all nuclei are cut in the equatorial plane results in a smaller mean nuclear 
profile area of the sections, compared to the smears. This was also found by Helander 
et al. (1985)." In the final evaluation, all four cytopreparatory techniques were equally 
good for morphometric grading. Since the Papanicolaou smear technique is the 
simplest of the four, it would be most suitable for morphometric grading of nuclear 
size. Considering the predictive value of nuclear DNA content and the vast 
development of image analysis equipment capable of analysis of multiple nuclear 
features, Feulgen stained cytological slides are a could alternative. 
Statistical evaluation showed that histomorphometry does not add to 
cytomorphometry, but cytomorphometry does add to histomorphometry. No doubt, 
this can be explained by the selective exfoliation of discriminating cells with large 
nuclei. Since it is easier to obtain material for cytology, this is a highly rewarding 
result. 
Patients A and В are interesting cases (see Figure 4). Both were examples of 
patients with recurrent low-grade superficial papillary carcinomas developing high 
grade carcinoma in situ during follow up.35,3" The follow up results of these two 
patients are shown in Table 11. 
Table 11. Case history of patients A and В (sec Figure 4). 
Patient A Patient В 
1980 Histology Grade-1 tumor 
1981 Histology Grade-1 tumor Histology Grade-1 tumor 
1982 - Histology Grade-1 tumor 
1983 Histology Grade-1 tumor Histology Grade-1 tumor 
1984 Histology Grade-1 tumor 
1985 - Histology Grade-21 umor 
1986 Cyiomorphometry of Cytomorphomeiry of 
bladder washing; bladder washing; 
Histology Grade-1 tumor Histology Grade-2 tumor 
1987 Histology Grade-3 + CIS Histology Grade-3 + CIS 
1988 - Histology Grade-3 invasive tumor 
In both patients, the cytological bladder washing of 1986 reflected the true status of 
the urothelium, that is of a high grade carcinoma. In that year, easily visible 
concurrent low-grade papillary tumors were removed for histologic diagnosis, giving 
the false impression that the prognosis was relatively favorable. The grade-3 
carcinomas in situ, (exfoliating the highly malignant cells in the bladder washings) 
were not diagnosed initially due to the fact that they were not macroscopically 
identified during cystoscopy. A year later, in 1987, the foci of high-grade carcinoma in 
situ were detected, probably partly due to the fact that at this moment there were no 
concurrent papillary carcinomas catching the attention of the cystoscopist. The 
cystectomy specimen (1988) of patient В contained extensive high-grade carcinoma in 
situ and many foci of invasive carcinoma. Patient A is receiving (1987) radiation 
therapy with little success. In none of the other low-grade papillary carcinoma cases 
was this reversal to high-grade cytology (due to carcinoma in situ) observed during 
follow up of 1-2 years. 
Before focusing on the second study in this chapter we want to shed some light 
on the development of image analysis systems and their influence on the approaches 
of our studies. In the study discussed so far we applied an interactive morphometry 
system. Nuclei were selected based on criteria, the contour was manually drawn on 
the digitizer tablet, and calculation of a limited number of nuclear features was 
performed. Although inexpensive and easy to use, such a system clearly has its 
disadvantages. First, due to the manual selection and outlining of the objects only a 
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limited number of nuclei can be analyzed. Moreover, the system did not allow 
densitometric measurements or more complicated analyses of nuclear shape. Since 
these features play an important role in tumor grading4,2"36 inclusion of these 
characteristics may enhance the value of the quantitative grading system. Therefore, 
for the second study in this chapter we applied the IBAS 2000 system.12 This system 
enables analysis of multiple nuclear features including densitometric analysis. 
Most quantitative studies using histological material, reported in the literature 
were performed on paraffin sections. We applied plastic sections for the following 
reasons: (1) a smaller section thickness3337, resulting in less overlapping nuclei37; (2) a 
more stable processing method, especially the absence of nuclear shrinkage in the 
hydrolysis step of the Feulgen staining.333 
The disadvantage of using histologic sections is that slices of nuclei are 
measured, instead of entire nuclei. Nielsen and associates3* estimated nuclear volume 
with point-counting and found only one of 35 patients with mean nuclear volume 
below 300 μιτι3 dying of cancer within a 5-year follow up, whereas 18 of 19 patients 
with a mean nuclear volume above 500 дш3 developed metastasis or died of cancer. 
The interactive nature of stereologic methods and the limited number of assessable 
nuclear features, however, overshadow advantages as simplicity and low costs of this 
technique. To recalculate the mean nuclear volume a stereologic approach was 
applied in the present study. Knowing the mean nuclear volume a calculation of mean 
nuclear DNA content could be made, considering the IOD in the formula. The two 
features (mtVOLUME, mtDNA) calculated this way classified 79% of the cases 
according to the tumor grade. In the multivariate approach, however, F values for the 
stereologic features (mtVOLUME, mtDNA) did not differ from the karyometric 
features (AREA, IOD) from which they were derived, moreover, the stereologic 
features did not provide additional information for the quantitative grading. 
Besides this stereologic approach the three feature groups, morphometric, 
densitometric, and texture features were used in concert to predict tumor grade. 
Morphometry of the nuclear profile in sections and cytologic smears proved to be 
effective.321,38 In the present study the morphometric features AREA, PERIMETER, 
60μm2ER, 90 /im2ER, FormELL, and FormPE were used. In the first study of this 
chapter we found a correlation value of AREA with grade of 0.7211 in Feulgen-
stained paraffin sections.3 This is close to the value found in the present study: 0.728. 
Helander37 showed that nuclear areas exceeding 90 μπι2 in GMA-embedded bladder-
carcinoma material were almost exclusively found in grade-3 tumors: the percentages 
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of 39 and 9 for respectively 60 μπιΈΙΙ and 90 дш2ЕЯ of grade-3 bladder tumors were 
remarkably well in agreement with the percentages of 40 and 10 found in the present 
study. These two features could very well discriminate between low-grade (grade 1 
and 2) and high-grade tumors (grade 3). 
Densitometry was used in the present study to assess the DNA content of the 
tumor cell nuclei, which proved an important feature for prognosis.17,353"3 Nuclear 
DNA content was also valuable for the grading of bladder cancer by flow 
cytometry.35"*"* Flow cytometry is basically a cytologic method requiring separation 
of the cells and for above-mentioned reasons we preferred to perform cytophotometry 
on sections. The DNA histogram obtained by densitometry can be interpreted visually 
or using algorithms. We chose the algorithms 5cER and 2cDI according to Boeking.'7 
The 2cDI has the highest F value of all features (Table 8), indicating that it is the 
most powerful discriminator of tumor grade. In 45% of the grade-2 tumors we found 
nuclei with more than 5c DNA content (suggesting aneuploidy). All grade-3 tumors 
had DNA-histograms that were grouped as aneuploid (based on 5cER). It should be 
noted that those aneuploid tumors with, for instance, a triploid subpopulation and 
lacking nuclei with DNA content over 5c, were not identified as aneuploid using 5c 
DNA as threshold. This theoretical problem seems to have no implications for 
bladder carcinoma, as can be deducted from the fact that Farsund and coworkers45 
found 43% of grade-2 tumors aneuploid by flow cytometry, compared to 45% in the 
current study. Tribukait and coworkers could also divide grade-2 tumors on base of 
proliferation and ploidy.43 It is of importance to note that in the present study 
aneuploid grade-2 tumors were not identical to grade-3 tumors: their 5cERs and 2cDI 
values were significantly lower, so it seems ill advised to group these together. 
Texture analysis can provide features describing chromatin patterns.'92047'50 The 
Markovian features'* were used in the present study and proved to be useful features 
of chromatin patterns in histologic and cytologic material.20,49,50 In this context it is of 
interest that of the seven features selected in the discriminant analysis three were 
texture features. Hence texture features did contain useful information on tumor 
grade not provided by the other features. 
Finally, with the classification rule in which seven morphometry, densitometry, 
and texture features are used in concert, 89% of the cases are classified correctly. All 
grade-3 tumors are classified according to the visual grading. 
To obtain a clinical relevant grading system using the proposed quantitative 
analysis a continuous scale should be used. In that case each tumor can be assigned a 
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quantitative grading score. In this way the oversimplification of dividing bladder 
carcinomas into three grades can be avoided. Whether this really results in a useful 
clinical method remains to be tested on a large clinical material. The subdivision of 
the visually determined grade-2 tumors could validate the additional use of image 
analysis to pathologists grading. 
We have to bear in mind, however, that the results of the presented studies are 
obtained in research laboratory settings where material processing and analysis was 
optimally controlled can not be extrapolated to clinical situations. Futher analysis of 
the grading techniques evaluated in this chapter with special regard to clinical 
applicability, therefore is mandatory. 
In this chapter we presented the studies on the correlation between karyometric 
features and visual tumor grading in cytological and histological material of 
transitional cell carcinoma. Nuclear profile area measured in bladder wash cytology 
showed a good correlation with histological tumor grade and aided in two cases in the 
earlier diagnosis of high-grade carcinomas. Multivariate analysis of karyometric 
features in histological material revealed additional information of the karyometric 
features to visual grading. To analyze the predictive value of quantitative grading 
systems karyometric data should be correlated to clinical follow up rather than to 
visual tumor grade. Hence, in Chapter 3 and 4 clinically oriented studies will be 
discussed. 
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ABSTRACT 
The reproducibility of karyometric analysis of transitional cell carcinoma is studied. 
The inter-individual consistency is low (r=0.55 p=0.0005) when 50 nuclei were chosen 
at random. When we used selection criteria, based on cell grouping and cytological 
features of malignancy, the consistency between two technicians appears to be 
significantly higher (r=0.90 p=0.015). Not only inter-individual consistency increased 
using the selection, but the correlation with histological tumor grade significantly 
improved for both technicians also. Analysis of a higher number (100 or more) of 
randomly selected nuclei resulted in reproducibility comparable to selective analysis. 
The results show that cytomorphometry can be a method for grading of bladder 
carcinoma when an accurate selection of nuclei is applied or a larger amount of nuclei 
is analyzed. Hence, karyometric studies must contain a clear description of the way 
the nuclei for measurement are selection. 
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INTRODUCTION 
Bladder neoplasms rank in the ten most common causes of cancer death.' Tumor 
grade correlates with prognosis," and nuclear area significantly correlates with tumor 
grade.** These facts make morphometry a valuable method in the grading of bladder 
tumors. 
Bladder washings of patients with bladder tumors often contain components of 
normal urothelium and non-malignant cells next to tumor cells.4 Hence, the cytological 
grading of bladder cancer is based on those cells with the most pronounced 
anaplasia.4 When measuring exfoliated cells in cytological material it is important to 
measure those cells that represent the true (histological) tumor grade. Due to 
practical limitations, like analysis time, only a low number of nuclei can be analyzed 
applying the interactive morphometric system as used in Chapter 1. This makes 
selection inevitable." The problem with selection is the risk of subjectivity, decreasing 
reproducibility. For this reason selective morphometry can only be used if: 1. the 
criteria for the selection of nuclei are clear and 2. there is little inter-individual and 
intra-individual inconsistency.910 In this chapter we test two different quantitative light 
microscopy settings for reproducibility. Using an interactive system (see Chapter 1), 
nuclear profile areas of 50 nuclei selected at random and according to microscopic 
criteria were measured. The reproducibility of automated image analysis of a larger 
amount of nuclei was tested for the system as described in Chapter 4. 
Recent developments in image analysis techniques have resulted in a reduction 
in the time required for analysis of larger numbers of nuclei (100-500). Using these 
techniques, selection might be redundant since a larger random sample of cells in the 
cytological material will more likely contain tumor cells. Moreover, a larger random 
sample provides more accurate information on all cells in the material. In Chapter 4 
we will discuss the application of automated karyometric analysis for the follow up of 
patients with superficial bladder cancer. Here, the reproducibility of automated image 
analysis of a larger amount of nuclei is tested. 
We wanted to answer the following questions: 1. How reproducible are 
karyometric analyses of cytological material in interactive and automated image 
analysis systems; 2. Can selection of nuclei increase reproducibility; 3. Does selection 
influence predictive value of karyometric analysis. 
MATERIAL AND METHODS 
Material for interactive cytomorphometric study 
The material consisted of 39 consecutive cases with the diagnosis of bladder tumor, 
graded histologically according to the WHO system. The histological material, 
obtained by transurethral resection was graded histologically and 
histomorphometrically according to the method described by Ooms et al.(1983).10 The 
histomorphometrical grading served as the basis for the grading of the cytological 
material. Eleven were graded as grade 1, 16 as grade 2 and 12 as grade 3. The 
cytologic material was obtained by means of bladder washing with physiological saline 
solution." The material was obtained in the Westeinde Hospital in The Hague. The 
earlier described fixation process was used." The sediment obtained after centrifuging 
was smeared on slides and stained using the Papanicolaou method. 
Material for automated karyometry study 
Bladder wash material for the automated karyometric analysis was obtained by 
similarly rinsing the bladder with saline solution. Material was instantly fixed in 50% 
ethanol containing 2% polyethylene glycol (Carbowax), Cytospin (Shandon) 
centrifuged slides were obtained and stained according to Feulgen. Forty-eight at 
random selected samples in a population of 1460 samples were analyzed by three 
technicians. 
Image analysis systems 
Cytomorphometrical measurements were made using a microscope connected with a 
computer MOP-video (KONTRON). Fifty nuclei were delineated manually by the 
technician in each slide. Each slide was measured twice by the same technician. Both 
technicians did one measurement at random and one selecting the nuclei according to 
the described selection criteria. The cytomorphometrical measurements took 
approximately 15 minutes per slide. Automated karyometric analysis was performed 
on the image analysis equipment as described in Chapter 4. All slides were analyzed 
by 4 technicians. Analysis comprised recording of 50 randomly selected images per 
slide applying manual focusing of each image. After recording by the technician the 
images were sequentially analyzed without operator intervention. Each detected 
nucleus in the images was contoured and numbered. After the computer analysis each 
detected nucleus was visually screened and artifacts or faulty segmentated nuclei could 
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be deleted. Analysis of normal bladder wash samples indicated a somewhat lower 
Feulgen staining in normal lymphocytes compared to presumably diploid bladder 
mucosa cells. Application of the earlier described correction factor of 1.19 for 
lymphocytes was necessary using lymphocytes as references for normal 2c DNA 
content.'2 
Selection process in cytomorphometric analysis 
The selection was as described in the first chapter for the cytomorphometric analysis 
and was conducted as follows: 
Step 1. 
First, the slide is screened for single, highly malignant cells. These cells always 
are found in the exfoliated material of high grade carcinomas. 
Not all loose-lying cells are malignant though. Squamous cells and normal 
urothelial cells do occur singly separated from cell groups but can easily be recognized 
as benign." 
The cellular features of the single, high-grade malignant cells are as follows: a. 
cytoplasm: variably dense, with vacuoles and irregular cell shapes; b. nucleus: enlarged 
nucleus, with an increased N/C ratio (approximately >0.60, Boon et al. 1981),14 
eccentrically situated in the cytoplasm, irregular shape, prominent nuclear border, 
coarse chromatin pattern, multiple, irregular shaped, prominent nucleoli. 
When single cells are present, with the above mentioned features, these are used 
for morphometry. 
Step 2. 
When no loose-lying cells with the described malignant features are present, the 
slide is screened for small papillary cell groups. 
Two types of small papillary cell groups are selected: 
1. loose clusters of only 5 to 15 clearly malignant cells 
2. small groups of less than 50 cells with round nuclei with little nuclear 
overlapping. 
Step 3. 
When these two types of cell grouping are not found, the slide is screened for 
large papillary groups. These consist of more than 50 cells, with smooth outlines, 
consist of many nuclei and are often very dense making measuring only possible at the 
edges of the cell groups. 
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Karyometric features 
In the cytomorphometric analysis using the MOP-videoplan (Chapter 1) only nuclear 
profile area was measured. The reproducibility of the automated karyometric analysis 
was tested for the karyometric features selected in the logistic regression function as 
calculated in Chapter 4 (2c Deviation Index and BEN, a nuclear shape feature, see 
Table 2 Chapter 1) and nuclear profile area and the number of analyzed nuclei per 
sample. 
Statistical analysis 
As in our earlier studies"* we found a strong linear dependency between standard 
deviation and mean nuclear area (mean of correlation in the four groups: 0.83). The 
statistical analysis of the data is complicated by the fact that a systematic correlation 
exists between standard deviation and mean value. In an earlier histomorphometric 
study Ooms et al. (1983b)'° also found this correlation. We attempted to eliminate this 
correlation by applying a variance-stabilising transformation on the original data and 
subsequently calculated the standard deviation. In this way the standard deviations do 
not contain information about the mean values and for this reason can be neglected. 
We tested this method and found it acceptable. As variance-stabilizing transformation 
we used the logarithm of the mean value. 
In order to investigate the inter-individual reproducibility of a certain factor 
when measured by two different technicians using the same protocol, one should at 
least in our opinion, pay attention to the following guidelines: 1. The measurements 
should be highly correlated. How large correlation coefficients should be is a 
somewhat subjective affair. We proposed that r>0.90 or r>0.95. An interpretation of 
r is that the bivariate scatterplot is shaped as an ellipse for which the length of minor 
axis 1, is (l-r)7(l+r)'* times the length of the major axis 12 (for r=0.90 l,:la=l:19*, for 
r=0.95 is 1,:1,= 1:39*). We used the Fisher's z-transformation to obtain a test statistic. 
2. The measurements should be exchangeable. This implies, among other things, that 
the measurements performed by one technician might have been performed by any 
other technician just as well. This is tested by assuming joint normality of (X,Y), 
where X is the random variable describing the measurement of technician A and Y 
that of technician В and using the GLR statistic for testing whether (X) = (Y). 
In order to test whether the inter-individual sample correlation coefficient 
increases significantly due to the selection process we applied a divided sample 
approach (to obtain independent samples) and use Fisher's z-transformation to obtain 
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a test statistic. 
To test the increase in consensus between cytomorphometry and 
histomorphometry when using selection let X denote a certain factor measured 
without selection and let Y denote the same factor with selection of nuclei to 
measure. In order to test whether X and Y are equally correlated with G (=grade) we 
postulate (to avoid statistical complexity) the ratio of variance of X to that of Y to be 
known and equalling, r2, say. Now testing H: (G,Y) = (G,X) is equivalent with testing 
IT: (G,ZT)=0, where ZT=X-TY. Under rather general conditions we have that under 
Τ = (n-2)* ^ 
Now we replace the nuisance parameter τ 2 by its obvious sample estimate to obtain 
an approximate test. 
For statistical analysis of reproducibility of the automated measurements the 
SPSS/PC+ 4.0 software was applied. A selection was made among the karyometric 
features. Besides nuclear profile area the karyometric features selected for the 
karyometric score for bladder washings, as described in Chapter 4, and the number of 
detected nuclei in 50 images were investigated for reproducibility. 
RESULTS 
Reproducibility of cytomorphometric analysis. For reasons indicated above we used 
the mean log nuclear area as a potential factor. Note that we have essentially four 
data-sets, namely the measurements of two technicians (Α,Β) each of which measured 
once with and once without selecting the nuclei (see Table 1). 
Table 1. The log mean variables and standard deviation of nuclear area for the two tfriinirians 
Grade 1. Grade 2. Grade 3. 
η mean SD η mean SD η mean SD 
technician A 
selective 
at random 
technician В 
selective 
at random 
11 
11 
5 
5 
3.58 
3.66 
3.34 
3.61 
0.14 
0.19 
0.12 
0.17 
16 
15 
16 
16 
4.17 
3.95 
4.20 
3.86 
0.16 
0.20 
0.29 
0.20 
11 
11 
11 
11 
4.67 
4.12 
4.74 
4.21 
0.25 
0.17 
0.27 
0.21 
The measurements based on the selection process gave rise to a significantly larger 
sample correlation (P<0.001, based on the divided sample test statistic) than the at 
random measurements. However, the hypothesis of exchangeability is still somewhat 
contradicted, although to a lesser extent than the exchangeability of the at random 
measurements (see Table 2). 
Table 2. Results regarding the reproducibility of selective and non-selective morphometry, (two 
technicians). 
selective r 0.90 
P-value 0.015 
non-selective r 0.55 
P-value 0.5Έ-3 
Not only does the selection improve reproducibility, it also increases the consensus of 
the technician (cytomorphometry) and pathologist (histomorphometry), in the sense 
that the sample correlation coefficient between the grade and the mean log area 
increases significantly (Table 3). 
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Table 3. Correlation between histological grade and the log mean nuclear area. 
selective non-selective significance 
of increase 
technician A 
technician В 
(n=38) 
0.93 
(n=33) 
0.86 
(n=38) 
0.66 
(n=34) 
0.50 
( · = 0.05>P>0.01 and ·*= 0.001 >p>0.001 ) 
To illustrate the above discussed reproducibility and consensus of the pathologist and 
technician the outcomes of the at random measurements of both technicians are 
displayed in Figure la, whereas those based on the selection process are displayed in 
Figure lb. 
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Figure 1. Correlation of nuclear profile area (log mean value per sample) between two 
technicians for random (a) and selective analysis (b). The different histological tumor 
grades are marked (grade 1: square, grade 2: triangle, and grade 3: circle). 
Reproducibility of karvometric analysis. The correlation of analysis of nuclear profile 
area, number of analyzed nuclei per sample, nuclear shape (BEN), and the 2c 
Deviation Index among three technicians is presented in Figure 2 and 3 (Technician A 
vs Β: η = 37; Technician A vs C: η = 28; Technician В vs C: η = 45).. In Table 4 the 
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correlations values between the measurements of the different technicians are shown. 
All correlations were significant and larger than 0.75, except for the 2c Deviation 
Index. This was caused by the large number of samples with 2cDI values smaller than 
1. In this group low correlation values between the three technicians was found. In 
routine application this is of minor importance since distinction of low 2cDI values ( < 
1.0) is of no clinical importance (see Chapter 4). The correlation values for nuclear 
profile area are comparable to those found for selective cytomorphometry. The 
random selection of images could cause differences in the analyzed number of nuclei 
per sample between technicians. Correlation of the number of nuclei analyzed, 
however, was high for all three technicians (Table 4). In samples where only a low 
amount of nuclei (<100) could be analyzed, the differences in nuclear profile area 
between the technicians were significantly higher (P<0.05) compared to analysis of 
larger numbers of nuclei per sample. 
Table 4. Correlation of karyometric analyses performed by three technicians. Two karyomeiric features 
are chosen regarding the prognostic evaluation as described in Chapter 4 (BEN and 2cDI). Nuclear 
profile area (NPA) is shown for comparison with the cytomorphomclric analysis. Since measurements 
were performed at random in SO images the number of nuclei detected in these images (NUCLEI) was 
also studied for the three technicians. 
Technician 
A vs В (n=37) 
A vs С (n=28) 
В vs С (n=45) 
NPA 
R 
0.892 
0.821 
0.811 
Ρ 
0.01 
0.01 
0.01 
NUCLEI 
R 
0.861 
0.925 
0.843 
Ρ 
0.01 
0.01 
0.01 
R 
0.801 
0.821 
0.837 
BEN 
Ρ 
0.01 
0.01 
0.01 
R 
0.692 
0.699 
0.724 
2cDI 
Ρ 
0.01 
0.01 
0.01 
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Mean Nuclear Prolile Area Mean Number of Nuclei per Sample 
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Figure 2. Mean nuclear profile area and mean number of nuclei analyzed per sample compared 
between the three technicians. 
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Figure 3. Mean BEN value and mean 2cDI per sample compared between the three technicians. 
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DISCUSSION 
Urinary cytology is a valuable tool for the follow up of patients with superficial 
bladder cancer.18·17 
Cytomorphometry of cells in the urine is used as a method to achieve a more 
reproducible way of cytological grading.46 In an earlier study we found a correlation 
value of 0.743 for cytomorphometrically determined nuclear area with histological 
tumor grade.' A possible explanation for an increase in nuclear area with tumor grade 
is the increase in amount of DNA in the tumor nucleus. Helander et al. (1985)1" 
found that grade-1 tumors were always diploid and grade-3 tumors consisted of 
aneuploid nuclei. The amount of DNA measured by flow cytometry shows a positive 
correlation with nuclear size."'1" 
Colpaert et al. (1987)* showed that subjective grading is influenced by a small 
number of larger nuclei, representing tumor grade. They found that 50 percent of the 
nuclei in grade-3 tumors were within normal values.* If nuclei, chosen at random are 
measured a high percentage of 'non-representative' cells will be analyzed. Hence, in 
our data we found a lower correlation of karyometric analysis of nuclear profile area 
and histological tumor grade when samples were analyzed randomly compared to 
selection of nuclei based on cytological selection criteria. 
The selection criteria applied were derived from interpretation criteria in visual 
cytology.' When screening the slide at low magnification three different types of cell 
grouping can be recognized: 1. single malignant cells; 2. small papillary groups and 3. 
large papillary cell groups. This division forms the basis of the selection process. 
When single malignant cells were present, this indicated loss of inter-cellular 
cohesiveness a feature of malignancy and present in grade-3 carcinomas.20"22 Small 
papillary cell groups were present in grade-2 as well as grade-3 tumor material. 
Exclusively large papillary cell groups occurred mainly in grade-1 tumors. This kind of 
cell group frequently was found in tumors of higher grade but then always next to 
small cell groups or single cells. The number of papillary groups in the material 
depends on both the size and the location of the tumor.22 Low grade tumor cells, 
characterised mainly by cell groups and less malignant cellular features are selected in 
step 3. 
A repeatable and reliable selection of nuclei can be achieved by carefully 
analyzing the cellular features accompanying malignancy. Many studies have discussed 
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cellular features used in the grading of bladder tumors.4"*29 Ooms et al. (1983b)10 
described a histomorphometric grading system in which selection is directed by the 
location of the cells in the tumor. They discriminated: DEEP; SUPERFICIAL; and 
LARGE nuclei in bladder tumors and found a significant correlation between 
histological tumor grade and nuclear profile area.10 In a following article they stress 
the importance of a clear selection of nuclei and show that the histomorphometric 
grading has better inter-individual consistency than the histological grading.9 Blomjous 
et al. (1988)2" selected visually only the 10 largest nuclei in histological sections of 
bladder cancer and found higher recurrence and progression rates in patients with a 
mean nuclear profile area over 95 μπι' compared to patients with smaller nuclei. For 
the selection of cells for quantitative analysis in urinary sediment Koss et al. (1980)27 
developed a selective mapping algorithm28 for automated detection of cells suitable for 
diagnosis at low resolution. Selected cells were then entered in high-resolution image 
analysis routines. The difference between the above mentioned (cytological) 
criteria2224,2' and the method used in the present study is the fact that in the current 
study, attention is paid to the cellular arrangements first. As the cell grouping is a 
feature that can be appreciated at low magnification this was used as the first step in 
the present analysis. The reason for this attention to the cell groups is that it 
simplifies screening and makes a graded analysis of the material possible. Individual 
cellular features become important in the second phase of selection. 
The described cytological criteria in combination improved both correlation with 
histological grade and interindividual reproducibility. For this reason we conclude that 
when analyzing a low number of nuclei in cytological material manually selection 
criteria are mandatory. Two issues, however, remain: 
- Selection of cells according to criteria requires subjective interaction, increasing 
the number of analyzed cells might make selection redundant. 
- Cytomorphometric analysis correlated with histological tumor grade, the latter, 
however, is not necessary correlated with tumor behavior, e.g. recurrence and 
progression. Since, bladder tumors often occur on multiple sites of the bladder, it can 
be regarded as general disease of the urothelium resulting in localized lesions. 
Although we have to mention that controversy on this point exists,2"0 we assumed that 
cytological characteristics of 'normal' urothelium in patients with bladder cancer might 
reveal pre-malignant changes that predispose for later tumor recurrences. 
To study these phenomena we conducted the study as presented in Chapter 4 of 
this thesis. Here we present the results on the analysis of the reproducibility of the 
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applied karyometric analysis. Several differences between our first morphometric 
studies of nuclear size and the automated karyometric analysis bladder washings exist. 
First, due to technical limitations the interactive image analysis equipment 
(KONTRON) in the early studies was capable of analyzing only a limited number of 
nuclei, whereas the system used in the study in Chapter 4 enabled analysis of several 
hundreds of nuclei in a similar amount of time. Second, the number of features per 
nucleus was higher in the later study. Third, besides analysis of correlation with 
histological grade, correlation with follow up data was pursued in the later study. 
Since we want to develop a clinical applicable quantitative analysis of cytological 
material we aimed at reducing time for analysis and subjective influences by analysis 
of randomly selected nuclei which could be conducted in an automated setting. No 
selection criteria were applied and only artifacts or out-of-focus nuclei were deleted. 
Moreover, this technique provides karyometric information of 'normal' bladder 
mucosa. The number of nuclei analyzed per sample influenced consistency of the 
measurements. For reproducible measurements we conclude from our data that at 
least 100 nuclei per sample should be analyzed when at random selection is 
performed. Reproducibility of the analysis conducted this way showed to be 
comparable to those obtained by selective cytomorphometry of a low number of 
nuclei. In Chapter 4 we will discuss the correlation with clinical findings. Anticipating 
on these results we mention here the fact that based on karyometric analysis a 
prediction of tumor recurrence in tumor-free samples is possible. This suggests that 
the criteria, as successfully applied for the detection and grading of tumors in 
cytological material may not be sufficient for the prediction of later tumor 
development since these changes occur in 'normal' urothelial cells. 
This study shows that: 1. Analysis of a low number of nuclei in bladder washing 
material is useful for grading of bladder carcinoma only when careful selection of 
nuclei is applied. 2. The selection process, based on cellular arrangement in the 
cytological material increases reproducibility and gives a better correlation with 
histological tumor grade. 3. Analysis of a larger amount of cells selected randomly 
reached acceptable reproducibility and can be an alternative to subjective selection 
criteria. 
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ABSTRACT 
Transitional cell carcinoma of the bladder shows a high recurrence rate after local 
treatment. Progression to higher stage occurs in 10-30% of the recurrent tumors and 
early detection of potentially progressive tumors is important. In the current study 
morphometric, densitometric, and chromatin texture features of nuclei of superficial 
bladder tumors (pTa-Tl) were studied to determine the value of karyometric features 
in the prediction of tumor progression. Seventy-two histological samples of 36 
patients, consisting of both the primary and the first recurrent superficial tumor were 
analyzed. Patients were divided into two groups: those with tumor-progression, 
defined as an increase in tumor stage or occurrence of metastatic disease, and those 
without. Discriminant analysis on 4 karyometric features resulted in correct prediction 
of prognosis of 78% and 97% in the primary and recurrent tumors respectively. 
Tumor grade and stage did not offer additional information concerning prognosis. 
Karyometric analysis of recurrent superficial transitional cell tumors can be useful in 
selecting patients that need more aggressive therapy. However, karyometric tumor 
characteristics of recurrent tumors were more predictive of progression than those of 
the primary tumor, whereas tumor grade was not different. Hence, continuous 
evaluation of the karyometric features is necessary for early detection of an increase 
in the malignant potential of the tumor. 
Karyomeiry in Recurrent Bladder Cancer 109 
INTRODUCTION 
Superficial transitional cell carcinoma (TCC) of the bladder account for approximately 
80% of all newly diagnosed tumors of this organ.1 The tumor is treated by 
transurethral resection with or without intravesical instillation with chemo and/or 
immunotherapeutic agents. However, 30%-90% of the tumors recur depending on 
grade, multifocality,1 and the treatment modality. Thiotepa resulted in a 49% 
recurrence rate.2 Intravesical Epodyl therapy resulted in recurrence rates of 21 to 
50%,3 adriamycin showed recurrences in 40-70%,*·5 and mitomycin С in 10-20% of the 
cases.' BCG instillations after TUR reduced the recurrence rate to 22% in a study by 
Shinka and associates (1990),7 but seemed of no value for reducing the number of 
recurrences in stage T, tumors. The multifocal occurrence of bladder tumors suggests 
a general disease of the urothelium rather than a localized process. This can be an 
explanation for the high recurrence rate. Although superficial at the time of diagnosis, 
10-30% of these tumors become invasive or metastasize in the course of the disease." 
In case of frequent recurrences and multiple tumors, progression rate can be as high 
as 83%." 
Early identification of patients with progressive superficial bladder tumors has 
implications for the treatment, since a more aggressive treatment is indicated for these 
patients. Nuclear features of tumor cells in transitional cell cancer showed predictive 
value for recurrence and prognosis.10'1 Nuclear profile area, its standard deviation, 
and DNA content (2cDI and 5cER)12 correlated best with visual assessed tumor 
grade.10'1,13"17 Ooms and associates (1983)" introduced a quantitative grading system 
with measurements of superficial, large, and deep cell nuclei separately in histological 
samples. De Prez and associates (1990)13 described the use of an image analysis 
system (Samba 200) measuring morphometries densitometric, and chromatin pattern 
features. These quantitative findings correlated well with visual grade. In the current 
study we analyzed whether nuclear features quantified by image analysis can play a 
role in predicting the prognosis in recurrent superficial bladder tumors. To test image 
analysis as a tool for patient follow up, the technique was applied in consecutive 
samples in order to compare primary and recurrent tumor of the same patient. 
MATERIAL AND METHODS 
Patients 
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Thirty six patients with superficial bladder tumors (stage Ta-Tl) underwent complete 
transurethral resection (TUR) of the tumor and were treated with fifteen intravesical 
instillations of adriamycine. Material of primary and first recurrent tumor was 
available. Mean follow up was 4.8 years (3-10 yrs). The patients were divided into two 
groups: patients with progressive and non-progressive tumors during follow up. Tumor 
progression was defined as an increase in tumor stage to T2 or more or the 
appearance of metastases. Considering the relatively small number of patients, time to 
progression was not taken into the analysis. 
Material 
Paraffin-embedded, formalin-fixed TUR material was available of all patients from the 
primary and recurrent tumor. Four μτη sections were cut, deparaffinized in xylene, 
rehydrated, and stained according Feulgen-Schiff (hydrolysis in 5 N H Q for 60 
minutes and 30 minutes in Schiff reagent (Merck, Darmstadt, Germany) at room 
temperature). Haematoxylin stained slides were used by the pathologist to mark the 
tumor areas of interest. The marks were copied to the Feulgen-stained slides. 
Quantitative microscopy 
Image analysis was performed with a VS100-AT framegTabber board (Imaging 
Technology, Wobum, USA) in a persona] computer (Compaq 386s). A videocamera 
(HCS-CCD, MXR, Vision Technology, Eindhoven, The Netherlands) connected to an 
Axioskop light microscope (Zeiss, Oberkochen, Germany) was used to record the 
images. Ten randomly selected images per slide were measured in these areas with a 
40 times objective (pixel size 0.024 μπι2). Analysis of one image took 3 minutes. The 
nuclear features measured are described in Table 2 and 3 of Chapter 1. The 5c 
exceeding rate (5cER) and 2c deviation index (2cDI) were calculated, with 30-50 
lymphocytes as internal reference. The 5cER represents the percentage of definitely 
aneuploid cells, the 2cDI the (mean square) deviation from the diploid value." 
Software used was written in TIM (TEA, Dordrecht) an image analysis language 
offering several basic modules for image recording, handling, and analysis. Additional 
software was written in TURBO-Pascal for chromatin texture analysis, Freeman chain 
code analysis for shape description, and data handling. 
Prior to image segmentation, the image was corrected for shading and a median 
filter was applied. Selection of nuclei was primary based on size and values for 
maximal bending energy (BEN), in order to eliminate overlapping nuclei and 
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artifacts.18 Visual inspection of the images overlaid by contours and numbers of the 
selected nuclei enabled screening for out-of-focus cells or artifacts. 
Of each feature the mean, standard deviation (SD) and 90* percentile was 
calculated. The measurements were divided into three groups: 1. values of primary 
tumor; 2. values of recurrent tumor; and 3. differences in values between primary and 
recurrent tumor. 
The SPSS/PC+ package (SPSS, Chicago, US) was used for statistical analysis. 
Mann-Whitney U-test and discriminant analysis were applied. To reduce the number 
of features in the discriminant analysis a selection of features was made based on 
results from the Mann-Whitney U-test, results from earlier studies,1" and correlation 
with tumor grade. The features selected this way were: the 90th percentile of the 
nuclear profile area, the SD of MAC (nuclear shape feature; the standard deviation 
represents the degree of nuclear polymorphism), 2cDI, and the mean of Markovian 
feature H3, a chromatin pattern feature, based on the co-occurrence matrix. These 
features describe the presence of very large nuclei (NIN of NPA), the presence of 
nuclear polymorphism (SD of MAC, standard deviation of MAC, a nuclear shape 
feature), the variance in DNA content (2cDI), and uneven distributions in chromatin 
pattern. 
RESULTS 
Progression and grade and stage 
Twenty-three patients did not show tumor progression after the recurrent superficial 
tumor. Progression was found in 13 patients during follow up (33%). Histological 
tumor grade in the primary-tumor group was not significantly different from the 
recurrent-tumor group (P>0.05). Whereas tumor grade of the recurrent tumor was 
significantly higher in progressive tumors (P<0.01, chi'-test), tumor grade was not 
correlated with progression in the primary tumor. Twenty-two percent of the tumors 
showed an increase in tumor grade in the recurrent tumors, which is in agreement 
with other studies.1* All tumors with a decrease in tumor grade between the primary 
and the recurrent lesion did not progress, in contrast to 4 of 8 cases which showed an 
increase in tumor grade (/>=0.03, chi2-test) and progressed. In agreement with 
Kaubisch and associates20 we did not find progressive tumors in patients with only 
grade-1 lesions as recurrent tumor, whereas only one patient with a grade-1 primary 
tumor showed progression. 
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Stage of the primary and recurrent tumor (T, or T,) was not significantly different. Of 
the recurrent cases tumor stage was higher (T,) in the tumors that subsequently 
progressed (P<0.05, chi2-test). Tumor stage of the primary tumor did not differ 
between progressive and non-progressive tumors. There was a tendency to higher 
tumor grade in stage-T, tumors as compared to stage-T„ although, this was significant 
neither in the primary, nor in the recurrent tumor. 
Karyometry and grade and stage 
Several karyometric features showed a correlation with histological tumor grade in the 
primary as well as in the recurrent tumors. Of the morphometric features, the mean 
nuclear profile area increased with tumor grade as did its coefficient of variation, 
indicating a higher anisokaryosis in the higher tumor grades. Grade-3 tumors had 
significantly higher values for 2cDI and 5cER, however, several cases of the high-
grade tumors had values within normal range. Features in both primary and recurrent 
tumors showed similar correlations with tumor grade. The results of the discriminant 
analysis resulted in 83% correct classifications. Karyometric features could not 
discriminate between stage-T. and stage-T, tumors. 
mean NPA (μπι2) mean NPA (um2) 
non-prograaaim progresa!' non-prograealv· progreeaiva 
Figure 1. Nuclear profile area in primary (a) and recurrent (b) tumors of patients with progressive 
and non-progressive follow up. 
Karyometry and progression 
The results of the Mann-Whitney U-test showed a significant difference (P<0.005) 
between progressive and non-progressive tumors for 4 of the tested karyometric 
features in the primary tumors and 19 features in the recurrent tumors (Table 1 and 
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Figure 1). 
Table 1. Karyometric features that were significantly different (P<0.001) between progressive (P) and 
non-progressive (NP) tumors in primary and recurrent tumors expressed as P-values bom Mann-
Whitney U-lesL When both primary and recurrent tumor features were not significant, the feature is 
not shown. 
mean NPA 
- SD NPA 
- NIN NPA 
- CV NPA 
mean PERI 
- SD PERI 
- NIN PERI 
mean MAXD 
-SDMAXD 
- NIN MAXD 
mean FPE 
mean MBEN 
- SD MBEN 
- NIN MBEN 
- S D MAC 
- NIN MAC 
-CVMAC 
mtDNA 
mtVOLUME 
mean IOD 
- SD IOD 
- NIN IOD 
sign, of 
difference 
between Ρ 
and NP in 
prim, tumor 
n.s. 
P<0.001 
n.s. 
P<0.001 
n.s. 
ρ<ο.ωι 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
P<0.001 
n.s. 
P<0.001 
P<0.001 
n.s. 
n.s. 
n.s. 
n.s. 
sign, of 
difference 
between Ρ 
and NP in 
recurr. tumor 
/><0.0001 
/><0.0001 
P<0.0001 
Я<0.0001 
/><0.0001 
P<0.0001 
P<0.0001 
P<0.0001 
P<0.0001 
P<0.0001 
/><0.001 
P< 0.001 
P<0.0001 
P< 0.001 
n.s. 
p<Q.oa\ 
P< 0.0001 
P<0.001 
P<0.001 
P<0.001 
P<0.001 
P<0.0001 
sign, of 
difference 
between Ρ 
and NP in 
difference values' 
P<0.001 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
P<0.001 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
') difference values are the differences of the karyometric feature values between primary and recurrent 
tumor. Or, in other words, the changes in the karyometric features of the recurrent tumor compared to 
the primary lesion. 
- SD = standard deviation 
- NIN = 90* percentile 
- CV = coefficient of variation ( ratio of SD and mean) 
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Multivariate analysis 
The Wilks method was used in a leave-one-out stepwise discriminant analysis (F to 
enter 3) to calculate a canonical linear discriminant function using the four selected 
feature values to discriminate between progressive and non-progressive tumors. The 
correct classification based on the selected nuclear features was highest in the 
recurrent tumors (97%). All non-progressive (NP) tumors (n=23) and 12 of 13 (92%) 
progressive (P) tumors were classified correctly (Table 3 and Figure 2b). Based on the 
primary tumors, a correct prediction of prognosis was obtained in 18 of 23 cases 
(78%) with no tumor progression (Table 2 and Figure 2a). 
Table 2. Classification result discriminant analysis karyometric features for prediction of tumor 
prognosis of samples of the primary tumors, (method: Wilk's; f-to-enter = 3). 
Standardized canonical discriminant function (P<0.001) 
Dscr. Score = (1.20846 • SDMAC) + (1.00225 · H3) 
Predicted Prognosis 
NP Ρ 
Follow-up 
NP (n=23) 18 (78.3%) 5 (21.7%) 
P(n=13) 3(23.1%) 10(76.9%) 
correctly predicted: 77.78% (28/36) 
Table 3. Classification result discriminant analysis karyometric features for prediction of tumor 
prognosis of samples of the recurrent tumor, (method: Wilk's; f-to-enter = 3). 
Standardized canonical discriminant function (P<0.0001) 
Dscr. Score = (0.88226 * SDMAC) + (1.11261 * 90* NPA) 
Predicted Prognosis 
NP Ρ 
Follow-up 
NP (n=23) 3 (100%) 0 (0%) 
P(n=13) 1(7.7%) 12(92.3%) 
correctly predicted: 97.4% (35/36) 
NP = non-progressive tumors 
Ρ = progressive tumors 
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Figure 2. Features selected in discriminant analysis on base of F-value for the primary and 
recurrent tumors. The line represents the zero-scores of the canonical discriminant 
function (primary (a) and recurrent tumor (b)). Notice the different karyometric 
features selected in the discriminant analysis for the primary and recurrent tumor 
group: SD of MAC was a useful feature in both groups; best classification was 
obtained of SD MAC in combination with NPA (nuclear profile area) in the recurrent 
tumors (b) and in combination with mean H3 (nuclear chromatin pattern) in the 
primary tumors (a). 
Ten of 13 tumors (77%) with tumor progression were classified correctly (Table 3). 
This resulted in a correct classification of 78% and 97% for the primary and recurrent 
tumors respectively (Figures 2a and 2b). When the discriminant function found in the 
recurrent tumors was applied on the primary tumor group the percentage of correctly 
classified cases did not change (Figure 3). 
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Figure 3. Canonical discriminant function (df) of the recurrent tumor (1) plotted in the primary 
tumor group. Line (2) represents the zero df scores when the analysis was done on the 
primary tumor group using the karyometric features selected in the recurrent tumors. 
In both cases (line 1 and line 2) sub-optimal division of Ρ and NP cases is obtained. 
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Tumor grade and stage were entered in the discriminant analysis in addition to the 
karyometric features. However, due to low F-values, tumor stage, grade, and changes 
in tumor grade were not selected in the stepwise analysis: i.e. there is no additional 
value of the classical features to the karyometric features for the prediction of tumor 
progression. 
All recurrent tumors and 6 of 7 primary tumors with a 5cER higher than 10%, 
suggesting non-diploid tumor cells, showed progression during follow up (Figure 4). 
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Figure 4. Sc Exceeding Rate in primary (a) and recurrent tumors (b). The mean value per case is 
plotted and the cases are divided into progressive and non-progressive disease during 
follow up. 
DISCUSSION 
Superficial transitional cell tumors of the urinary bladder are characterized by a 
tendency to recur after resection. Gilbert and associates (1978)" reported a 
recurrence rate of 70% and found an increase in tumor grade in 25% of the recurrent 
tumors. Other studies reported up to 90% recurrence rate1 depending on grade, stage, 
and treatment modality used."-7*1 
From a prognostic point of view the risk of invasion of a treated primary 
superficial tumor is more important than recurrence rate. In patients with a recurrent 
tumor, 10-30% progression to invasion is detected.' Moreover, Althausen and 
associates' reported progression rates as high as 83% in patients with frequent tumor 
recurrences and multiple tumors. For superficial bladder tumors progression and 
recurrence rate are highest in pTlG3 tumors.21 However, progression rates for pTaG3 
Karyometry in Recurrent Bladder Cancer Ц 7 
and pTlG2 tumors are similar, indicating that tumor stage alone can not predict 
tumor progression accurately. The pathological staging results from the present study 
showed no difference in progression rate between all pTa and pTl primary tumors. 
Tumor staging in small superficial bladder tumors is often difficult13 and might have 
caused the discrepancy between these findings and earlier studies. 
In case of a superficial bladder tumor, apart from tumor stage several tumor 
characteristics have been investigated for prediction of tumor behavior. Tumor grade 
is generally used as a stage-independent indicator of tumor behavior. The subjectivity 
of tumor grading has led to quantitative methods to describe tumor cells and nuclei in 
microscopic images. 
In the present study quantitative light microscopy is used to characterize cell 
nuclei in bladder tumors. Since only a limited number of nuclei can be analyzed, 
selection criteria will influence results. Contrary to other studies10'5 that used selected 
nuclei, in the present study only the tumor area was selected to reduce subjectivity. 
Subsequent analysis was performed in randomly chosen images within this area. This 
procedure was also used in an earlier study and resulted in good correlation between 
grading and karyometric features.'6 
Several nuclear features were significantly different between the progressive and 
non-progressive tumors in the primary tumor group. Primary tumors containing non-
diploid cells reflected by high values for 2cDI and 5cER often progressed. Although 
Blomjous and associates (1989)" found correlation between the karyometric features 
of the primary tumor and progression rates, the present data showed best prediction 
of progression by karyometric features of the recurrent tumors. The presence of large 
nuclei in recurrent tumors, measured by the 90'" percentile of the nuclear profile area 
was correlated with tumor progression. This is in agreement with earlier studies.'015 
Blomjous and associates (1989)15 found increased recurrence and progression rates in 
patients with tumor cells with large nuclei (mean profile area > 95дт2). The presence 
of large nuclei correlated with tumor grade in a study by Ooms and associates 
(1983).10 Unlike the present study, these histological studies10,16 applied criteria for 
selection of nuclei based on nuclear size which may affect reproducibility.23 Nuclear 
size, either measured in selected or in random chosen nuclei is clearly correlated with 
tumor behavior. 
Nuclear polymorphism and abnormal nuclear shape are characteristics of high-
grade tumors. Montironi and associates (1985)24 could discriminate the different tumor 
grades using the nuclear roundness factor (NRF). For reasons discussed elsewhere" 
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the NRF is theoretically less useful in grading bladder tumors. Therefore we choose, 
besides the NRF, a shape feature derived from the Freeman chain code of the 
nuclear profile contour. This method enables detailed analysis of convexities and 
concavities in the nuclear structure.18 Although the mean NRF was significantly lower 
in progressive tumors, indicating more abnormal nuclear shapes in these tumors, the 
standard deviation of the MAC, a Freeman chain code derived feature, had additional 
value to nuclear size for predicting progression and is thus preferable over the NRF. 
The finding that features of the primary tumor were of less predictive value, 
using either the classical or karyometric features is somewhat disappointing and 
illustrates the importance of regular follow up of patients with superficial bladder 
tumors. In seven cases the classification of the primary tumor was different from that 
of the recurrent tumor (in two cases this meant 'down-grading': i.e. whereas the 
primary tumor predicted progression, the recurrent tumor did not). In none of the 
seven cases prediction based on the primary tumors was correct and only in four the 
change in karyometric prediction was accompanied by a change in grade or stage 
which illustrates the grade-independent prognostic value of karyometric analysis. 
Although the discriminant function in primary and recurrent tumors is not equal, 
Figure 3 illustrates that the classification results do not improve when the function 
derived for the recurrent tumor is used to classify the primary tumors (see line 1 in 
Figure 3). 
Soloway (1989)25 divided recurrent tumors into 'true recurrences' and 'new 
occurrences'. Another possible cause of recurrence is tumor implantation." Which 
cause of tumor recurrence underlays the recurrent tumors in the present study is 
difficult to determine based on karyometric features alone. To test the similarity of 
the two tumors, the differences of the karyometric feature values between primary 
and recurrent tumor were taken into analysis. Differences in karyometric features did 
not correlate with progression. Whereas these differences were of additional value to 
the primary tumor data for predicting progression no additional predictive value to 
the data from the recurrent tumors was shown. We therefore conclude that a change 
in tumor as measured with karyometric analysis can not predict progression and that 
it is the data from the recurrent tumor rather than from changes in the primary tumor 
that determine prognosis. 
In conclusion, karyometric analysis of recurrent superficial bladder tumors has a 
strong predictive value for tumor progression. Multivariate analysis techniques indicate 
additional predictive value of the features that describe the presence of extremely 
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large (NINAR) and polymorph (SD MAC) nuclei. Visual grading of the histological 
slides has no additional value to these features. All karyometric features could be 
measured on routine formalin-fixed, paraffin-embedded material, and can easily be 
incorporated in routine diagnostic procedures. The low predictive value of analysis of 
the primary tumor, however, indicate the need for careful (karyometric) follow up of 
patients with superficial bladder tumors. 
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ABSTRACT 
A quantitative cytological analysis of 1600 bladder wash samples from 695 patients 
attending operation room and outpatient department was performed. In a pilot study 
karyometric analysis was useful for the discrimination of tumor and non-tumor 
samples and a correlation of the karyometric features with the histological tumor 
grade was found. In a logistic regression analysis (n=115) for the presence of tumor, 
two karyometric features were found: the 2c Deviation Index and the mean of BEN, a 
nuclear shape feature. The function was evaluated in a large population (n=1336). 
Sensitivity of the karyometric analysis for the detection of tumor by bladder washing 
was 90.6% and specificity was 69.8%. The low specificity was possibly caused by the 
absence of histological confirmation in the outpatient samples where only 
cystoscopical interpretation was available: 97% of the false-positive samples were 
obtained at the outpatient department. Moreover, the recurrence rate during follow 
up (median 7.3 months, range 3-26.3) was 20% for the false-positive scored samples, 
whereas overall recurrence rate was 4.2%. The logistic evaluation showed that bladder 
washings fixed in Carbowax are well suited for mailing and karyometric analysis. This 
quantitative approach to cytology can be particularly useful for the longitudinal follow 
up of patients with superficial bladder cancer. 
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INTRODUCTION 
The follow up of patients with superficial bladder cancer is done by cystoscopy and 
urine cytology. Low reproducibility and the inability of quantitation hamper visual 
interpretation of cytological material.1 Flow-cytometric studies showed that ploidy 
analysis of bladder wash material is a sensitive method of tumor detection." Since, 
flow cytometry does not enable simultaneous visual interpretation and selection of 
cells, quantitative light microscopic techniques can be used for DNA content analysis 
instead." Moreover, the latter technique can also be used for the quantitation of a 
panel of nuclear and cellular features other than DNA content.0 The group of Koss in 
the Montefiore Medical Centre in New York has extensive experience with an image 
analysis system for the classification of cells in voided urine.1'0,1' Sensitivity of this 
system was particularly high for high-grade tumors but low-grade lesions were less 
readily diagnosed. The cell-to-cell reference classification and the use of voided urine 
instead of bladder wash material are two reasons for the low diagnostic yield. In this 
chapter we will discuss the use of a quantitative approach to cytology of bladder 
washings. Besides nuclear DNA content we analyzed several karyometric features on 
Feulgen-stained cytospin preparations to answer the following questions: 1. Can we 
develop an inexpensive system for the quantitative analysis of cytological material of 
bladder washings?; 2. Does karyometric analysis offer information on the histological 
tumor characteristics and can it be used to predict early tumor recurrences?; 3. Is a 
grading system based on the karyometric analysis clinically useful as a diagnostic tool?. 
MATERIAL AND METHODS 
Patient Population and Material Sampling 
Patients attending outpatient department or operating room during follow up or 
treatment of a superficial bladder cancer were eligible. The material was obtained by 
rinsing the bladder vigorously, at least twice with saline, either through a catheter or a 
cystoscope. 25cc of the material was instantly fixed in 25cc 50% ethanol containing 
2% polyethylene glycol (Carbowax) and stored at 5°C. Bladder washings were always 
performed after emptying of the bladder and prior to intravesical manipulations or 
instillations. After arrival in the laboratory the material was centrifugued (2000x, 10 
min.) and the pellet resuspended in Carbowax fixative. For staining, the material was 
Cytospin centrifuged (Cytospin, Shandon) on gelatin-coated slides, post-fixed with 
124 Chapter 4 
Böhm fixative (85% methanol, 10% buffered formalin, 5% acetyl acetic acid glacial) 
and Feulgen stained (5 N HCl 60 min., Schiff-reagens (Merck), 30 min. both at room 
temperature). 
Karyometric analysis 
The karyometric analysis was performed on the Feulgen stained slides using a PC-
based image analysis system. The system consisted of a framegrabber board (VFG-
framegrabber, Imaging Technology, Wobura, MA) in a Compaq 386s personal 
computer. Image handling and analysis software was written in TIM (TEA, 
Dordrecht). Images of 512x512 pixels were digitized and stored on computer hard-
disk, prior to analysis. In the image analysis steps the images were corrected for 
background shading and filtered prior to segmentation applying local segmentation 
routines based on gTey value histogram interpretation (iso-data threshold 
determination). After thresholding, several binary operations were conducted including 
detection and separation of overlapping objects. Of each nucleus a panel of 
morphometric, densitometric, and chromatin textural features calculated (Table 2 and 
3, Chapter 1) and the automaticly contoured and numbered nuclei were marked in 
the image for verification by the technician. Of each slide 50 randomly selected 
images containing 100 to 500 nuclei were analyzed after recording on the harddisk of 
the computer. Recording of these images took 4 minutes per slide. The 50 images per 
slide were automaticly analyzed, without intervention by the technician, in 80-100 
minutes. After the automatic analysis the selected nuclei are contoured and numbered 
in the images enabling 'post-analysis' verification of the objects visually. Lymphocytes 
in the material were used as reference for 2c DNA content after applying a correction 
factor of 1.19. For interpretation of the DNA histogram obtained by analysis of the 
integrated optical density (IOD) per nucleus, the 2c Deviation Index (2cDI), 5c 
Exceeding Rate (5cER), and a measure of polyploidy (PPR, percentage of polyploid 
nuclei) were calculated. Moreover, DNA histograms were scored as diploid, 
aneuploid, or tetraploid. Aneuploidy was defined as an abnormal peak outside 2c (1.8-
2.2c) and 4c (3.8-4.2c) regions, tetraploid histograms had 4c peaks containing more 
than 20% of cells with or without G,M peaks at 8c DNA content. Of each sample the 
mean value for each karyometric feature was calculated. As a measure of variation 
within the sample the difference between the 15th and 85th percentile was calculated. 
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Pilot analysis 
Initially 124 bladder washings for a pilot analysis were sampled prior to histological 
biopsies of the tumor. Two karyometric features showed correlation with the presence 
of tumor: 2c Deviation Index (2cDI) and a nuclear shape feature PASS. 
log 2cDI 
12 14 16 
m e a n of PASS 
Figure 1. Scalierplot of 2cDI and mean PASS per sample by histological tumor grade 
(Gl:squarc; C2:triangle; G3:circle). The box contains 85% of normal cases. The arrow 
indicates the increase in tumor grade (n=124). 
Moreover, a correlation of the karyometric features with histological tumor grade was 
found (Figure 1). These findings suggested the applicability of the system for the 
grading of bladder wash samples. After adaptation of the image analysis facilities 
(extension of image storage capacity and faster processing), a study for validation of 
these results was conducted. 
Hence, 1600 samples were obtained in five urological institutes (october 1990 to 
december 1992) from 695 patients. Each bladder washing was send to our laboratory 
and accompanied with an application form with patient data. From the 1600 samples 
149 (9.3%) were not suitable for karyometric analysis due to an abundant number of 
inflammatory cells or low number of urothelial cells. 
For calculation of the multivariate analysis function, 115 samples were analyzed 
in a logistic regression analysis. The samples were selected from the entire population 
on the following criteria: the sample should be the first sample of the patient present 
in the study and histopathological confirmation of the presence or absence of tumor 
should be available. The group was divided into samples from patients with (n=88) 
and without (n=27) histological cancer. 
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To validate the function, the chance on tumor, as calculated from the 
karyometric features was correlated with the pathological or cystoscopical findings in a 
large population (n=1336). The material was divided into different groups: samples 
without macroscopical or microscopical tumor (n=830); samples with tumor (n=203); 
samples taken during intravesical therapy (n=155); samples with non-transitional cell 
cancer lesions, like squamous cell carcinoma (n=8); and samples from patients with 
prostatism complaints (n=140). In 111 cases the sample was obtained at the operation 
room prior to transurethral resection of the tumor, 1225 samples were from patients 
attending the outpatient department. The distribution of samples per patient is given 
in Table 1. 
Table 1. Distribution of number of samples per patient-
number of samples total 
perpatnt: 1 2 3 4 5 6 7 8 9 10 11 12 
number of 
samples: 695 280 153 101 80 55 36 25 14 7 4 2 1451 
number of 
patients: 415 127 46 27 25 19 11 11 7 3 2 2 695 
Patient Data Management 
Since for each bladder wash sample an application form was filled in all data 
concerning earlier treatments were available at the time of the karyometric analysis. 
The databases containing this information were linked to the karyometric analysis so 
that the report form contained both karyometric analysis results of the analyzed and 
prior samples as well as all data available of the patient. 
Reproducibility 
In Chapter 2 the reproducibility of the karyometric analysis among three technicians 
was tested. It was concluded that at least 100 nuclei should be analyzed when random 
selection is applied. Since samples were send by mail we also tested the influence of 
fixation time and transportation. When fixed in Carbowax solution, fixation of at least 
three days is necessary to obtain optimal Feulgen staining. The samples obtained in 
the collaborating institutes were compared with samples in our institute. The former 
samples were send by mail whereas the latter were received in our laboratory within 
one day after bladder rinsing. Karyometric feature values for samples without tumor 
were compared and no significant difference between samples send by mail and the 
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samples from our institute was observed (P > 0.10, ANOVA). 
Statistical Analysis 
To obtain a variance stabilizing transformation the logarithmic value of the 
karyometric features was used (see Chapter 1). For comparison of two groups the 
non-parametric U test analysis according to Mann-Whitney was applied. A 
multivariate logistic regression analysis of the karyometric features was performed to 
discriminate the tumor and non-tumor group. To avoid patient dependent influences, 
only the first sample per patient was used to calculate the regression function. 
RESULTS 
Of the sampled 1451 bladder washings, follow up was available with a median of 7.3 
months (range 3 - 26.3 months). In the univariate analysis of the 115 samples from the 
operation room, several karyometric features were significantly different between 
tumor and non-tumor samples. Of the nuclear shape features mean BEN per sample 
was significantly higher (P < 0.0001, Mann-Whitney U test), whereas mean PASS was 
significantly lower (P<0.0001, Mann-Whitney U test) in tumor samples compared to 
non-tumor samples (Figure 2 and 3). A high negative correlation for mean PASS and 
mean BEN per sample was found (r = -0.8531, Ρ < 0.001). 
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Figure 2. Mean BEN values by 
histological tumor grade. 
Figure 3. Mean PASS values by 
histological tumor grade. 
Nuclear size as estimated by the nuclear profile area increased with an increase in 
histological tumor grade and was significantly higher in grade-3 compared to grade-1 
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and 2 tumors (P<0.0001, Mann-Whitney U test). The analysis of nuclear DNA 
content revealed significant higher values for 2cDI, 5cER, and PPR in samples from 
patients with bladder cancer. The 2cDI and 5cER increased with tumor grade. 
In the multivariate analysis of the karyometric features, the mean BEN and 2cDI 
were selected in the model for the prediction of the presence of tumor (Table 2, 
Figure 4). 
Table 2. Régression function calculated in (he logistic regression analysis of the karyometric features 
for the presence of tumor. 
SE, 
intercept 
log(BEN) 
log(2cDI) 
-9.2864 
25.6120 
1.2261 
2.0972 
5.3981 
0.5431 
0.0001 
0.0001 
0.0240 
XBela = -9.2864 + (25.6120 · log(BEN)) + (1.2261 · log(2cDI)) 
and: 
" к м * "" 
1 + 6 " » 
The lines for the chances on tumor (p) can be obtained as follows: 
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Figure 4. Distribution of tumor and non-tumor scores in the scatterplot of the 2cDI and the 
mean BEN per sample. Note the logarithmic character of the function, due to the use 
of logarithmic karyometric features in the analysis. 
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The distribution of the samples in this population is given in Table 3. Sensitivity of the 
karyometric analysis for the detection of tumor in the bladder was 90% in this 
population; specificity 70%. All eight false-positive scored samples (P,,™, £ 50% and 
no histological tumor) had Ρ^„ values smaller than 75% (Figure 5). Of the seven 
false negative scored cases ( Р
Ь т и
 < 50% but histologically tumor present) six were 
histologically grade-1 and one grade-2 tumors. All grade-3 and CIS cancers had P lumor 
> 50%. The sensitivity for grade-1 tumors was 7 1 % (15/21) and 96% (29/30) for 
grade-2 cancer (Figure 6). 
Table 3. Cross table of the karyometric prediction of tumor and the histological findings in the 115 
samples analyzed in the logistic regression analysis (n=115). 
karyometric prediction 
no-tumor 
(Pu™ < 50%) 
tumor 
(Ρ*™ > 50%) 
actual status 
no tumor 
tumor 
19 
7 
8 
81 
3.20 
1.60 -
8.00 
3.20 
2.00 
BEN BEN 
Figure 5. Scattergram of samples without Figure 6. 
histological bladder cancer (n=27). 
Samples with histological 
cancer by tumor grade (n=88) 
(square:Gl; triangle:G2; circle:G3). 
Verification analysis 
To evaluate the function found in the logistic regression analysis for each of 1033 
samples the P , ^ was calculated and each sample was scored as tumor ( P , ^ > 50%) 
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or non-tumor (Ρω«» < 50%). In Table 4 the karyometric score is compared to the 
actual status. Sensitivity for the detection of tumor in this population was 90.6 % and 
specificity 69.8%. Of the false positives (n=250) 242 (97%) were samples obtained at 
the outpatient department, whereas overall 8 1 % was obtained at this location (P < 
0.0001, chi-square test). 
Table 4. Crass table of actual status (assessed bjstopalbologically or cystoscopicalry) and karyometric 
prediction of the presence of tumor (n=lQ33) 
karyometric prediction 
no-tumor 
( P ^ < 50%) 
actual status 
no tumor 580 
tumor 19 
Moreover, follow-up data in the false positive group revealed a significant higher 
frequency of recurrent tumors compared to the rest of the population (20% versus 
4.2%, Ρ < 0.0001, chi-square test). Of all samples followed by a tumor recurrence 
during follow up (n=51), 44 (86.4%) showed a karyometric score suspicious for tumor 
( P — * 50%) (Figure 7). 
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Figure 7. Scattergram of karyometric features BEN and 2cDl for samples followed by tumor 
recurrence (n=51). Note that only seven cases had Ρ^„, values smaller than 50%. 
tumor 
ίΛ— * 50%) 
250 
184 
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Cytology and karyometric analysis 
To compare the sensitivity and specificity of the kaiyometric analysis with the visual 
cytology, a subset of 104 samples was analyzed with both techniques. Due to 
inadequate material (too few diagnostic cells) 8 samples were not suited for 
cytological analysis. In Table 5 the cross tables for the cytological and kaiyometric 
analysis are given. Sensitivity for cytology was 71.6% and for the kaiyometric analysis 
95.2% in this population; specificity was 60% and 65% for both techniques, 
respectively. Of the false negative samples in cytology, 43% (10/23) were tumors with 
a histological grade higher than grade 1. The false negatives in the karyometric 
analysis consisted of three grade-1 and one grade-2 tumor. 
Table 5. Comparison cytological and kaiyometric analysis with actual tumor status (n=104). 
cytology karyometric score 
no tumor tumor no tumor tumor 
actual status 
no tumor 9 6 13 7 
tumor 23 58 4 80 
Bladder washing and voided urine 
Since the bladder washing procedure still requires invasion with either a catheter or a 
cystoscope into the bladder, we compared it with the karyometric analysis of voided 
urine as well. In the Figures 8 and 9 the correlation between the karyometric analysis 
of voided urine sample and subsequent bladder washing is shown for the two 
karyometric features in the logistic regression function (n=40). No significant 
correlation was found for the two features. In a multivariate analysis for the 
discrimination of tumor versus no tumor samples, only the karyometric feature values 
from the bladder wash samples were of value. 
132 Chapter 4 
a 
•о 
1) 
Ό 
О 
> 
1.00 
1.00 1.20 1.40 1.60 1.80 2.00 
BEN in BW 
о 
α 
•Ό 
•ο 
Ο 
> 
Q 
ο 
Figure 8 and 9. Correlation of karyomctric features mean BEN and 2cDI in bladder washing and 
concomitant voided urine sample. 
DISCUSSION 
Superficial transitional cell carcinoma (TCC) of the bladder has a high recurrence rate 
after transurethral resection (30-90%).12'3 Grade, prior recurrence rate, and 
multiplicity are the most important predictors of recurrences in these tumors.'4,15 
Compared to superficial cancer, invasive disease constitutes a much greater threat to 
the patient's health. Because 10-30% of superficial TCC progress to an invasive 
phenotype, prediction of tumor progression forms an important issue in bladder 
cancer management."·" Progression to an invasive phenotype is best predicted by; the 
tumor grade, size, and recurrence rate.14 Grade-3 tumors were five times more prone 
to metastasis than grade-1 tumors (30% vs 6%).14 These findings indicate the 
importance of tumor grading as a prognostic factor. 
Exfoliation of tumor cells in urine, as was initially demonstrated by Papanicolaou 
in 1945," offers a powerful diagnostic tool for detection and grading of patients with 
TCC of the bladder. Although sensitivity for high-grade tumors is high (94-100%), 
low-grade lesions are less readily detected by cytology (sensitivity: 30-60%).'"° The 
criteria for detection of neoplastic cells in urine are seemingly straight forward, but 
the sometimes low number of abnormal cells, the inability of quantitation, and the 
high variety of atypical characteristics demand much experience of the cytologist. 
Reproducibility of cytological grading systems, therefore, is disturbingly low.' 
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Furthermore, comparison of subsequential samples from one patient for the early 
detection of cytological abnormalities is arduous. 
Quantitative analysis of cytology can be divided into flow cytometric and image 
analysis methods. 
Flow cytometric studies showed the diagnostic value of DNA content analysis of 
bladder washings. Sensitivity for the detection of tumor varied from to 50 to 83%, 
dependent on tumor grade.2 3 4 , e · 7 , 2 ' DNA content analysis provided information on 
tumor behaviour: of diploid superficial bladder tumors 2-8% progress to invasive 
disease (> T2), whereas 35-50% of aneuploid tumors do. Although not conclusive, 
these data show that DNA content analysis is an important prognostic parameter. A 
disadvantage of flow cytometry is the fact that visual control of measured objects is 
impossible. Visual control is particularly useful in samples with much debris and large 
amounts of lymphocytes. Koss et al. (1989)3 found DNA content analysis by image 
analysis techniques to add information to flow cytometry by more selective analysis of 
abnormal cells as is made possible by image analysis techniques. In a recent study 
Amberson et al. (1993)" applied DNA content analysis by image analysis in those 
cases where cytological interpretation was ambiguous. Sensitivity for both low-grade 
and high-grade lesions increased with more than 10%. DNA content assessment by 
image analysis, therefore, is an important diagnostic tool in quantitative cytology. 
Since visual tumor grading is based on several cellular and nuclear features, 
attempts have been made to come to multivariate quantitative grading by image 
analysis of voided urine sediments.1022 Bladder washings enable the harvest of more 
and better preserved material than voided urine.4,23 We, therefore, tested a 
multivariate approach for the early detection and grading of recurrent bladder tumors 
using bladder washings. The features were all based on nuclear characteristics applied 
in the visual assessment of tumor grade. In Chapter 1 we described the use of nuclear 
size in a cytomorphometric study and found it to be correlated with visual tumor 
grade. Besides size, nuclear shape and chromatin texture features were included in the 
present study. We calculated nuclear shape features based on the Freeman chain 
code.24,2* In this way size independent measures of nuclear shape were obtained. A 
correlation with histological tumor grade was observed. Low-grade tumors were 
characterized by low 2cDI values often in normal range. Detection of these tumors 
was frequently possible due to abnormal values of nuclear shape. For high-tumors 
abnormal DNA ploidy patterns resulted in increased 2cDI values, whereas nuclear 
shape was also different from tumor free samples. In the pilot study, a nuclear shape 
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feature (MPASS) describing the degree of ellipse-shape of the nucleus was found to 
be particularly of value for the detection of low-grade cancer. Since the 2cDI of low-
grade tumors was in normal range an additional value of this nuclear shape feature 
was expected. In a multivariate analysis the 2cDI and MBEN, a feature highly 
correlated with MPASS, were selected for the prediction of tumor. The value of 
karyometric analysis was confirmed in a large population. Of the grade-1 tumors 71% 
could be detected, which compares favorably with the detection rate of low-grade low-
stage lesions by flow cytometry (64%)s and cytology were low-grade lesions are 
identified infrequently (51%).1β,2β Sensitivity for histologically high-grade lesions was 
100% for the karyometric analysis and comparable to detection rates of flow 
cytometric analysis.3 
These data show that karyometry is well suited for the detection of bladder 
cancer by bladder washings. Although a difference between the population in the pilot 
study and the verification analysis existed (in the pilot study, histological confirmation 
of tumor was present; in the second analysis tumor was only detected by cystoscopy) 
in both populations a tumor could be missed, resulting in a 'false'-positive karyometric 
score. This is one of the reasons for the low specificity in both populations. 
Another cause of the relatively low specificity could be the predictive value of 
the karyometric analysis. Tumor recurrence and progression are determine prognosis 
in superficial bladder cancer.14 Tumor markers predicting recurrence and progression, 
therefore, are subject of many studies. Proliferation rate, ploidy pattern, and several 
possible molecular biological markers and monoclonal antibodies are of prognostic 
value in bladder cancer. The multifocal origin of bladder cancer suggests a general 
disease of the urothelial mucosa. Tumor biopsies alone do not provide information on 
the general status of the mucosa. Bladder washing provides a simple means for 
sampling material from the entire bladder mucosa. Compared to voided urine more 
and better preserved cells are obtained, originating from the entire bladder mucosa." 
The short-term follow up in the present study revealed a high recurrence rate (20%) 
in patients with negative cystoscopical findings but a karyometric score that indicated 
tumor. Moreover, 86% of all tumor recurrences were preceded by a cystoscopically 
tumor-negative sample with positive karyometry score. The low specificity of the 
karyometric analysis therefore, is partly caused by its predictive value of later tumor 
development. Hence, careful follow up of the patients with a false-positive 
karyometric score is advisable. We therefore developed a report form presenting both 
karyometric score and clinical history (Figure 10). 
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Figure 10. Report form with karyomctric analysis results and patient data. 
Since theoretically "normal" and "abnormal" cells are present concomitantly in the 
sample, in an earlier study we also investigated the distribution of cells with different 
karyometric phenotype within the samples.2" Based on the karyometric score per 
sample each nucleus was scored as either "normal"', or "abnormal" depending on its 
ploidy level (deviation from 2c in the population) and shape as calculated by BEN. 
For each sample we then calculated the percentage of normal nuclei, i.e. nuclei with 
2cDI and BEN values within normal range. The percentage of normal cells was 
significantly lower in tumor samples (/> < 0.05). Moreover, with an increase in tumor 
grade, the percentage of normal cells decreased. This may be caused by the higher 
exfoliation rate of high-grade tumor cells. Unfortunately, tumor size could not be 
established accurately in these patients but will certainly influence the number of 
"abnormal" nuclei shed in the bladder washing. Surprisingly, however, percentages for 
"normal" nuclei were not significantly different in invasive and superficial tumors. 
The influence of intravesical therapeutic instillations on (bladder wash) cytology 
have been described.3031 BCG instillations resulted in an increased number of 
polyploid cells2 whereas mitomycin-C (MMC) treatment gave rise to cytological 
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abnormalities several months after instillation.3"2 The bladder wash samples taken 
during or within 2 months after intravesical therapy were separatly analyzed. The 
percentage of recurrent tumors (5%) during follow up in this group (n=155) was 
similar to the entire population. The patients in the intravesical instillation group that 
developed a recurrent tumor had P,,,^ values larger than 70%. These findings indicate 
that, although, the karyometric score is influenced by BCG or MMC instillations, 
samples of patients at risk still exhibit more abnormal karyometric scores. 
The logistic evalution shows that the applied combination of fixation and mailing 
of samples provides adequate sample preservation for cytological as well as 
karyometric analysis. Recently the NCI provided recommendations for the 
preservation of bladder washings for flow cytometry.4 We added polyethylene glycol to 
the described fixation method in 50% ethanol for better preservation of cytological 
features.29 For storage longer than 7 days the material was centrifuged and 
resuspended in Carbowax and stored at -20°C. 
From our findings we conclude that karyometric analysis provides a sensitive 
method for the detection of tumor in the bladder. A karyometric score of two nuclear 
features (2cDI and BEN) was designed. High-grade lesions were always detected 
whereas sensitivity for low-grade lesions was 7 1 % . The low specificity (58%) is partly 
explained by the predictive value of later tumor recurrences. 
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ABSTRACT 
The variation in tumor cell differentiation within one renal cell carcinoma, also 
termed tumor heterogeneity, renders visual tumor grading of these carcinomas 
difficult. Karyometric analysis enables description of nuclear characteristics of multiple 
tumor areas. Hence, karyometric analysis can be used to quantify tumor heterogeneity 
and thus may aid in a more objective grading of renal cell carcinoma. Of 121 patients 
with renal cell carcinoma (RCC) (tumors UICC stages: 1 [5 cases], 2 [23 cases], 3 [33 
cases], and 4 [60 cases]) clinical and karyometric features were studied to obtain 
routinely applicable prognostic factors. Several parts of the tumor were analyzed, to 
obtain a measure of tumor heterogeneity. Univariate and multivariate Cox regression 
analyses were used to determine the predictive value of karyometric features 
independent of tumor stage and other clinical characteristics. The Cox univariate 
regression analysis showed correlation of several clinical and karyometric 
characteristics with survival. Of the clinical characteristics TNM stage, tumor size, 
weight reduction and performance status were significantly associated with survival. 
The karyometric features, especially those measurements associated with tumor 
heterogeneity (e.g. differences in nuclear size or chromatin texture between tumor 
subpopulations) were of value in predicting prognosis. In the Cox multivariate 
regression analysis the Robson and UlCC-stages proved to be the most powerful 
predictors of survival (/><0.0001). Of the clinical features, weight reduction and 
performance score were the only characteristics offering additional information to 
tumor stage (P< 0.0001). From the karyometric analysis quantification of anisokaryosis 
in the tumor at time of diagnosis offered additional prognostic information. Moreover, 
the differences of karyometric features within the tumor presumably associated with 
tumor heterogeneity correlated with survival. Using the features from the multivariate 
analysis, prognostic groups could be defined. We conclude that karyometric analysis 
offers a useful means for quantifying tumor heterogeneity. Multivariate Cox analysis 
revealed additional value of a grading system based on karyometric analysis to tumor 
stage. 
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INTRODUCTION 
Renal cell carcinoma (RCC) accounts for 3 percent of all malignancies and the 5-
years survival rate is 30 to 60%.' The tumor is characterized by its unpredictable 
clinical course and only limited effective treatment modalities are available. The 
staging system initiated by Flocks and Kadesky and popularized by Robson and 
associates is based on the extent of the tumor and correlates with survival.2,3 Another 
widely used staging model is the TNM system of the American Joint Committee for 
cancer staging which classifies the tumor according to the anatomical extent of 
disease.4 This has been the basis of the staging by the International Union against 
Cancer.5 However, within subgroups of patients as defined by these classification 
models, the clinical course of RCC is still diverse. 
No important improvement in the survival of patients with RCC has been 
achieved during the last decades. Surgery remains the cornerstone of treatment and 
the only way to cure the patient. New treatment modalities like immuno- and 
chemotherapy are under investigation.6,7 Response rates for these treatments in the 
overall population of metastasized disease are low (10-30%). There are, however, 
indications that selection of patients based on prognostic factors can improve response 
rates.'1' Therefore,we investigated clinical and pathological features of patients with 
RCC for their prognostic value. 
For several tumors, grading offers prognostic information. Considering the 
extensive tumor heterogeneity in renal cell carcinoma'0 we sought to develop an 
objective grading system analyzing several parts of the tumor. Karyometry is used to 
quantify nuclear features and offers an objective measure of tumor phenotypic 
characteristics. Since heterogeneity will probably result in nuclear differences in light 
microscopy, comparison of the karyometric feature values of different areas within the 
tumor can be an objective measure of tumor heterogeneity. 
In order to obtain insight in the prognostic value of such karyometric grading the 
features were correlated with patient survival. Moreover, the karyometric grading was 
compared to classical prognostic features in a multivariate analysis. 
MATERIAL AND METHODS 
Material 
Data were obtained of 121 patients (77 men; 44 women) with a RCC treated between 
1983 and 1990 with tumor nephrectomy. The patient age ranged from 32 to 85 years 
(median 67 years). The median follow up was 21 months (range 4 - 133 months). 
All the patients could be classified according to the TNM(V)-model and staged 
according to the Robson and the International Union against Cancer (UICC) 
classification models.35 
For patients with metastatic disease several adjuvant treatments were given. In 
65 M+ patients one or more forms of immuno- and/or chemotherapy were given 
(IFNalpha + IFNgamma: n=58, IFNalpha: n=5, vinblastin: n=l , IL2 + IFNalpha: 
n=l) . In 7 patients palliative radiotherapy was given after the tumor nephrectomy. At 
the time of diagnosis of the primary tumor these additional treatments did not 
improve survival significantly: 3 years survival rates for treated and non-treated 
metastasized disease was 0.27 and 0.30 respectively (log-rank test, P>0.05). Hence, all 
121 patients could be grouped and analyzed for prognostic factors irrespective of the 
additional treatment given after tumor nephrectomy. We should notice that these 
therapy modalities were only used in patients with detectable metastases. 
Clinical features 
Various clinical characteristics of the patients, in earlier studies found to be associated 
with the outcome of the disease, were recorded for subsequent analysis. Besides 
patient age and gender, these included variables used for the classification models like 
pathologic stage, haematogeneous and lymphogeneous metastases, venal invasion of 
the tumor and tumor size. Moreover, general indicators of the patients physical 
condition were documented like performance status (Karnofsky score), history of 
weight reduction, and serum haemoglobin concentration at time of diagnosis. 
Karyometry features 
All paraffin-embedded archival material for each patient was reviewed by one 
pathologist (H.S.). Morphologically different tumor areas were marked for further 
karyometric analysis. The selection of areas was based on differences in histology 
(papillary and non-papillary) or cytology (clear, granular, and spindle cell). 
Karyometric analysis consisted of nuclear morphometry, densitometry, and chromatin 
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pattern analysis with a PC-based image analysis system (VFG-framegrabber board, 
Imaging Technology, Woburn, MA) in a Compaq 386s personal computer). Image 
handling and analysis software was written in TIM (TEA, Dordrecht). For analysis, 4 
μιπ thick paraffin-embedded sections were deparaffinized and Feulgen-Schiff stained 
as room temperature. Within the marked areas, nuclei in 50 randomly chosen images 
were analyzed with a lOOx objective. After shading correction and image filtering a 
local segmentation procedure was performed based on the grey-value histogram in the 
subimage. Of each nucleus in the recorded images a panel of karyometric features 
was measured (see Table 2 and 3 Chapter 1). At least 100 tumor nuclei were 
measured per tumor area. A sequence of 200 images could be analyzed in 5 hours. Of 
the analyzed nuclei data and images were recorded, thus enabling manual rejection of 
out-of-focus or faulty segmented objects after the measurement by the operator. For 
each sample the 2c Deviation Index (2cDI) and 5c Exceeding Rate (5cER) were 
calculated." 
Since in all tumors morphologically different tumor areas were marked by the 
pathologist, a measure of heterogeneity could be calculated as follows. In all tumors 
for every nuclear feature the tumor area with the highest and lowest value and their 
differences were determined. We also analyzed whether karyometric analysis of tumor 
areas marked by the pathologist was different from at random measurements in the 
tumor. Hence, besides data of the different tumor areas all values of the tumor areas 
were merged and median and difference of 15* and S^* percentiles were calculated to 
obtain a subpopulation independent measure of tumor heterogeneity. 
The karyometric measurements were tested for inter-individual reproducibility 
among three technicians. For this purpose we have chosen randomly 28 out of the 121 
RCC patients. Three technicians performed independently karyometric measurements 
of nuclei in the marked tumor areas. The measured feature values were analyzed for 
their inter-observer agreement using a two-way ANOVA. To test the reproducibility 
of the selection of tumor areas by the pathologist the procedure was performed twice 
by two persons in 10 randomly selected patients. 
Statistical methods 
The time from treatment to death was studied using survival analysis. The Kaplan-
Meier method was used to estimate the survival function in a group. Differences of 
survival functions between groups were tested for statistical significance using log-rank 
test and Wilcoxon test. The 3-years survival rates with 95% confidence intervals were 
144 Chapter 5 
calculated using the Kaplan-Meier method. Cox univariate and multivariate regression 
analyses (i.e. proportional hazard model) were performed to estimate the influence of 
the clinical and karyometric on the survival time.12 Both forward and backward 
stepwise-selection procedures were used to find the best model in predicting the 
survival time. The stepwise-selection procedure was performed in two parts. In part I, 
the selection was used to find all clinical features to define either the best or an 
equivalent model. The Bonferroni correction was used for model entry of a variable. 
The same procedure was also performed on the karyometric feature group. In part II 
the selection procedure was performed on the features from the two feature groups 
selected in the previous step. 
To obtain a prognostic score (RCC-score: good, intermediate, and poor 
prognosis) based on the selected features in the multivariate analysis, the linear part 
of the best multivariate model (XBeta) from the selection procedure was used. The 
levels of the RCC-score were arbitrarily chosen from jumps in the XBeta values of the 
present patients group. 
RESULTS 
Clinical features 
During the follow-up period 68 (56%) patients died from RCC. The overall 3-years 
survival was 48%. The Kaplan-Meier estimators for survival for both Robson and 
UICC classification models in our patients are shown in Figure 1 and 2 respectively. 
The differences between the 3-years survival percentages of the stages is presented in 
Table 1. 
Table 1. Three-ycais survival values for different stages in UICC and Robson stages. 
il 3-yrs LCL UCL 
Robson stage 
A 
В 
С 
D 
stage 
1 
2 
3 
4 
20 
14 
32 
55 
5 
23 
33 
60 
0.83 
0.77 
0.53 
0.27 
0.67 
0.82 
0.59 
0.29 
0.60 
0.55 
0.35 
0.15 
0.13 
0.67 
0.41 
0.17 
1.00 
1.00 
0.71 
0.39 
1.00 
1.00 
0.76 
0.41 
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Figure 1. Kaplan-Meier survival curves for the Robson staging (stage A: n=20, stage B: 
n=14; stage C: n=32; stage D: n=55). 
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Figure 2. Kaplan-Meier survival curves for the tumor staging according to the UICC 
(1987) (stage 1: n=5; stage 2: n=23; stage 3: n=33; stage 4: n=60). 
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Several clinical features appeared to be related with survival. Of the pathological 
features an increase in T, M, or N stage was significantly correlated with a shorter 
survival (Р< 0.005, Cox regression analysis). The presence of venal invasion (V), 
patient age and sex, a low serum haemoglobin concentration at time of diagnosis, and 
the histological tumor type, however, were not significantly related with a shorter 
survival (/>>0.10, Cox regression analysis). Other clinical characteristics that predicted 
a shorter survival were large tumor volume, a history of weight reduction, and a low 
Kamofsky score (Table 2). 
Table 2. Results from the univariate Col's regression analysis of the influence of the clinical variables 
at the beginning of the treatment on the survival in renal cell carcinoma. 
η В SE, Ρ relative 
hazard' 
UICC-stage (1987) 
Τ 
Ν 
M 
V 
tumor size 
tumor type 
haemoglobin 
weight reduction 
Kamofsky score 
age 
sex 
121 
121 
121 
121 
121 
106 
121 
112 
112 
108 
121 
121 
-0.830 
-0.530 
-0.848 
-1.230 
-0.531 
-0.068 
-0.093 
0.203 
0.806 
0.046 
-0.005 
0.039 
0.194 
0.175 
0.250 
0.266 
0.250 
0.030 
0.333 
0.105 
0.260 
0.013 
0.009 
0.257 
0.000 
0.002 
0.000 
0.000 
0.120 
0.025 
0.779 
0.053 
0.002 
0.000 
0.561 
0.878 
0.436 
0.588 
0.428 
0.292 
0.588 
0.934 
0.911 
1.225 
2.240 
1.047 
0.994 
1.040 
') relative hazard of survival per unit of measurement. Example: The probability to survive another 
month for a person is 7% lower in comparison to a person with a one mm smaller tumor. 
Karyometry features 
The reproducibility test of the marking of morphologically different tumor areas by 
the pathologist revealed differences in areas in 5 of 10 selected patients. Microscopic 
review of the different selected areas, however showed similarity in morphology. 
Moreover, the karyometric analysis of the areas resulted in non-significant differences. 
The karyometric measurements were tested for inter-individual reproducibility among 
three technicians. For only three of 32 karyometric features discrepancies were found 
among the technicians: the same observer scored significantly higher values for one 
feature (MH3) and differences were found for two other features (MAREA, MIOD). 
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This resulted in a higher percentage of explained variance due to the observers 
compared to the total variance (2%, 6%, 8% respectively). For the other features the 
explained variance was less the 1%. Comparison with the percentage explained by the 
variation between slides showed that differences between observers might be of minor 
importance: percentages explained by the variation between slides was 85%, 71%, and 
68% respectively for the features (MH3, MAREA, MIOD) and 78% to 93% for the 
remaining features. 
The mean number of morphologically different tumor areas as marked by the 
pathologist per tumor was 2.05 (range 1 to 5) and was not correlated with survival 
(P>0.10, Cox regression analysis). 
Univariate analysis of the karyometric features showed a correlation between 
several nuclear characteristics and survival (Table 3). Of the nineteen karyometric 
features that were related with survival, two were subpopulation independent features. 
Eleven of the subpopulation dependent features that correlated with survival were 
features describing differences between tumor areas within the tumor. Karyometric 
features that showed best correlation with survival were variations in nuclear shape as 
described by the standard deviation of the bending energy (SDBEN), variances in 
nuclear size (SDAREA) and 'coarseness' of the chromatin as measured by the inverse 
difference moment of the requantitated pixel value co-occurrence matrix (Markovian 
feature НЗ). 1 3 Я 
Multivariate analysis 
Table 4a shows the results of the Cox multivariate regression analysis. Within this 
analysis the clinical variables tumor UlCC-stage, the presence of weight reduction at 
time of diagnosis, and the Karnofsky score were the most important characteristics for 
survival. Besides these clinical characteristics the karyometric feature variation of the 
standard deviation of the nuclear size in different areas of the tumor showed 
additional prognostic significance. To study the significance of karyometric analysis in 
high-stage patients multivariate Cox analysis was performed on all UlCC-stage 4 
patients with known karyometric analysis (n = 52). Similar to the findings in the 
entire group, the karyometric analysis offered prognostic value as did the clinical 
characteristics. However, in the high-stage tumor group the highest value for the 
karyometric texture feature describing chromatin pattern coarseness per tumor (H3, 
inverse difference moment) was the best predictor of survival of both the karyometric 
and clinical features. 
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Table 3. Univariate regression analysis according Cm of karyomelric features and survival in renal cell 
carcinoma. 
feature SE, relative 
hazard 
subpopulation-dependcnt 
L MP ASS 
LSDOD 
UMAREA 
U SDIOD 
UMH3 
D2cDI 
D5cER 
D MAREA 
D SDAREA 
DMFPE 
DMBEN 
D SDBEN 
DSDOD 
DMIOD 
D SDIOD 
DMH3 
subpopulation-indcpendent 
SIOD 
MEDH4 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
115 
-0.145 
-8.859 
0.034 
0.113 
Z925 
0.060 
0.040 
0.016 
0.044 
1.563 
0.915 
3.741 
3.910 
0.058 
0.112 
3.969 
0.137 
-1.187 
0.067 
4.035 
0.017 
0.040 
0.885 
0.028 
0.020 
0.008 
0.016 
5.143 
0.449 
1.693 
3.808 
0.025 
0.045 
2.055 
0.055 
0.599 
0.029 
0.028 
0.044 
0.004 
0.002 
0.029 
0.043 
0.046 
0.006 
0.040 
0.042 
0.005 
0.009 
0.020 
0.014 
0.016 
0.013 
0.048 
0.865 
0.000 
1.035 
1.120 
18.636 
1.063 
1.042 
1.016 
1.045 
4.772 
2.494 
42.149 
49.924 
1.060 
1.118 
52.942 
1.147 
0.305 
L : lowest mean population value 
U : highest mean population value 
D : (D = U - L) diff. between values of highest and lowest population 
S : diff. between 15th and 85th percentile of merged populations 
MED : median value of all populations merged 
2cDI s 2c Deviation index 
5cER = 5c Exceeding rate 
AREA - nuclear profile area 
BEN = bending measure: difference in maximal and minimal value in smoothed difference 
Freeman chain code 
FPE = form PE 
H3 = Markovian texture feature: inverse difference moment 
H4 = Markovian texture feature: rotation moment 
IOD = integrated optical density 
OD = optical density 
PASS = nuclear shape feature: number of passes through threshold of smoothed difference 
Freeman chain code 
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The presence of weight reduction at diagnosis offered only additional prognostic value 
to this karyometric feature. This indicates that karyometric analysis was the most 
important prognostic factor is this group. 
With the best predictors for survival, both the clinical (tumor stage, weight 
reduction, and Karnofsky score) and karyometric features (variation in nuclear size) 
we were able to form prognostic groups in the entire population of 121 patients. The 
results are shown in Table 4b and Figure 3. The prognostic score (RCC-score) was 
calculated using the formula found in the Cox regression analysis. Subdivision of the 
patients group into three groups based on the XBeta value resulted in significantly 
different Kaplan-Meier curves (Figure 3). Good prognosis (3-years survival: 80%) was 
found for patients (n=39) with a XBeta value lower than -2.3, whereas patients 
(n=28) with a XBeta value higher than -1.0 had a poor prognosis (3-years survival 
21%). The 3-years survival for the patients with intermediate prognosis was 41% 
(n=54). 
Table 4a. Multivariate Cox's regression analysis of clinical and karyometric features with survival of 
patients with a renal cell carcinoma. 
Clinical features 
UlCC-stage (1987) 
Karnofsky score 
weight reduction 
Karyometric features 
DSDAREA 0.044 0.018 0.018 1.045 
(anisokaryosis) 
a 
0.875 
•0.039 
-0.740 
SE, 
0.225 
0.014 
0.280 
Ρ 
0.001 
0.006 
0.008 
relative 
hazard 
2.398 
1.041 
2.096 
Tibie 4b. Calajlaüon of the RCC-score based on the features found in the Cox's multivariate 
regression analysis and number of tbc patients in the prognostic groups based on the RCC-score. 
XBeta ( 0.875 * stage) + 
(-0.040 * Karnofsky score) + 
(-0.740 * weight reduction) + 
( 0.044 * D SDAREA) 
stage 
Karnosfky score 
weight reduction 
D SDAREA 
: UlCC-stage (1987) 
: performance status (0-100) 
: weight reduction prior to diagnosis (=1), else 2. 
: difference of SD of nuclear size within the tumor. 
RCC-score XBeta 3-yrs 
survival (%) range 
good prognosis 
intermediate prognosis 
poor prognosis 
<-2.3 
-2.3 - -1.0 
> -1.0 
39 
54 
28 
80 
41 
32 
(65-95) 
(27-55) 
(6-37) 
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Figure 3. Kaplan-Meier survival curves of different prognostic groups according the RCC-
scores (good-prognosis group: η=39, intermediate prognosis: η=54, and poor 
prognosis: η=28). 
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DISCUSSION 
The main problem in the management of patients with RCC is the unpredictable 
clinical course of the tumor. Since tumor grading of RCC is hampered by considerable 
tumor heterogeneity we investigated a karyometric grading system for the 
quantification of differences within the tumor presumably associated with 
heterogeneity. The karyometric grading was tested for its additional prognostic value 
to classical characteristics. 
Karyometric analysis, i.e. the quantification of cell nuclear features in light 
microscopy has been successfully applied for the grading of several cancers. In renal 
cell carcinoma, Tosi and associates and Bibbo and associates found a positive 
correlation between morphometric results and survival in patients with stage-I 
disease.1516 Murphy and associates described a nuclear shape analysis which allowed 
the correct assignment of outcome of localized carcinoma which may become 
available in clinical practice.17 From the studies done so far it has become clear that 
nuclear size as well as nuclear shape are of prognostic value in RCC. However, the 
number of patients in these studies was rather small. Moreover, tumor areas for 
analysis were often chosen at random and none of the studies distinguished different 
parts within the tumor. 
From flowcytometric studies""8 we learned that considerable heterogeneity of 
tumor cell populations exists in RCC. The origin of multiple cell populations within 
the same tumor can most likely be found in genetic instability, a trait of aggressive 
neoplasms. Therefore tumor grading systems including measures for tumor 
heterogeneity as the Gleason grading for prostate cancer,14 may be of additional 
prognostic value. Karyometric analysis offers a means to quantify nuclear features 
within the cell clones. Hence, the technique can be used to obtain a measure for the 
level of phenotypical differences between the cell clones within the same tumor. We 
postulated that the degree of nuclear phenotypic differences within the tumor as 
assessed by karyometric analysis is indicative for tumor heterogeneity and thus may in 
fact correlate with genetic instability in the tumor development. Since increased 
genetic instability might result in more rapid progression to malignant, e.g. 
metastasizing phenotype the karyometric grading of tumor heterogeneity might be a 
good predictor of tumor malignancy. 
In the present study morphologically different areas within the tumor were 
selected by the pathologist and karyometrically analyzed. Whereas the number of 
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marked tumor areas per tumor was of no prognostic value, data from our study 
indicate prognostic value for the degree of heterogeneity as assessed by the 
differences of karyometric phenotype between subpopulations. Heterogeneity in DNA 
content (2cDI), nuclear size, shape, and chromatin pattern were all correlated with 
survival, which is in agreement with other studies.'*'7 
To evaluate the additional value of karyometric tumor grading to classical tumor 
characteristics we also analyzed several clinical characteristics. 
The stage of the tumor, including invasion of the vena cava, and the presence of 
tumor bearing lymph nodes or metastases allows to make subdivisions of patients with 
regard to survival. The local extent of tumor at the time of surgery is the most 
important single variable in determining survival." Because the TNM(V) classification 
defines the anatomic extent, it is often at the basis of further stratification of risk 
factors.1"1 The patients in the current study were classified according to the TNMV 
and Robson system and it appeared that a higher stage was related to a lower 
survival. More explicitly, not only tumor stage but also the presence of lymph node or 
distant metastases showed to be an important prognostic indicator for survival. In the 
univariate analysis they all appeared to be of prognostic significance. It is now clear 
that vena cava invasion, when curatively operated, is not a prognostic indicator as 
such.22 The reason is that it is often associated with factors that heavily influence 
survival, as was also seen in our study.20 
Other features, related to survival, were performance status (Karnofsky score) 
and a history of weight reduction. These obvious clinical characteristics were also 
found by others, and should be included in a prognostic factor analysis.'921 Size of the 
primary lesion, indirectly related to the T-stage, was not an independent prognostic 
factor, as was also seen by others.21 RCC are divided in the literature into clear cell, 
granular cell, spindle cell, and oncocytoma type tumors. Although oncocytomas are 
characterized by a favorable clinical course, the prognostic importance of the other 
tumor types is not clear.22'27 In our series oncocytomas were excluded and no 
difference in correlation with survival was found for the other tumor types. 
To obtain features that independently predict survival, a multivariate analysis 
was performed. It was obvious that tumor stage, history of weight reduction, and the 
karyometric features that illustrate the heterogeneity of the tumor appeared to be the 
most important prognostic factors in patients with RCC. With these factors we were 
able to define certain risk groups that can be used for treatment decision and the 
development of future clinical trials. 
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In tumors already metastasized at time of diagnosis (stage IV) karyometric 
analysis appeared to be the best predictor of survival. However, the karyometric 
features describing heterogeneity in the tumor were less predictive of survival in this 
patient group. It is therefore tempting to speculate that in metastasized disease 
malignant behaviour of the tumor is more determined by the presence of malignant 
cell clones rather than by the chance of development of an even more malignant 
phenotype as possibly represented by tumor heterogeneity. In this light, we consider 
high-stage tumor as completely dedifferentiated cancer that gained full malignant 
potential. 
We conclude that clinical and karyometric features correlate with tumor 
behaviour. Moreover, a combination of karyometry and clinical data offer the best 
prediction of survival. Tumor heterogeneity, as quantified by karyometric analysis 
plays an important role in tumor behaviour. The factors analyzed in this study may be 
of use to individualize the treatment of patients with RCC. 
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ABSTRACT 
Of patients presenting with a renal cell carcinoma (RCC) the tumor is localized (T,. 
,Ν,,Μ,,) to the kidney in 50% of cases. The risk of progression after radical tumor 
nephrectomy in these patients is 45-65%. In order to predict the chance on recurrence 
or development of metastases after nephrectomy tumor markers are necessary. 
Besides tumor stage, tumor grade was shown to be of prognostic value. Tumor 
heterogeneity, however, may render visual grading systems difficult and subjective. In 
the present study we investigated a quantitative grading system focusing on objective 
measures for tumor heterogeneity. The karyometric grading system was correlated to 
follow up data and tested for its additional predictive value to clinical and pathological 
tumor characteristics. 
Material from 52 patients with Τ,^ Ν,,Μι, tumors was studied. During follow up of 
at least 3 years, 21 patients developed local recurrence or distant metastases. The 
tested clinical and pathological features were age, sex, weight loss, performance status, 
serum haemoglobin concentration, tumor stage, tumor size, and histological tumor 
type. Multiple areas per tumor were karyometrically analyzed on cell nuclear features 
to obtain a measure of heterogeneity of nuclear features within the tumor. 
In an univariate Cox analysis for risk of progression, of the clinical and 
pathological characteristics only performance status appeared to have prognostic 
significance; the karyometric characteristics of nuclear shape, nuclear size, and 
chromatin patterns were also predictors of tumor progression. In a multivariate 
analysis differences in chromatin pattern within the tumor were the best predictors of 
progression; only Τ stage added to the prognostic significance. 
In conclusion, heterogeneity of chromatin patterns within the tumor as assessed 
by karyometric analysis appeared to be the tumor feature strongest correlated with 
tumor progression in patients with a localized RCC. Only tumor stage offered 
additional prognostic value in this model. 
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INTRODUCTION 
In approximately 50% of patients with renal cell carcinoma (RCC) the tumor is 
confined to the kidney or the surrounding tissue.1 Notwithstanding the sometimes 
large size of the tumor at time of diagnosis, complete macroscopical removal of the 
tumor can often be achieved by radical surgery. The chance of local recurrence or 
development of distant metastases, however, is still 45-65 %.*3 Moreover, the prognosis 
of patients with progressive disease after radical tumor nephrectomy for a locally 
confined tumor is very poor: mortality rate of 74% at 1 year.3 Hence, the overall 5-
year survival rate for localized renal cancer ranges from 50 to 90 %.'** 
Earlier studies revealed several predictors of tumor progression in renal cell 
carcinoma.7"" Tumor stage is considered to be the most important factor.' However, in 
localized tumors, stage alone could not predict outcome.1 Histological tumor features 
like tissue architecture, cell type, and tumor grade may be of prognostic value.66,10·11,12 
Papillary growing tumors have been reported to have a more favorable prognosis,11 
but pure papillary tumors are rare,13 which may be the reason for contradictory 
reports.7,14 Of the different cell types spindle-cell tumors exhibited a poor prognosis 
compared to granular and clear cell carcinomas, the most predominant cell types 
found.6·1315 The latter two cell types are often found concomitantly in the same tumor 
rendering tumor typing more difficult. Besides the distinction of oncocytomas and 
spindle-cell tumors the subdivision of RCC on base of histological and cytological 
characteristics is of little prognostic value. 
However, tumor grading of RCC proved to be useful.716 In particular nuclear 
atypia was correlated with tumor behavior7 and quantitation of nuclear shape by 
image analysis techniques (karyometry) had predictive value in patients with localized 
disease.2,17 
Heterogeneity of tumor cell populations within a tumor, as is indicated by the 
high percentage of mixed-cell tumors and shown in flow-cytometric analysis,16 will 
affect tumor grading. The origin of different phenotypes within the tumor is not clear 
and the influence of this phenomenon on tumor prognosis has not been studied 
extensively.13,16 Due to heterogeneity, grading of only one part of the tumor, as is 
normally performed in RCC, might not be sufficient, whereas grading of multiple 
tumor areas is time consuming, tedious, and may have detrimental effect on the 
already low reproducibility of tumor grading systems in general.2021 Quantitative 
analysis of nuclear DNA content by flow cytometry seemed rewarding in assessing 
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both tumor heterogeneity and prediction of behavior1*·2*23 although results are 
equivocal.24 Image analysis in light microscopy enables analysis of a wide range of 
nuclear (karyometry) and cellular features (cytometry), including nuclear DNA 
content.29 Since these can be assessed in different parts of the tumor image analysis 
can be used for quantitation of tumor heterogeneity. 
In many clinical trials the role of immunotherapy for disseminated RCC has 
been studied.2" The low response rates found (14-30%) may be caused by positive 
response in only a selected group of patients.2728 It appeared that especially patients 
with: good performance status, relatively low tumor burden,2* no central nervous 
system or bone metastases, and a long interval between nephrectomy and appearance 
of metastases benefit from immunotherapy.3031 These characteristics often apply to 
patients with localized disease, who therefore might be good candidates for early 
immunotherapy.3* Considering the toxicity of these therapy regiments, however, 
careful selection of patients on base of prognostic factors is mandatory. 
Since tumor progression after radical surgery will probably be due to outgrowth 
of micro-metastases that already exist at the time of tumor nephrectomy but can not 
be detected with present diagnostic tools, other predictors of tumor progression are 
needed. To find prognostic factors we studied clinical, pathological, and karyometric 
features for correlation with tumor progression in patients with localized renal cancer. 
Karyometric analysis was applied to obtain quantitative information on tumor 
heterogeneity. 
MATERIAL AND METHODS 
Patients 
We analyzed data of 52 patients (31 men; 21 women) with clinically localized RCC 
treated between 1983 and 1989 with radical nephrectomy. The median age was 57.4 
years (range, 29-93 years), followup was at least 3 years (median, 60 months). 
No evidence of lymph node metastases was found in pathologic examination of 
lymphadenectomy specimens and no distant metastases could be detected at routine 
examination including computed tomography of abdomen and lung tomography. 
Tumors were classified according to the tumor-nodes-metastases (TNM) system 
developed by the International Union against Cancer, which classifies cancer cases 
according to the anatomic extent of disease (Hermanek et al., 1987). Localized 
disease was defined as stage Τ,^ Ν,,Μο. As an endpoint in follow up tumor progression 
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was studied. Progressive disease was defined as renal fossa recurrence or development 
of distant metastases. 
Clinical features 
From literature study several clinical features were chosen for correlation with follow 
up data. The features included were patients age, performance status (Karnofsky 
score), a history of weight loss, and serum haemoglobin concentration at time of 
diagnosis. Besides clinical features the following pathologic characteristics were 
recorded: Τ stage, tumor size, and histologic tumor type. 
Histological material 
Depending on tumor size 10 to 20 blocks per tumor were cut from all tumor parts. 
Material of the resected tumor parts was formalin-fixed (buffered, 4%) and embedded 
in paraffin. Two consecutive 4 μπι slides were cut from each block of the resected 
tumor. One slides was used for hematoxyline staining and interpretation by the 
pathologist. The second slide was stained according to Feulgen (5 N HCl, 60 min. and 
Schiffs reagent, Merck, 30 min. both at room temperature) and used for karyometric 
analysis. The slides were cover-slipped (mounting medium: Permount SP15, Fisher 
Scientific). 
Karyometric features 
One pathologist (H.E.S.) reviewed all histological material and marked the 
morphologically different tumor areas for karyometric analysis. The selection of areas 
was based on differences in histology (papillary and non-papillary), cytology (clear, 
granular, and spindle cell), and degree of nuclear atypia. Since this is an important 
step in the quantitative grading that introduces a subjective element we tested the 
selection of tumor areas inter- and intraindividually by two pathologists in 10 
randomly selected tumor samples. Karyometric analysis consisted of nuclear 
morphometry, densitometry, and chromatin pattern analysis (see Table 2 and 3 of 
Chapter 1) with a PC-based image-analysis system (VFG-framegrabber board, 
Imaging Technology, Woburn, MA) in a Compaq 386s personal computer. Image 
handling and analysis software was written in TIM (TEA, Dordrecht). Images of 
512x512 pixels were digitized and stored on computer hard-disk prior to analysis. In 
the image analysis steps the images were corrected for background shading and 
Filtered for segmentation applying local segmentation routines based on grey value 
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histogram interpretation (iso-data threshold determination). After thresholding, 
several binary operations were conducted including detection and separation of 
overlapping objects. Of each nucleus a panel of morphometric, densitometric, and 
chromatin textual features calculated (Table 2 and 3 Chapter 1) and the automaticly 
contoured and numbered nuclei were marked in the image for verification by the 
technician. Of each tumor area 50 images including SO to 200 nuclei were analyzed. 
Lymphocytes in the slide were used as reference for 2c DNA content after applying a 
correction factor of 1.19. 
To assess the degree of nuclear tumor heterogeneity we applied the following 
mathematical interpretation of the karyometric analyses of the different areas per 
tumor. In all tumors for every nuclear feature the karyometric feature value of the 
tumor area with the highest and lowest value and their differences was determined 
resulting in karyometric measures of nuclear differences within the tumor. To study 
the effect of separate analysis of tumor areas compared to analysis of more random 
measurements, all data per tumor were merged and median and difference of 151" and 
85№ percentiles were calculated to obtain a more subpopulation independent measure 
of tumor heterogeneity. 
Statistical methods 
For analysis of reproducibility the ANOVA test was applied. As an endpoint in follow 
up tumor progression was studied. The Kaplan-Meier method was used to estimate 
the progression rate. Differences obtained were tested for statistical significance with 
the log-rank test and the Wilcoxon test. The 3-year tumor progression rates, with 95% 
confidence intervals, were calculated. 
Cox's univariate and multivariate regression analyses (i.e., proportional hazard 
model) were performed to estimate the influence of the clinical and karyometric 
features on time to tumor progression. Both forward and backward stepwise selection 
procedures were used to find the best model for predicting the disease-free interval. 
The selection procedure was performed in two parts. In part I, the selection was used 
to find all clinical variables to define either the best or an equivalent model. The 
Bonferroni correction was used for model entry of a variable. The same procedure 
was also performed on the karyometric feature groups. In part II we used the 
selection procedure on both clinical and karyometric features selected in the previous 
step. 
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RESULTS 
Ginical features 
Progressive disease occurred during follow up in 21 (40%) patients, of which 15 
(71%) died of disease. The 3-year progression rate was 33% for T, (n=5), 29% for T2 
(n=23), and 47% for T3 (n=24). The differences between the progression rates for 
the tumor grades were not significant in the Wilcoxon test (P = 0.19) or the log-rank 
test (P = 0.17). 
Tumor stage, patient age and sex, serum haemoglobin concentration at the time 
of diagnosis, histologic tumor type, tumor size, and history of weight loss, were not 
significantly related to progression (P>0.10) in the univariate Cox regression analysis. 
Of the clinical features only Kamofsky score was significantly correlated with 
progression (P < 0.05), i.e. patients with a low Kamofsky score at the time of 
diagnosis were at risk to develop tumor progression (Table 1). 
Table 1. Univariate Cox's regression analysis of clinical features and tumor progression. 
Beta SBeta Ρ R 
Sex 
Age 
Kamofsky score 
Weight loss 
Haemoglobin 
Τ stage 
Tumor size 
Tumor type 
Karyometry features 
In the univariate Cox analysis no relation was found between the absolute number of 
marked tumor areas and progression. Of the nine karyometric features, that 
significantly correlated with tumor progression eight were features calculated from the 
different tumor areas and one (MEDPASS, median of nuclear shape descriptor PASS 
of all tumor areas in the tumor) was a feature weighted for the number of nuclei 
analyzed in the different areas (Table 2). Differences in karyometric-feature values 
between different tumor areas within the tumor were highly correlated with 
progression, illustrating the prognostic value of karyometricly assessed tumor 
0.674 
-0.008 
-0.051 
-0.772 
-0.100 
0.686 
0.094 
0.350 
0.450 
0.016 
0.243 
0.487 
0.178 
0.408 
0.071 
0.520 
0.1343 
0.6241 
0.0369 
0.1130 
0.5722 
0.0927 
0.1836 
0.5006 
0.041 
0.000 
-0.137 
-0.064 
0.000 
0.076 
0.000 
0.000 
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heterogeneity. 
Table 2. Karyometric features significantly correlated with tumor progression in univariate Сок 
regression analysis. 
Beu SBeta Ρ R 
I ^ c D I * 
UMBEN 
D SDAREA 
D MSCAT 
D M H 1 
D S D H 1 
D M H 3 
D M H 5 
MEDPASS 
-0.234 
2.243 
0.102 
1.281 
5.934 
6.322 
60.002 
2.799 
-0.254 
0.117 
1.108 
0.041 
0.454 
2.009 
2.424 
19.386 
1.001 
0.121 
0.0464 
0.0429 
0.014 
0.0048 
0.0032 
0.0091 
0.0020 
0.0051 
0.0351 
-0.118 
0.122 
0.170 
0.206 
0.219 
0.185 
0.232 
0.204 
-0.132 
Noie®): L= lowest population value 
U= highest population value 
D= U-L 
MED= median value for entire tumor (all populations merged) 
·) 2cDI = 2c Deviation Index (Bocking.1984) 
MBEN = mean bending nuclear shape factor (based on smoothed differences in Freeman 
chain code), describing nuclear irregularity. 
= standard deviation of nuclear area 
= mean scatter: variance in pixel values (texture feature) 
= mean HI (Markovian feature: entropy) 
= standard deviation HI 
= mean H3 (Markovian feature: inverse difference moment) 
= mean H5 (Markovian feature: inverse rotation moment) 
= median value in tumor of PASS (nuclear shape factor based on smoothed 
differences in Freeman chain code) 
Reproducibility analysis showed discrepancies for only three of 32 karyometric 
features among three technicians: the same observer scored significantly higher values 
for one feature (MH3) and differences were found for two other features (MAREA, 
MIOD). This resulted in a higher percentage of explained variance due to the 
observers compared to the total variance (2%, 6%, 8% respectively). For the other 
features the explained variance was less than Wo. Comparison with the percentage 
explained by the variation between slides showed that differences between observers 
might be of minor importance: percentages explained by the variation between slides 
SDAREA 
MSCAT 
MH1 
SDH1 
MH3 
MH5 
MEDPASS 
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was 85%, 71%, and 68% respectively for the features (MH3, MAREA, MIOD) and 
78% to 93% for the remaining features. 
Multivariate analysis 
Clinical, pathological and karyometric features were finally tested in a multivariate 
analysis. A selection of features had to be made in order to reduce the number of 
variables in the analysis. Selection was done on base of results from the univariate 
analysis and findings in earlier studies. The selected features were: presence of weight 
reduction, patients sex, Karnofsky score, tumor stage, and the karyometric features: 2c 
deviation index (2cDI), highest mean of BEN and PASS (nuclear shape descriptors) in 
the tumor, and the differences within the tumor between the analyzed areas of the 
following features: standard deviation of nuclear profile area, mean SCAT value per 
area, mean and standard deviation of entropy (Markovian feature 1.), mean of inverse 
difference moment (Markovian feature 3.) and rotation moment (Markovian feature 
4.). 
The difference between tumor areas within the tumor of the chromatin pattern 
descriptor, mean of the inverse difference moment of the co-occurrence matrix 
(Markovian feature 3.) was the best predictor of tumor progression in this model 
(Table 3). Although substitution of one of all other karyometric features, except the 
2cDI in the model resulted in only slightly inferior predictive value. Otherwise, only Τ 
stage showed additional prognostic significance. In the multivariate analysis, sex, age, 
presence of weight loss at the time of diagnosis, histologic tumor type, tumor size, and 
Karnofsky score did not add to prognostic significance. 
Table 3. Multivariate Cox regression analysis of clinical and karyometric features and tumor 
progression. 
Step Beta SBeta Ρ 
1. D MH3' 61.330 19.90 0.002 
2. Tumor stage 1.086 0.492 0.027 
' Differences between populations with highest and lowest values of the inverse difference moment of 
the co-occurrence matrix (Markovian texture feature) within tumor. 
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DISCUSSION 
The presence of multiple morphologically different tumor areas in renal cell 
carcinoma is a known phenomenon. Histological as well as cytological patterns can 
differ widely within a single tumor. In a population of 162 cases Delahunt et al. 
(1987)13 found only 23% with a solely papillary growth pattern. Medeiros et al. (1988)' 
found large intra-tumor variation in cytological patterns whereas Fuhrman et al. 
(1982)7 revealed differences in the level of nuclear atypia. Tumor grading systems for 
RCC often only consider the least differentiated part of the tumor regardless of the 
presence of other tumor parts. In order to obtain a measure for heterogeneity 
comparison of tumor areas is necessary. Visual grading based on cellular and nuclear 
features does not enable quantitative comparison. Since nuclear atypia was correlated 
to cytological cell type'3 and nuclear grading proved a powerful tool for grading RCC7 
we choose quantitative analysis of nuclear phenotype to assess tumor heterogeneity. In 
this approach morphologically different tumor areas are compared. We should bear in 
mind, however, that different cellpopulations in heterogeneous tumors do not 
necessarily grow in separate tumor parts and mixing of populations may occur. 
Therefore we also considered the variation of nuclear phenotype within each tumor 
part. 
Karyometric analysis has been shown to be of prognostic significance. Several 
authors found a positive correlation between morphometric results and survival in 
patients with stage-I disease.2'734 Others found a prognostic discriminant in the nuclear 
size of all RCCs.™ Murphy and associates (1990)2 described a nuclear-shape analysis 
that predicts outcome of a localized carcinoma and might become available for 
clinical use. 
In the present study we found several karyometric features to correlate with 
tumor progression in localized tumors. Again nuclear shape was significantly 
correlated with tumor behaviour. When compared with measures of tumor 
heterogeneity, however, these were the strongest predictors of tumor progression. The 
presence of heterogeneity in nuclear size (anisokaryosis) in the different tumor areas 
was significantly related to tumor progression. The importance of heterogeneity is also 
illustrated by the results of the chromatin-texture analyses: recurrence or progression 
is earlier in patients with a high variance in nuclear chromatin patterns as measured 
by the Markovian texture features in the different tumor areas. 
To obtain features that predict recurrent disease independently, we performed a 
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multivariate analysis. Of the clinical and karyometric characteristics, the features 
describing variance in chromatin pattern within a tumor were significantly correlated 
with the chance of local recurrence or of development of metastatic disease in the 
multivariate model. Of all the other clinical features, only tumor stage yielded 
additional information. 
Although tumor heterogeneity has been described for several tumors and its 
correlation with prognosis has been reported, we can only speculate on the reason for 
the worse prognosis of heterogeneous tumors.™37 A cause of tumor heterogeneity can 
presumably be found in genetic instability in the tumor resulting in development of 
several viable tumor cell populations with increased risk on development of a cell 
population with a more malignant phenotype. 
The presence of large differences in phenotype between populations, as can 
routinely be described by karyometric analysis, could be a useful predictive tool. The 
karyometric features were tested as prognostic factors in a patients population with 
localized RCC (T,^ N0 M0). The chance of local recurrence or development of distant 
metastases in patients with locally confined RCC is 45-65%." Moreover, the prognosis 
of patients with progressive disease after radical tumor nephrectomy for a locally 
confined tumor is very poor: a mortality rate of 74% at 1 year has been recorded.3 
Many clinical trials have studied the role of immunotherapy in patients with 
RCC.29 In patients with metastatic disease, 14-30 % reacted positively to this type of 
therapy."2* Especially patients with good performance status, relatively low tumor 
burden, no central nervous system or bone metastases, and a long interval between 
nephrectomy and appearance of metastases seemed to benefit from 
immunotherapy.30,3' Because patients with a low tumor burden react better to 
immunotherapy, patients with localized disease might benefit from this kind of 
treatment. The karyometric analysis of routinely processed slides can offer additional 
information and may be used to identify patients at risk. In a prospective randomized 
trial testing adjuvant immunotherapy in localized RCC the method will be further 
analyzed as a prognostic tool. 
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ABSTRACT 
The intra-tumor heterogeneity in different locations in the prostate was determined by 
karyometric image analysis and compared with local tumor progression in a 
retrospective analysis of 65 patients with localized adenocarcinoma of the prostate. In 
these 65 radical prostatectomy specimens 290 tumor locations were documented. Of 
each location tumor volume was estimated and Gleason grade determined. 
Quantitative image analysis of nuclear size, shape and chromatin pattern was 
performed. As measures for intra-tumor heterogeneity, differences in Gleason grade 
and karyometric feature values were evaluated. Moreover, of each tumor area the 
location within the prostate was documented. Gleason grade and karyometric features 
varied widely in the prostate. Tumor locations in the apex (n=92) had significantly 
larger and more irregular-shaped nuclei (P < 0.005) compared with basally located 
tumors (n=49). Significant differences in nuclear shape were also found in different 
locations in the equatorial plane of the organ. Tumor heterogeneity in chromatin 
pattern features was found to correlate with local extension (seminal vesical invasion, 
extracapsular tumor growth, positive resection margins) and lymph node metastases. 
This correlation was even stronger in case more pathological features were present. In 
view of the observed tumor heterogeneity, (karyometric) analysis of multiple tumor 
areas in the prostate is advisable for optimal evaluation of prostate carcinoma. 
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INTRODUCTION 
Prostate cancer is the second cause of cancer-related death in males. However, only 1 
of 3 patients with prostate cancer will finally die of the disease.1 The increase in life 
expectancy and the improvement in diagnostic facilities are the main factors 
responsible for an increase in the number of patients diagnosed with prostate cancer. 
More than 50% of the patients have metastatic disease, at the time of diagnosis.2 
Curative treatment modalities for these patients are lacking and prognosis is poor.3 At 
the other end of the malignancy spectrum we encounter tumors confined to the 
prostate. These low-stage cancers can be divided into: latent carcinoma, found at 
postmortem examination; incidental carcinoma, found after resection for benign 
prostatic hyperplasia; and clinical prostate cancer, diagnosed by either digital rectal 
examination, PSA serum test, or ultrasound imaging.4 
It has been postulated that the different types of localized cancer are related to 
their anatomical location within the prostate.' The prostate is composed of three 
zones: the peripheral, central, and transition zone. Tumors originating in the 
peripheral zone would be more readily diagnosed by digital rectal examination, 
whereas, incidental cancer found in transurethral resection material develop in the 
transition zone of the prostate. Recently, Greene et al. (1991)" observed aneuploidy at 
lower cancer volume in peripheral zone cancers compared to transition zone tumors. 
These findings indicate that both the anatomical location and biological differences 
within the prostate may play a role in the malignant potential of localized cancer 
lesions in the prostate. 
The location of the tumor within the prostate also is of influence on the pattern 
of capsular penetration. In the basal part of the prostate the neurovascular bundle 
runs distally through the capsula before entering the prostate, whereas in the apical 
part short branches innervate directly through the capsula. Hence, neural invasion in 
the basal area is only rarely accompanied with positive resection margins, whereas, 
apical invasion of the neural branches more rapidly results in extensive extracapsular 
tumor growth.7 
Which factors may predict the malignant behaviour and development of 
progressive disease in localized prostate cancer after radical prostatectomy? Five-year 
recurrence rates after prostatectomy increase with tumor stage ranging from 0% for 
small incidental cancers (stage Al or Tl) to 8% for stage B2 or T2c cancer.' Seminal 
vesical involvement and capsular penetration negatively influence prognosis.·"10 Tumor 
size was an important predictor of metastases; no metastases were found in tumors 
smaller than 4 cc." In addition to tumor size, grade provides prognostic information.7 
Unfortunately grading of prostate cancer was found to be of low reproducibility.12 
Quantitative interpretation of cell nuclear features by image analysis techniques 
(karyometry) showed correlation of nuclear size and shape with prognosis and 
improved grading reproducibility.13,14 In particular variation of karyometric features 
within the tumor were of predictive value.14 For renal cell carcinoma we applied 
image analysis techniques for quantitative assessment of phenotypic nuclear 
heterogeneity, a possible result of genetic instability. Karyometric features describing 
heterogeneity were important predictors of tumor progression.15 
In the present analysis we studied karyometric features in prostate tumors after 
radical prostatectomy to answer the following questions: 1. Are karyometric tumor 
characteristics related to the location of the tumor in the prostate; 2. What is the 
degree of karyometric heterogeneity in localized prostate cancers; 3. How do 
karyometric features correlate with clinical tumor characteristics. 
MATERIAL AND METHODS 
A retrospective analysis of 65 radical prostatectomy patients with a median follow up 
of 3 years (range 2-11 years) was performed. Clinical and pathological data were 
recorded. For staging the TNM classification was applied10 (Table 1). For clinical 
staging, digital rectal examination, serum PSA level, and transrectal ultrasound were 
used. Each patient was routinely screened using bone scan and CT scan for the 
presence of metastases. 
The prostatectomy material was routinely processed (formalin fixation and 
paraffin embedding). A mean of 11.4 blocks (range 5-23) per prostatectomy specimen 
was available. The prostatectomy material was cut as follows: the apical and basal cap 
were laminated in ventral-dorsal direction; the lobes of the organ were laminated in 
the equatorial plane. Although archival material was used and whole organ mounts 
were not available, determination of location of the tumor was almost always possible, 
since location of each block was documented in the pathology report. In case the 
location of a block was hazardous (n=8) the block was used in the analysis of tumor 
heterogeneity, but excluded for comparison of location. For each case the presence of 
seminal vesical invasion was documented as well as tumor growth outside the prostate 
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Table 1. The TNM-dassUkaüon system for prostate adenocarcinoma.'* 
Tumor extent 
- incidental tumor: 
+ < 5% of resected tissue 
+ > 5% of resected tissue 
- tumor identified by needle biopsy 
- tumor confined within prostate 
+ half a lobe or less 
+ more than half a lobe 
+ both lobes 
- tumor extends through capsula 
+ unilateral 
+ bilateral 
+ invades in seminal vesical 
- tumor fixed to adjacent structures 
+ bladder neck external sphincter 
rectum 
+ levator muscles pelvic wall 
Τ 
la 
lb 
lc 
2a 
2b 
2c 
3a 
3b 
3c 
4a 
4b 
Lymph nodes 
- can not be assessed 
- no lymph nodes 
- one lymph node ( < 2cm) 
- (multiple) node(s) ( 2-Scm ) 
- nodes > Sem 
Metastases 
- can not be assessed 
- no distant metastases 
- distant metastases 
non-reg. lymph nodes 
bone 
other site 
N 
X 
0 
1 
2 
3 
M 
X 
0 
la 
lb 
lc 
capsula. A mean of 8.5 lymph nodes (range 2-21) per prostatectomy was removed and 
histologically examined for metastases. All hematoxylin-stained slides per patient were 
reviewed and each tumor area was marked on the slide and the location in the tumor 
was documented. For location purposes the following division of the prostate was 
made: 1. left or right lobe; 2. apical (caudal 1 cm of prostate), central, or basal part 
(cranial 1 cm of prostate); 3. dorsal, ventral, or lateral; 4. peripheral, transition, or 
central zone. The size of the tumor location was expressed as percent of each block 
and estimation of tumor volume in cc was made using a grid placed over the 
microscopic slide. In the 65 prostatectomy specimens, 290 tumor locations were 
documented (mean 4.5, range 1-15). 
Karyometric analysis 
For karyometric analysis 4 μπι slides were cut adjacent to the hematoxylin stained 
material. Sections were mounted on slides and Feulgen staining was applied: 5 N HCl, 
60 min. and Schiffs reagent 30 min. both at room temperature. The marked tumor 
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areas were copied on the Feulgen-stained slides. The image analysis system consisted 
of a routine light microscope (Axioskop, Zeiss, Oberkochen, Germany) mounted with 
a CCD-videocamera (HCS, Eindhoven, The Netherlands) connected to a 
framegrabber board (VFGplus-AT, Imaging Technology, Woburn, MA, USA) in a 
personal computer (Compaq 386s, 16 MHz, Houston, Tx, USA). The karyometric 
analysis consisted of recording of 50 images per tumor area using manual focussing 
using a 40x objective (NA 0.75). Automaticly the nuclei present in these images were 
segmented and analyzed by the system for 32 nuclear features including nuclear size 
and shape features (morphometry), DNA content analysis (densitometry), and analysis 
of chromatin pattern (texture analysis, Markovian features) (see Table 2 and 3, 
Chapter 1). The original image (512 χ 512 pixels, 8 bits) was corrected for shading by 
subtracting a background image. For smoothing of boundaries an uniform and 
percentile filter were applied on the black-and-white digital image. Segmentation of 
nuclei was performed applying local thresholding procedures (isodata thresholding) 
for optimal correction of local background illumination. After the analysis, the 
segmented nuclei were contoured and numbered in the original images enabling visual 
verification. In this way measurement of artifacts and out-focus nuclei could be 
avoided. The reproducibility of this system was tested earlier and found acceptable.15 
DNA histograms were analyzed using the 2c Deviation Index (2cDI) and the 5c 
Exceeding Rate (5cER) as defined by Boeking." Each histogram was scored as 
Aneuploid, when the main peak was over 2.5c DNA content, or Diploid, when the 
main peak was in range of 1.5 to 2.5c." 
Prognostic groups 
Since the clinical follow up of most cases was too short to allow analysis of 
progression, karyometric features were compared to four known pathological features: 
seminal vesical invasion, extracapsular tumor growth, positive surgical margins, and 
lymph node metastases." Moreover, the patients were grouped as follows: group A: 
none of the above pathologic features present (n=26); group B: one pathologic 
feature present (n=16); group C: two pathologic features (n=14); group D: three 
pathologic features (n=6); group E: all features present (n=3). 
Statistical analysis 
Of all karyometric features mean and coefficient of variation were calculated for the 
analyzed tumor areas. The mean, minimal, and maximal value for the analyzed tumor 
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areas per patient were calculated to obtain measures for intra-tumor heterogeneity of 
nuclear phenotype. In each patient the highest and lowest Gleason grade were 
recorded as well as the distribution in tumor volume of the different tumor areas. For 
comparison of different locations the Student's Mest and the ANOVA test were 
applied. The Mann-Whitney U-test was applied to compare karyometric feature values 
in the different prognostic groups. Comparison of multiple features was done in 
logistic regression analysis using the Statistical Package for the Social Sciences 
software (SPSS/PC+ version 4.0, Chicago, USA). In multiple regression analyses 
logarithmic values of the karyometric features were calculated. 
RESULTS 
Tumor stage and grade 
The distribution of clinical and pathological stage is given in Table 3. Correct clinical 
staging in Tj and T3 tumors (n=53) was obtained in 32 cases (60%), 3 cases (6%) 
were overstaged, and 18 cases (34%) were clinically understaged compared to the 
pathological stage (Table 3). The correlation of grading of the initial needle biopsy, 
when available, and the prostatectomy specimen is given in Table 4. Overall 
agreement in differentiation was found in 26 cases (49%). The biopsy material 
resulted in undergrading in 21 cases (40%) and in overgrading in 6 cases (11%) 
compared to prostatectomy specimen. 
Tabic 2. Comparison of clinica] T-stage and pathological stage in 65 radical prostatectomy specimens. 
Prostatectomies after diagnosis of tumor in TURP material were clinical stage-1 tumors. The actual 
pathological stage of the prostatectomy specimens in these cases (n=9) is presented. Three carcinoma 
were found in prostate materia] of cystectomy specimen and clinically staged Tr 
Pathological stage 
2a 2b 2c 3a 3b 3c 4a total 
clinical stage 
TO 1 1 1 3 
Tl 3 3 1 1 1 9 
T2 7 2 12 6 3 8 38 
T3 3 6 5 1 15 
14 2 16 14 4 14 1 n=65 
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Seminal vesical invasion was found in 17 cases (26%), extracapsular tumor growth in 
28 (43%), positive lymph nodes were found histologically in 8 cases (12%), and 
positive resection margins in 21 cases (32%). Of all tumors, 39 (60%) had at least one 
aneuploid tumor area (Table 5). 
Table 4. Comparison of differentiation of biopsy and the prostatectomy specimen. Biopsy material was 
available in 53 cases. 
Prostatectomy 
WD MD PD total 
Biopsy* 
WD9 9 ( 36% ) 15 ( 60% ) 1 ( 4% ) 25 
MD 4 ( 17% ) 15 ( 63% ) 5 ( 20% ) 24 
PD 2 ( 50% ) 2 ( 50% ) 4 
n=53 
') Overall agreement in differentiation was found in 26 cases (49%). The biopsy material 
undergrade*! the tumor in 21 cases (40%) and overgraded in 6 cases (11%) compared to 
prostatectomy specimen. 
e ) WD = well differentiated; MD = moderately differentiated; PD = poorly differentiated 
Prognostic groups 
The distribution of the pathological features in the five prognostic groups is presented 
in Table 6a. Note that nine of 16 cases with only one prognostic feature present had 
extracapsular tumor growth. On the other hand, most patients with lymph node 
metastases (5 of 8) were scored in prognostic group D and E, indicating that lymph 
node metastases occurred mainly in patients that already had other pathological 
features present (Table 6a). In Table 6b the prognostic groups are compared to the 
pathological tumor stage. Note the heterogeneity of group В (presence of one 
pathological feature) as compared to the overall tumor stage. 
Table 5. Ploidy pattern in 290 tumor areas in 65 radical prostatectomy specimen. 
Gleason grade 
2 3 4 5 η 
Diploid 5 106 66 21 198 
Aneuploid 2 30 31 29 92 
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Karyometric analysis and tumor differentiation. 
Gleason grade and karyometric analyses were available for 290 tumor areas. A 
tendency existed for increase in Gleason grade with estimated tumor volume: Gleason 
grade 2 occurred only in tumors smaller than 1.2 cc (n=7). The location of the tumor 
was not correlated with differentiation (Table 7). In the univariate analysis, the 2cDI 
of the separate tumor locations increased with an increase in Gleason grade per 
location (Figure 1) probably due to a significantly higher percentage of aneuploid 
tumors in the higher Gleason grades (Table 5). 
Table 6a. Distribution of cases in the five prognostic groups (n=6S). 
Sem. ves. Extra Caps. Pos. lymph Pos. resection 
invasion growth nodes margins 
Prognostic group 
A (n=26) 
В (n=16) 
C(n=14) 
D (n=6) 
E (n=3) 
0 
2 
6 
6 
3 
n= = 17 
0 
9 
10 
6 
3 
n= 28 
0 
1 
2 
2 
3 
n=8 
0 
4 
10 
4 
3 
n=21 
Table 6b. Comparison of prognostic group with overall pathological tumor stage. 
Pathological stage 
2a 2b 2c 3a 3b 3c 4a total 
Prognostic group 
A 13 1 11 1 26 
В 1 1 5 5 2 2 16 
С 6 2 6 14 
D 2 4 6 
E 2 1 3 
η=65 
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Figure 1-4. 
1. Correlation of 2cDI with Gleason grade in different tumor locations (n=290); 
2. Correlation of overall tumor differentiation in the 65 prostatectomy specimens with 
variation in 5cER between different tumor locations within the tumor; 
3. Tumors with and without extracapsular tumor growth against heterogeneity in chromatin 
pattern (Markovian feature: DL2); 
4. Tumors with and without seminal vesical invasion against heterogeneity in chromatin 
pattern (Markovian feature: DL2). 
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Overall tumor differentiation in the 65 cases was best predicted by the heterogeneity 
in the percentage of aneuploid cells, as estimated by the variation in 5cER among the 
measured tumor areas (Figure 2). 
Table 7. Distribution of tumor locations in the prostate by Gleason grade of 290 analyzed tumor areas 
in 65 patients. Zonal location could be determined in 277 tumor locations (96%). 
Gleason grade 
2 3 4 5 
Cranial-Caudal locations 
apical 1 49 30 16 
central 3 62 37 24 
basal 3 25 30 10 
n=290 
Dorsal-Ventral locations 
dorsal 2 55 46 20 
lateral 1 21 13 7 
medial 3 50 25 20 
ventral 1 10 13 3 
n=290 
Zonal locations 
peripheral zone 7 124 78 40 
transitional zone . 4 7 2 
central zone . 3 7 5 
n=277 
Karyometric analysis and tumor location 
The ANOVA analysis revealed differences in karyometric features in the apical, 
central, and basal tumor locations (P < 0.05). Hence, we compared the karyometric 
features in the apical and basal tumor locations and found significant differences (P < 
0.05) for five (MMAXD, MFELL, MP ASS, MFPE, MSCAT) (Table 8). The results 
from the karyometric analysis indicated larger and more irregular-shaped nuclei in the 
apical tumor locations compared to basal areas (Table 8). Gleason grade and tumor 
volume for apical and basal tumor locations, however, were not significantly different 
(P > 0.10). Karyometric analysis of non-malignant prostate glands (n=10) adjacent to 
cancer revealed no significant difference in karyometric analysis of basal and apical 
areas. 
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Tabic 8. Mean and Standard Deviation of karyometric features significantly different in apical (n=92) 
veisus basal (n=49) tumors (Student's /-test). Only peripheral zone tumors in both areas were 
compared (n=141). For locations in the equatorial plane 109 tumor locations were compared in 
ANOVA analysis and p-values for significantly different features are shown. 
p-value 
f-test 
0.011 
0.041 
0.005 
0.021 
0.008 
MMAXD® 
MFELL 
MPASS 
MFPE 
MSCAT 
Apical 
(n=92) 
mean ± SD 
8.53 ±1.23 
0.720+0.040 
16.18+1.70 
0.7328±0.017 
6.20+0.67 
Basal 
(n=49) 
mean±SD 
7.99+1.11 
0.734±0.036 
17.01 + 1.49 
0.738±0.013 
6.53+0.73 
Dorsal 
(n=65) 
Lateral 
(n=28) 
Medial 
(n=5) 
Ventral 
(n=ll) 
ANOVA 
F ratio ρ 
MBEN 
MFPE 
MFELL 
MPASS 
1.52±0.14 
0.735±0.016 
0.732±0.036 
16.99+1.66 
1.42±0.12 
0.743+0.012 
0.746+0.033 
17.40±1.63 
1.48+0.07 
0.739±0.008 
0.739+0.022 
16.59+0.72 
1.58±0.19 
0.729+0.014 
0.706+0.036 
16.24+1.23 
4.353 
3.561 
3.457 
4.286 
0.006 
0.017 
0.019 
0.007 
The M at the beginning of a feature name refers to the mean feature value per tumor 
location. 
When tumor locations in the central part of the prostate (n=124) were compared in 
the equatorial plane, several differences were observed. Nuclear shape was found to 
be significantly more irregular in the ventral compared to the dorsal and lateral tumor 
areas as assessed by karyometry (Table 8). 
As far as zonal distribution of prostate cancer was concerned, we found most 
tumor areas located to the peripheral zone (86%) and no karyometric differences 
were found among the three different zones (P > 0.05, ANOVA test). 
Karyometric analysis and local tumor extent 
To study the relation of karyometric features with tumor stage we calculated for each 
case (n=65) the maximal, minimal, and mean value for all karyometric features as 
well as the Gleason grade per tumor area. Seminal vesical invasion and extracapsular 
tumor growth were correlated with several pathological and karyometric features. 
Decreased differentiation was accompanied with an increased risk of seminal vesical 
invasion and extracapsular tumor growth as was the heterogeneity in tumor grade as 
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Table 9. Differences between tumors with and without the presence of pathological progression 
markers (seminal vesical invasion, extracapsular tumor growth, positive resection margins, and lymph 
node metastases) by differentiation and heterogeneity in Gleason grade within the tumor (n=65). 
Sem. ves. Extra Caps. Pos. lymph Pos. resection 
invasion tumor growth nodes margins 
No Yes No Yes No Yes No Yes 
Differentiation 
WD 
MD 
PD 
Heterogeneity in 
no difference 
difference = 1 
difference = 2 
15 2 
29 10 
4 5 
Gleason grade1 
26 6 
18 6 
4 5 
14 
19 
4 
22 
11 
4 
3 
20 
5 
10 
13 
5 
15 
35 
7 
31 
19 
7 
2 
4 
2 
1 
5 
2 
14 
27 
3 
25 
14 
5 
3 
12 
6 
7 
10 
4 
4) Difference in Gleason grades between tumor area with highest and lowest Gleason grade. 
expressed by the largest difference in Gleason grade found between different tumor 
areas (Table 9). 
The presence of lymph node metastases was not related to the differentiation of 
the initial tumor (Table 9). It should be noted that only a low number (n=8) of 
patients with positive lymph nodes was present, since, in general, no prostatectomy is 
performed in patients with positive cryosections of lymph node material during 
operation. In the patients where prostatectomy was performed with lymph node 
metastases this was done either because only a very small amount of tumor cells was 
present in the lymph node biopsies (n=3) or the lymph node metastases were only 
detected post-operatively, in the total resection preparation (n=5) . Tumor volume was 
significantly higher in patients with extracapsular tumor growth (P < 0.05, Mann-
Whitney U-test) and seminal vesical invasion (P < 0.005, Mann-Whitney U-test). 
Although a tendency existed towards higher tumor volume in patients with positive 
lymph nodes, this was not significant (P > 0.10). Several karyometric features were 
correlated with the presence of extracapsular tumor growth. The heterogeneity in 
chromatin texture (Markovian texture feature L2) was significantly higher in tumors 
growing through the prostate capsula (Ρ = 0.0047) (Figure 3) and invading the 
seminal vesículas (Ρ = 0.0008) (Figure 4). In a multivariate regression analysis, this 
was independent of tumor volume and heterogeneity in Gleason grade. The presence 
of positive margins at the bladder resection area was significantly correlated with 
irregular nuclear shapes (P = 0.021) (Figure 5) and nuclear polymorphism (P = 
0.0076) (Figure 6). 
Correlating the five prognostic groups with the karyometric analysis and 
pathological findings in a multiple regression analysis again the heterogeneity in 
chromatin patterns within the tumor, as described by DL2 was selected as best 
predictive feature (Figure 7). 
ζ a 
< 
2 
No Yes 
Positive resection margins 
2 
Ш 
η 
Q 
No Yes 
Positive resection margins 
-1 
Q 
А В 7 Г ί> È 
Prognostic group 
Figure 5-7. 
5. Tumors with and without positive resection margins against maximal value of BEN 
(MAMBEN) (nuclear shape feature higher values represent more irregular shaped nuclei); 
6. Tumors with and without positive resection margins against heterogeneity in nuclear shape 
(BEN); 
7. Correlation of heterogeneity in chromatin pattern (DL2) with an increase in number of 
pathology prognostic markers (prognostic group). 
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DISCUSSION 
The site of origin of the tumor in the prostate may influence tumor phenotype* and 
clinical behaviour.19 Hence, we studied pathological and karyometric features in 
different tumor locations within the prostate. 
Radical prostatectomy is often applied as treatment for localized prostate 
cancers.20 Five year survival for these patients is 75-85% and comparable to an age-
matched population.21 The actuarial rate for the development of distant metastases in 
localized disease after five years is 7%." These data indicate that local radical therapy 
although effective for most localized tumors will still be insufficient to control later 
development of distant metastases in a small number of patients. Besides metastasis, 
local recurrences threaten the patients' health. Unlike development of metastases, 
local recurrences can be reduced by radical local treatment.' In non-surgically treated 
patients local progression rates up to 84% at five years have been reported,2224 
whereas radical surgery reduced this figure to 2-10% in organ-confined and 8-23% in 
extracapsular disease.** 
The short follow up of patients in our population made progression and survival 
analysis hazardous.25 Hence, seminal vesical invasion, tumor growth through the 
capsula, positive resection margins, and lymph node metastases were chosen as 
pathological prognostic markers, since these features were previously found to 
correlate with prognosis." 
Capsular penetration and seminal vesical involvement in radical prostatectomy 
specimens were accompanied with an increased risk of local recurrence (8-23%)"° and 
distant metastasis (30%)e at five year follow up, compared to tumors confined to the 
prostate (0-10% local recurrence and 1% distant metastases).8' Besides local extent of 
the tumor, grade was of value mainly when used in combination with tumor volume.7,2" 
Recent studies indicate that grade alone can be sufficient to predict progression. To 
circumvent the subjectivity of visual tumor grading, several quantitative techniques 
have been applied. Flow cytometry,2527 tissue PSA levels,2" and proliferation rates29 
could be used to separate prognostic groups but for the individual patient predictive 
value was doubtful. The finding of nuclear shape analysis as a prognostic marker is 
ambiguous. Nuclear roundness factor (NRF) was found by some to be of prognostic 
value.13-30,31 But patient populations were small, what may account for the fact that in 
larger populations no predictive value of NRF was found."14 In combination with 
DNA content and Gleason grade nuclear shape was not useful to predict local tumor 
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extent." 
When analyzing tumor material, heterogeneity within the tumor should be taken 
into account101' and may have prognostic value."33 The frequent discrepancy in 
differentiation grade between biopsy and prostatectomy material found in the present 
study is in accordance with the data in the literature'0 and is probably due to intra-
tumor variation. The recently proposed prognostic factor, based, among other clinical 
features, on the variation of nuclear shape, confirms the importance of intra-tumor 
heterogeneity.30 Blom et al. (1990)" found variation in nuclear size of predictive value 
for survival. Both Partin30 and Blom,14 however, did not discriminate the locations of 
the different tumor areas in the prostate. This becomes particularly important 
regarding the anatomy of this organ.34 Since capsular penetration occurs along nerve 
branches innervating the prostate postero-laterally, transition zone tumors, 
predominantly found in tissue removed for transurethral resection, are less frequently 
accompanied with growth outside the capsula and in general have a more favorable 
prognosis.3,35·™ Moreover, there is reason to belief that besides anatomical differences, 
biological differences exist between peripheral and transition zone cancer. In 30 
patients with stage-Α or В disease, non-diploid tumor areas were found at lower 
tumor volume in nontransition compared to transition zone located tumors.' Likewise 
Greene et al. (1991)" we found aneuploid tumors located to the transition zone to be 
larger compared to peripheral zone cancers. However, the group of transition zone 
tumors was small and was overall of larger volume. This suggests that in our 
population the transition zone cancers represented a more progressed type of cancer 
compared to those transition zone tumors studied by Greene et al. (1991)." 
Differences in innervation pattern, possibly accounting for variation in capsular 
penetration patterns between peripheral and transition zone tumors also apply for 
basal and apical parts of the prostate.7 The short distance of the apical innervation 
plexus through the capsula causes earlier capsular tumor outgrowth in this part of the 
prostate compared to more basally located tumors.7 Moreover, cancer found in 
prostates removed with radical cystectomy were predominantly located to the apex of 
the organ. The karyometric analysis of apical and basal tumor locations in the present 
study, revealed more irregular-shaped and larger nuclei in the locations in the apex. 
Tissue processing is probably not the reason for this finding, because normal prostate 
gland, adjacent to cancer, did not exhibit the karyometric differences. Since several 
studies found correlation of nuclear size14 and shape1331 with prognosis, it is tempting 
to speculate that tumors located towards the apex may comprise a more aggressive 
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type. Although, this was not significant in our analysis the volume of tumors with 
positive margins at the apical resection area tended to be smaller than tumors 
invading the resection site at the bladder. It is of interest, however, that tumors 
invading the apical resection margin were significantly less heterogeneous in nuclear 
phenotype and had less irregular-shaped nuclei compared to cancers present in the 
bladder resection margin. 
Besides differences in the basal-apical location of prostate cancer, nuclear shape 
values also varied in different locations in the equatorial plane of the prostate. Hence, 
prognostic value of nuclear shape, as indicated in some studies'3,3'·3* may represent 
differences in tumor location within the prostate. Follow up data, in fact, are required 
to study this hypothesis. Nevertheless, these findings illustrate the need for the analysis 
of multiple tumor areas. 
When the pathology prognostic markers were related to the karyometric 
findings, it became evident that several karyometric features correlated with more 
progressive tumor growth, independent of tumor location. Seminal vesical invasion 
and extracapsular tumor growth were both more common in heterogeneous tumors as 
described by variation in chromatin pattern between different tumor locations within 
the prostate. Karyometric heterogeneity was positively correlated with tumor volume, 
an important prognostic feature. In the logistic regression analysis, however, the 
karyometric analysis of nuclear heterogeneity was the most predictive characteristic 
for seminal vesical invasion and extracapsular tumor growth. In cancer not confined to 
the surgical specimen, the maximal value for nuclear shape irregularities (BEN) 
present in the different tumor locations was significantly higher than in tumors 
confined to the prostate. Heterogeneity of nuclear shape, however, within the tumor is 
considerable. Remarkably, variation in nuclear shape was the most powerful predictor 
of the presence of tumor in the surgical margins. In a logistic regression analysis, 79% 
of all cases was correctly classified in organ-confined or extra-prostatic disease based 
on the heterogeneity in chromatin pattern (Markovian feature L2) and the tumor 
volume. 
When studying combinations of prognostic features it became apparent that 
capsular penetration was a relatively early event in cancer progression since most 
cases were found without one of the other markers present. With an increase in the 
number of positive markers, tumor heterogeneity in nuclear phenotype increased. 
The findings of the present study confirm that nuclear shape irregularities are 
correlated with more progressed localized disease in prostate cancer. Analysis of 
different tumor locations, however, revealed considerable intra-tumor variation. In 
particular tumors located to the apex showed increased nuclear shape irregularities. 
Whether this has prognostic implications remains unclear. Heterogeneity in 
karyometric features was overall the best predictor of local progression, independent 
of tumor volume. 
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SUMMARY 
The biology of tumors can be considered as a continuum ranging from low to high 
malignant potential. Although the extremes in this spectrum can be defined, for the 
vast majority of tumors no objective prognostic markers exist. Tumor stage and grade 
are now generally applied to predict the course of disease and select the most 
appropriate treatment in patients with urological cancer. In the molecular biology 
field, several genes have been liked to tumor behavior. The phenotypical tumor 
characteristics assessed in tumor grading, still provide important information on tumor 
malignancy. Unfortunately, low reproducibility and the lack of quantitative tumor 
markers render visual tumor grading less consistent. Hence, the cellular and nuclear 
features, used in the tumor grading criteria, have been quantified by image analysis 
techniques. In this thesis an outline is given of the available quantitative light 
microscopic analyses for the grading of urological cancers. Besides, our studies on the 
quantitative grading of bladder, renal cell, and prostate cancer are presented. 
The Introduction (pp 9 - 56) gives an overview of the grading systems applied 
for prostate adenocarcinoma (prostate cancer), urothelial cell carcinoma (urinary 
bladder cancer), and renal cell carcinoma (kidney cancer). Furthermore, the available 
quantitative light microscopic techniques are described and the advantages and 
disadvantage are discussed. For each urological tumor the useful quantitative features 
are summed for tumor grading. Several conclusion are drawn after reviewing the 
literature: 
1. Most studies comprise an analysis in research settings, where conditions are often 
standardized. Conclusions derived can not always directly be applied on routine 
practice. 
2. Consequently, we consider standardization of preparation and image analysis 
routines of utmost importance. 
3. Overviewing the literature several important features should be tested on their 
clinical applicability considering the results from research studies. For prostate cancer 
nuclear DNA content and possibly nuclear shape could be of additional value to 
routinely used tumor markers. Bladder cancer grading and especially follow up could 
be supported using DNA analysis of histological biopsies and quantitative analysis of 
(bladder washing) cytology. For renal cancer the yet routinely applicable methods are 
considered to be rare and more research oriented study is needed. 
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4. Further study on the use of quantitative light microscopy should include the 
following elements 
- Clinical integration should be pursued for several features (see under 3). 
- The logistic elements of such applications need further investigation. 
- New approaches to quantitative grading should include tumor heterogeneity. 
In the first chapter (pp 57 - 88) we describe the work on the quantitative grading of 
bladder cancer in both cytological and histological material. The optimal cytological 
preparation method is determined for nuclear size analysis and it is concluded that 
nuclear profile area in cytology can be useful for the grading of bladder cancer. In the 
second study we applied multivariate analysis for the grading of bladder cancer in 
histological plastic-embedded material. Its was concluded that multiple features could 
be more useful for tumor grading than nuclear profile area alone. 
The second chapter (pp 89 - 105) describes the factors influencing reproducibility of 
quantitative analyses. In case of analysis of only small parts of the material, e.g. 50 
nuclei, random selection of nuclei resulted in both low reproducibility and low 
correlation with tumor grade, whereas the application of selection criteria gave more 
consistent results. It should be beared in mind, however, that these criteria again 
introduce a subjective element in an initially objective intended analysis. Hence, in the 
second part of this chapter we report on the reproducibility of quantitative analysis of 
bladder washing material. Since more advanced image analysis techniques were 
available at this time we choose to trade the selection criteria for an increase in the 
number of analyzed nuclei. In the latter setup both reproducibility and correlation 
with clinical data was acceptable. 
In the third chapter (pp 107 - 120) we applied a quantitative grading method in 
recurrent bladder cancer. Histological material from both the primary and first 
superficial tumor recurrence were karyometrically analyzed. The visual grading of 
neither the primary tumors nor the recurrences was useful for prediction of tumor 
progression during follow up. The karyometric features of the recurrent tumors, 
however, were useful for prediction of tumor progression, whereas the analysis of the 
primary tumor did not result in adequate prediction. It was concluded that 
karyometric features offer information beyond tumor grade. Moreover, karyometric 
analysis provided information on progressive changes in superficial cancer over time, 
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not detected by visual tumor grading but already indicative of later tumor progression. 
A routine application of karyometric analysis is discussed in the fourth chapter (pp 
121 - 138). In a pilot study two karyometric features were found useful for the 
prediction of presence of tumor in the bladder based on bladder washing material. 
The features also proved to correlate with tumor grade. To evaluate the routine 
applicability of a grading based on these features 1336 samples in five urological 
institutes were obtained and send to our laboratory. Karyometric analysis resulted in 
90% sensitivity and 70% specificity for the detection of tumor. All carcinoma in situ 
cases could be detected. Moreover, the karyometric analysis correlated with clinical 
follow up in 787 patients indicating that the analysis provides early recognition of 
patients with potentially progressive cancer phenotypes using bladder washing. 
The value of quantitative light microscopy in renal cancer is discussed in the fifth 
chapter (pp 139 - 154). Histological material of 121 patients is quantitatively analyzed 
with special reference to tumor heterogeneity. In a Cox multivariate analysis including 
both clinical, pathological, and karyometric features tumor stage appeared to be the 
most important prognostic factor. Karyometric features showed to have additional 
prognostic information. In particular, increased heterogeneity in nuclear size and 
chromatin patterns in different areas of the tumor were indicative of more malignant 
potential of the tumor. 
In the sixth chapter (pp 155 - 167) we applied the karyometric approach described in 
chapter five for the prediction of tumor progression in patients with an initially low-
stage renal tumor. Since no detectable metastases are present in these patients at 
time of diagnosis radical tumor nephrectomy would principally eradicate the disease. 
Heterogeneity in chromatin texture as assessed by analysis of several tumor areas was 
the best predictor of later tumor progression in a multivariate Cox analysis. 
The seventh chapter (pp 169 - 187) describes the use of karyometric analysis in 
prostate cancer. Karyometric analysis was correlated to several clinical features and 
so-called pathological progression markers (seminal vesical invasion, extracapsular 
tumor growth, positive resection margins, and lymph node metastases). Nuclear shape 
irregularities, earlier found to be a bad prognostic indicator, were more pronounced in 
tumors located to the apex of the organ. Heterogeneity in karyometric features 
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(chromatin pattern, DNA content, and nuclear shape) was significantly more abundant 
in cancers not confined to the prostate compared to organ-confined disease. This was 
independent of tumor volume, an important prognostic marker. 
The studies in this thesis comprise the application of quantitative light microscopy in 
research as well as clinical settings in urological oncology. As such, the technique can 
be supportive in the routine clinical diagnosis of bladder wash cytology and renal cell 
cancer. For prostate adenocarcinoma the data are merely of scientific relevance. 
Future analysis of prostate biopsy material may be a field of application. 
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SAMENVATTING 
De maligniteli van tumoren kan beschouwd worden als een continuum, variërend van 
laag naar hooggradig kwaadaardig. Alhoewel de uitersten in dit spectrum vaak te 
definieren zijn, bestaan er geen duidelijke objectieve prognostische factoren voor het 
meerendeel van de tumoren. Tumor graad en stadiering zijn in de klinische praktijk 
de meest belangrijke factoren en bepalend voor de therapie keuze. Recent moleculair 
biologisch onderzoek toonde een verband tussen bepaalde genen en tumorgedrag. 
Phenotypische tumor karakteristieken worden echter alom gehanteerd in tumor 
gradering. De lage reproduceerbaarheid en de onmogelijkheid van quantificering 
maken tumor gradering minder aantrekkelijk. Beeldanalyse van cel en celkern 
kenmerken in licht-microscopische beelden maakt objectivering van tumorgradering 
mogelijk. In dit proefschrift wordt een review gegeven van de literatuur op het gebied 
van de quantitatieve gradering van urologische tumoren middels karyometrie (de 
quantificering van celkern kenmerken). Tevens worden enkele studies van de 
quantitatieve gradering van blaas, nier, en prostaat kanker beschreven. 
De introductie (pp 9 - 56) geeft een overzicht van de visuele graderings criteria 
voor de gradering van prostaat, blaas en nier tumoren. Bovendien worden de 
beschikbare parameters en de voor- en nadelen van quantitatieve licht-microscopie 
beschreven. Na review van de tot nu toe gepubliceerde studies leidde tot enkele 
conclusies: 
1. De meeste studies omvatten patiënten populaties en technieken in onderzoeks 
opstellingen. De gebruikte technieken waren echter niet gelijk in iedere studie 
waardoor vergelijking van resultaten niet altijd mogelijk is. 
2. Standardisatie van materiaal bewerkingen en metingen is een eerste vereiste voor 
een implementatie van beeldanalyse in de klinische praktijk. 
3. Uit de studies bleken enkele parameters van nut en dienen deze te worden 
geïntegreerd in verdere studies. Bij prostaat tumoren waren DNA-inhoud en mogelijk 
celkern vorm parameters met prognostische waarde. Blaas tumor gradering en met 
name de follow-up van patiënten met blaas kanker kan worden ondersteunt met 
DNA-histogram analyse in bijvoorbeeld (blaasspoeling) cytologie materiaal. 
Onderzoek naar quantitatieve licht-microscopie van niercel tumoren heeft nog niet 
geleid tot een evident klinisch voordeel van deze techniek. Wel bestaat er correlatie 
tussen enkele parameters en tumor gradering. 
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4. Verder study naar quantitatieve licht-microscopische parameters in urologische 
oncologie dient de volgende dementen te bevatten: 
- Klinische integratie van de gevonden parameters. 
- De logistieke elementen behoeven nadere analyse. 
- Tumor heterogeniteit dient geïmplementeerd in de analyse. 
In het eerste hoofdstuk (pp 57 - 88) worden de studies beschreven naar de 
quantitatieve gradering van cytologisch en histologisch materiaal van urotheelcel 
tumoren van de blaas. De optimale cytologische preparatie techniek werd bestudeerd 
en celkern oppervlakte in cytologisch materiaal was een goede maat voor visuele 
tumor graad. In een tweede studie in dit hoofdstuk werd plastic ingebed weefsel 
gebruikt voor de quantitatieve gradering van blaastumoren. Combinatie van meerdere 
parameters resulteerde in een betere correlatie gradering met visuele tumor graad. 
Het tweede hoofdstuk (pp 89 - 105) beschrijft de factoren van invloed op de 
reproduceerbaarheid van quantitatieve analyses. Analyse van slechts een klein aantal 
willekeurig geanalyseerde celkernen (50) per sample resulteerde in een lage 
reproduceerbaarheid en lage correlatie waarden tussen kerngrootte en visuele tumor 
graad. Na gebruik van selectie criteria verbeterde zowel de reproduceerbaarheid als 
de voorspelling van tumor graad. Wel dient hier vermeld dat het hanteren van selectie 
criteria een subjectief element in de analyse betekend in een in opzet objectieve 
gradering. Vandaar dat in de tweede studie in dit hoofdstuk een groter aantal 
celkernen werd geanalyseerd per sample. De analyse van 100 of meer celkernen in 
blaasspoelingen resulteerde in acceptabele reproduceerbaarheid en goede correlatie 
met histologische tumor graad. 
In het derde hoofdstuk (pp 107 - 120) wordt de toepassing van quantitatieve licht-
microscopie in recidiverend oppervlakkig urotheelcel carcinoom beschreven. 
Histologisch materiaal van zowel de primaire als de eerste recidiverende tumor 
werden karyometrisch onderzocht. Visuele gradering, noch van de primaire tumor, 
noch van de recidief tumor verspelden het optreden van latere tumor progressie. The 
karyometrische parameters van de recidiverende tumor waren echter voorspellend 
voor het optreden van tumor progressie. Wij concludeerden dat karyometrische 
analyse een betere prognostische factor is dan tumor graad. Voor de voorspelling van 
tumor progressie is nauwkeurige follow-up van recidief tumor echter noodzakelijk. 
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Een routinematige toepassing van karyometrische analyse wordt beschreven in het 
vierde hoofdstuk (pp 121 - 138). In een kleine pilot studie worden twee 
karyometrische parameters gevonden voor voorspelling van tumor in de blaas aan de 
hand van analyse van blaasspoelings materiaal. Tevens zijn deze parameters bruikbaar 
voor de gradering van de tumor. In een grote populatie van 1336 blaasspoeling 
samples, verzameld in vijf urologische klinieken worden de gevonden parameters 
getest. De sensitiviteit van de karyometrische test was 90% terwijl een specificiteit van 
70% gevonden wordt. De lage specificiteit wordt mede verklaard door de hoge 
predictieve waarde voor tumor recidieven. Van alle tumor recidieven had 86% een 
afwijkende karyometrische score in het sample voor het tumor recidief. Tevens 
werden in deze studie de logistieke aspecten van routinematige karyometrische 
analyse bestudeerd. 
De resultaten van deze studie impliceren dat de voorgestelde sample versturing en 
karyometrische analyse een routinematig toepasbare, methode van follow-up van 
patiënten met een oppervlakkig blaas carcinoom. 
Karyometrische analyse van niercel tumoren is beschreven in het vijfde hoofdstuk (pp 
139 - 154). Histologisch materiaal van 121 patiënten werd geanalyseerd met speciale 
aandacht voor tumor heterogeniteit. In een Cox multivariate analyse, waarin klinische, 
pathologische en karyometrische parameters gezamenlijk werden geanalyseerd bleek 
de karyometrische analyse additionele waarde te hebben voor de voorspelling van 
overleving. Met name karyometrische parameters die heterogeniteit in celkern grootte 
en chromatine patroon beschreven waren van prognostische waarde. 
In het zesde hoofdstuk (pp 155 - 167) werd karyometrische analyse gebruikt voor de 
voorspelling van tumor progressie in patiënten met gelocaliseerd niercel carcinoom 
die middels tumor-nefrectomie in opzet curatief werden behandeld. Veertig procent 
van de patiënten ontwikkelde tumor progressie tijdens follow-up. Tumor 
heterogeniteit zoals geobjectiveerd middels karyometrie was de meest belangrijke 
prognostische factor in deze populatie. 
Het zevende hoofdstuk (pp 169 - 187) beschijft het gebruik van karyometrie in de 
analyse van verschillende tumor locaties in prostaat adenocarcinoom. Karyometrische 
parameters bleken gecorreleerd te zijn met verschillende pathologische kenmerken 
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van tumor progressie (vesícula seminalis ingroei, extracapsulaire tumor groei, tumor in 
het resectievlak en lymfklier metastasen). Celkern vorm onregelmatigheden waren 
meer frequent aanwezig in tumors gelocaliseerd in de apex van de prostaat. Wederom 
bleek heterogeniteit in karyometrisch analyse een belangrijke factor samenhangend 
met extracapsulaire tumor groei. Dit bleek onafhankelijk van de tumor gradering en 
tumor grootte. 
De studies in dit proefschrift toonden aan dat karyometrische analyse informatie 
verschaft over urologische tumoren die additioneel is aan de visuele tumor graderings 
systemen. Bovendien kan de techniek inzicht geven in het groei verloop van tumoren. 
Gezien de toegenomen ontwikkelingen op het gebied van de beeldanalyse apparatuur 
vormt de methode een routinematig bruikbare ondersteuning van de klinische en 
patholoog-anatomische beslisneming in de uro-oncologie. 
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Stellingen behorende bij het Proefschrift 
QUANTITATIVE LIGHT MICROSCOPY IN UROLOGIC ONCOLOGY 
Quantitatieve interpretatie van objecten in licht-microscopische beelden ondersteunt, 
meer dan vervangt, de opinie van de patholoog-anatoom. 
Het groot aantal criteria in de visuele licht-microscopische gradering van tumoren 
verminderd de reproduceerbaarheid van deze methode. 
Zolang evidente basale oorzakelijke factoren van kanker onbekend zijn is iedere 
gradering slechts te baseren op empirisch gevonden 'tekenen' van maligniteit. 
Quantitatieve licht-microscopie vormt een bruikbare methodiek voor de objectivering 
van phenotypische heterogeniteit van tumoren. 
Standardisering van materiaal verwerkingsmethoden en beeld analyse technieken is 
een eerste vereiste voor de routinematige toepassing van karyometrische analyse. 
Prognose voor kanker patiënten is afhankelijk van drie factoren: 'the response of the 
patient, the commissions and omissions of the physician, and the potentialities of the 
neoplasm'. 
(Mostofi, Cancer Chemother. Rep., 59: 111, 1975) 
Tumor heterogeniteit is een belangrijke prognostische factor bij het niercelcarcinoom. 
De anatomische locatie van maligne ontaarde cellen binnen de prostaat is van 
prognostische betekenis. 
De vaak iets geringschattende houding ten aanzien van vroeger wetenschappelijk 
onderzoek zou een positieve bijdrage aan het relativerend wetenschappelijk 
bewustzijn kunnen vormen. 
De steeds verdere etherdilutie in de vorm van een toenemend getal in televisie 
zendkanalen doet een homeopathische grondgedachte vermoeden. 
Zwaartekracht kan worden opgevat als de oppervlakte spanning van de aarde: het 
verlaagd bergen en doet diepten dichtslippen. 
Een basisinkomen als maatschappelijke vluchtstrook vergemakkelijkt het invoegen 
maar verminderd niet de kans op panne. 
Het houden van vee en kweken van gewassen zijn sinds mensenheugenis geaccep-
teerde vormen van indirecte genetische manipulatie. 
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